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Abstract 
Background and purpose: Isodense swelling is a known early ischaemic 
change, and it is most likely to represent penumbra tissue on acute non-contrast 
computed tomography (NCCT) scan. However, in general,  its detection by 
observers showed very poor interobserver agreement, which has been attributed 
to a lack of defining criteria that differentiate it from hypodensity. The aim of 
this study is to assess the reliability of detecting isodense swelling within the 
first six hours post stroke onset.  
Methods: A three-stage study was designed to test the effect of defining 
criteria and training on the reliability of detection of isodense swelling on acute 
NCCT. NCCT and perfusion computed tomography (PCT) scans of patients with 
acute stroke of less than six hours’ duration were reviewed retrospectively. A 
web-based tool was used to present NCCT scans to readers of different 
backgrounds (expert and trainee stroke neurologists and neuroradiologists), who 
evaluated the scans independently by the Alberta Stroke Program Early CT Score 
(ASPECTS). In the pre-training stage, nine readers assessed 19 repeated scans (a 
total of 40 scans) obtained at different slice thicknesses (0.9 mm and 5 mm) and 
both with and without clinical information. In the consensus stage, definitions 
for isodense swelling and hypodensity were extracted from simultaneous analysis 
of NCCT and PCT scans used in the pre-training stage, and potential definitions 
were circulated to participants for agreement. In the post-training stage, 11 
readers assessed 32 scans (5 mm slice thickness) with clinical data after training 
using the consensus definitions and reviewing examples. Cerebral blood volume 
(CBV), cerebral blood flow (CBF) and mean transient time (MTT) in each ASPECTS 
region on all PCT scans were calculated and compared across the three NCCT 
appearances (normal, hypodense or isodense swelling, and the fate of each 
ASPECTS region was determined on follow-up NCCT scans.  
Results: Training increased detection of isodense swelling from 29.4% to 
46.8%; significantly (P = 0.0001) improved interobserver agreement from very 
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poor (k = 0.09) to fair (k = 0.30); and ameliorated the predictive power of 
isodense swelling for penumbra as classified by ASPECTS regions of interest 
(ROIs) from [sensitivity 9% (confidence interval (CI): 1.9%–24.3%); likelihood 
ratios positive and negative, 2.5 (CI: 0.6–10) and 0.95 (CI: 0.84–1.06), 
respectively] to [sensitivity 41% (CI: 30.3%–52.8%); likelihood ratios positive and 
negative, 5.5 (CI: 3.3–11) and 0.64 (CI: 0.53–0.77), respectively]. Detection of 
hypodensity did not change significantly with training. Exclusion of outliers 
improved interobserver agreement for isodense swelling to moderate (k = 0.50). 
Experience, speciality and clinical information had no significant effect on 
agreement; however, 5 mm slices increased interobserver agreement on 
hypodensity significantly (k = 0.34 to k = 0.46, P = 0.01). Intraobserver 
agreement on both hypodensity and isodense swelling was almost perfect. 
Hypodensity had low sensitivity for core (41.6% (CI: 33% - 50.7%)) but good 
likelihood ratios positive and negative (13.7 (CI: 7.5–24.8) and 0.6 (CI: 0.50–
0.70), respectively). Both isodense swelling and hypodensity were highly specific 
(93.8% and 96.9% for penumbra and core, respectively). CBV was increased 
significantly in isodense swollen areas compared with hypodense areas (P < 
0.05). Only 38.3% of isodense swollen ROIs ended in infarction and absence of 
recanalisation increased odds of infarction four-fold, whereas 90% of hypodense 
ROIs infarcted with odds of infarction 11 times greater than those of ROIs with 
isodense swelling.  
Conclusion: Penumbral tissue in acute stroke patients appears on NCCT as 
isodense swollen areas that are distinguishable from hypodense regions’ 
appearance. The detection of penumbral tissue can be improved significantly by 
training. Isodense swelling most frequently returns normal, particularly in 
evident recanalisation, and its prognostic value might differ from that of 
hypodensity.  
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Aims  of chapters I and II; 
1- Introducing general idea on stroke as a disease. 
 
2- Discussion of pathophysiology of brain ischaemia and evolution of the 
concept of penumbra( the salvageable tissue). 
 
 
3- Giving general idea on thrombolytic therapy. 
 
4- Approaching the early signs of acute ischaemia on non-contrast computed 
tomography scan (NCCT), their terminology, importance, detection and 
measurement. 
 
 
5- Reviewing the previous studies on observer agreement on early signs of 
ischaemia in NCCT and comparison of the ways were used to report the 
final results. 
 
6- Shedding light on the multimodal approach of acute ischaemic stroke. 
 
  
7- Contrasting the role of CT in approaching patients with acute stroke with 
the role of other imaging techniques, particularly, magnetic resonance 
imaging MRI. 
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Chapter I: Introduction 
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1.1 Definition and epidemiology of stroke. 
Stroke is defined by The World Health Organization as a rapidly developing 
focal (or global) brain dysfunction of vascular origin lasting more than 24 hours, 
thus including ischemic stroke, subarachnoid haemorrhage, intracerebral 
haemorrhage and cerebral venous thrombosis(1). It is the fourth most common 
cause of adult disability, the second highest cause of death worldwide(2) and 
the third highest cause of death in western world(3). Most studies of stroke 
epidemiology originate from the developed world, although over two thirds of 
strokes are thought to occur in developing countries(4). Ischemic stroke is by far 
the most common type of stroke, constituting around 80% of all strokes, of which 
60% are attributable to large-artery ischemia[ ischaemia of main arteries and 
their branches and non-small vessel disease ischaemia] (1). According to 
Framingham’s study, the frequency of different types of acute cerebrovascular 
disease were 60% caused by atherothrombotic brain infarction, 25.1% by cerebral 
emboli, 5.4% by subarachnoid haemorrhage, 8.3% by intracerebral haemorrhage 
and 1.2% by undefined disease(5). 
1.2 Types of stroke. 
1- Ischemic strokes 
These constitute the majority of strokes. Thrombosis and embolism of 
cerebral arteries are the predominant cause. Less common causes include: 
severe hypotension, which is responsible for “hypotensive stroke”; vasospasm, 
which follows subarachnoid haemorrhage; arthritis, such as in giant cell arthritis; 
and chronic subacute infections, such as tuberculosis. 
2- Haemorrhagic strokes  
These are closely related to hypertension as a classical aetiology but can 
rarely be caused by other pathologies, such as small vessel malformations.  
Intracerebral bleeding can occur anywhere in the brain, but mainly in deep 
penetrating vessels.  
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1.3 Risk factors 
There are a number of factors which predispose a particular person to 
developing stroke. These include(6);  
A) General risk factors: these include age, gender, race, familial clustering, 
cigarette smoking, drug and alcohol abuse, being overweight and inactivity. 
B) Specific risk factors  
        1- Hypertension; this is the most common precursor of cerebral 
infarction with increased risk with high systolic and diastolic values, although 
even alone an elevated systolic pressure is highly predictive of stroke. 
        2- Heart disease; this is the second most powerful risk factor after 
hypertension. Cardiac arrhythmia can cause embolic stroke. Atrial fibrillation is 
a well-known cause. 
        3- Previous stroke; this increases the risk of recurrent strokes many 
times. 
        4- Transient ischemic attacks; these are defined as a neurological deficit 
similar to that caused by stroke, but which resolves completely within 24 hours 
of onset. They are caused predominantly by small emboli. Intracerebral bleeding 
might also be a cause occasionally. Whether it is associated with focal or non-
focal symptoms, it carries a high risk of development into stroke(7). 
        5- Carotid artery disease; atherosclerosis leads to stenosis and 
subsequent reduction of cerebral blood flow, which increases the risk of 
ischemic injury. Atheromatous plaques also work as a source of emboli. 
        6- Hypercholesteremia. 
        7- Diabetes Mellitus. 
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1.4 Pathophysiology of stroke. 
Disruption of blood supply to brain tissue is the substrate of cerebrovascular 
diseases (figure 1-1). Changes in the vessel wall may trigger blockage of blood 
flow in this vessel. Two major mechanisms can lead to obstruction of cerebral 
blood vessels and cessation of blood supply.  The first is thromboembolism, 
which is by far the most predominant cause of stroke. The most common sources 
of emboli are the heart and large arteries. Atrial fibrillation is considered the 
highest risk condition among other cardiac arrhythmias associated with 
developing of stroke. Heamodynamic failure is the second mechanism which may 
cause flow disruption and is very uncommon. For example, it may lead to severe 
systemic hypotension or low cardiac output. The blood vessel occlusion might be 
complete or partial (stenosis), however, intracranial disease is rare so stenosis is 
not often seen. These changes may also weaken the vascular wall causing blood 
to break through it into brain parenchyma, resulting in compression, 
displacement and damage.  
Atherosclerosis is a notable cause of cerebrovascular diseases, although acute 
or chronic vascular diseases of inflammatory origin might be engaged in some 
instances, such as collagen disorders and chronic infection(5). It is thought that 
chronic fibroproliferative disease supplied by lipids (4) endothelial cells, 
leuckocytes and intimal smooth muscle cells  play the major role in the 
evolution of this disease. Endothelial cell dysfunction leads to aggregation of 
lipids inside smooth muscle cells and recruits leuckocytes to form fatty streaks. 
The response-to-injury hypothesis gives an explanation of the progression of such 
precursor lesions to clear atherosclerosis, postulating that an injury that induces 
fibroinflammatory repair process ends in formation of atheromatous plaque(8). 
After plaque rupture or erosion, the clotting cascade is activated leading to 
progressive thrombosis with subsequent obstruction of blood supply and source 
of emboli. 
Cerebral small-vessel disease is another cause of narrowing vascular lumen 
and failure of cerebral autoregulation. It is responsible for lacunar infarcts and 
intracerebral large and microbleeds(9). Hypertension and aging are well-known 
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risk factors. It is caused by subendothelial accumulation of pathological 
substances which lead to structural alterations rendering the vessel wall fragile. 
When these vessels do not progress to rupture, segmental vessel occlusion 
develops(10). 
 
Figure 1. 1 The mechanism of cerebrovascular occlusion by thromboembolism 
[Reconstructed from Google images for atherosclerosis] 
 
1.5 Ischaemic strokes 
Transient or permanent reduction in cerebral blood flow to an area of major 
brain artery beyond  a critical duration of time results in ischemic infarction of 
brain tissue(11). The development of infarction, its distribution and size depend 
on the particular patient situation, site and mechanism of occlusion and 
adequacy of collateral circulation. Infarct sizes can vary from a few millimetres 
to the whole of a hemisphere(12). Territorial infarcts occur when a major 
cerebral artery is occluded.  When the main stem is blocked and the general 
haemodynamic situation is poor, it results in total territorial infarct (figure1-
2a). However, if there is some partial supply from neighbouring anastomoses, 
the supply area located adjacent to the main stem will infarct (figure1-2b), but 
if the main stem is stenosed and still supplying the periphery then the infarct 
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area will be shifted to the centre of territory (figure1-2c). Sometimes, infarcts 
may evolve in a watershed area between large territories when arteries are 
stenosed causing Cerebrovascular insufficiency (figure1-2d) (13). 
 
 
Figure 1. 2: Different types and sizes of ischemic infarctions with their 
haemodynamic patterns (modified from Zulch(13) and Brainin(5)). 
 
Lacunar infarcts (microinfarcts) are essentially caused by small-vessel disease, 
and, rarely, by microembolization. They mostly occur in deep-perforating artery 
territory.(5). 
1.6 Cerebral blood flow 
Under normal conditions, cerebral blood flow is kept at a relatively constant 
rate of 50ml/100g/min. It declines gradually with reductions in cerebral 
perfusion pressure. The cerebrovascular bed is under the control of a number of 
factors which act to secure energy supply and guarantee the rapid adjustment of 
local cerebral blood flow (CBF) to the active brain areas. These could be 
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myogenic, metabolic or neurogenic factors. The flow is largely independent of 
perfusion pressure alterations over a wide range of pressure, extending in 
normotensive people from 60mmHg to 130mmHg(14). Vascular resistance is the 
key to maintaining constant CBF by changing the calibre of principle cerebral 
resistance vessels (autoregulation). The same change occurs with raised 
intracranial pressure in the case of fixed arterial blood pressure. However, the 
pressure-flow regulation cannot maintain CBF beyond its upper and lower limits, 
but these may be reset in some chronic conditions. For instance, in long-standing 
hypertension the CBF is kept the same at higher perfusion pressure values which 
can reach up to 150mmHg, while the lower limit is shifted upward to levels of 
80mmHg (12). Cerebral blood vessels are innervated by both, sympathetic and 
parasympathetic fibres and their effect on CBF regulation is quite small. 
In the normal brain, CBF is strictly joined to the physiological conditions of 
brain regions (metabolic regulation). Thus, increased neuronal activity in a 
particular brain area entitles it to enhanced cerebral flow. The flow-metabolism 
coupling mechanism is not fully understood, but release of vasodilators from 
activated neurons, including nitric oxide, adenosine, potassium and hydrogen, 
may have a role in this process.  
Arterial blood gases are another modulator of CBF. Variations in CO2 have a 
profound effect on CBF. Arterial hypercapnia causes cerebral vasodilatation and 
increases CBF. In contrast, arterial hypocapnia causes vasoconstriction and 
decreases CBF. CO2 reactivity is mediated by changes in H
+ concentrations in 
cerebrospinal fluid surrounding arterioles. With constant pCO2, alterations in 
blood pH have little effect on extracellular pH and CBF. On the other hand, 
changes in arterial pO2 are associated with minor changes in CBF, which rises 
when pO2 decreases to 50mmHg, and doubles at 30mmHg. Below this threshold, 
the increase in CBF that accompanies hypoxia is probably because of increased 
extracellular PH. 
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1.7 Infarction core and the concept of 
ischemic penumbra 
Cerebrovascular insufficiency is associated with reduced perfusion pressure, 
which induces local homeostatic mechanisms to preserve normal neuronal 
function and oxygen uptake. Auto-regulation of CBF compensates for the early 
drop of perfusion pressure, and, with further drops, CBF begins to fall and this is 
compensated by increased oxygen extraction. Areas of reduced CBF, which are 
fully compensated by increased oxygen extraction, are known as oligaemic flow 
zones.  However, with more drop in perfusion pressure, the compensatory 
mechanisms become exhausted and tissue hypoxia develops. The affected tissue 
will suffer different levels of ischaemia ranging from moderate to severe with 
tissue necrosis and infarction (core) according to the level of ischaemic CBF. In 
this context, the impairment of energy production influences the energy 
consuming processes in a consecutive manner: first by impairment of the 
functional activity of the brain, i.e. electrical activity resulting in neurological 
symptoms; then, at more severe degree of hypoxia, suppression of the metabolic 
activity is needed to preserve its structural integrity. The blood flow rates of the 
two different thresholds of hypoxia for preservation of functional and structural 
integrity are established. When the blood flow range is between “electrical” and 
“membrane” failure, the neurons become functionally silent but remain 
structurally intact for a time. During focal ischemia, this flow range correlates 
with a coronal region embedded between the necrotic infarct core and the 
normal brain figure (1-3). This has been termed the “penumbra”. This name is a 
descriptive term in analogy to the partly illuminated zone around the complete 
shadow of the moon in full solar eclipse. Ischemic penumbra is a dynamic 
process because tissue tolerance to ischemic damage is dependent on residual 
blood flow and duration of blood flow disturbance (15). 
The concept of penumbra in focal cerebral  ischemia was first presented by 
Astrup in 1981, who defined it as regions of brain tissue where reduced blood 
flow is sufficient to cause hypoxia severe enough to halt physiological function, 
but not so complete as to cause irreversible failure of energy metabolism and 
cellular necrosis (16). Since that time, the concept of penumbra has become 
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increasingly important with the expansion of the treatment of acute ischemic 
stroke. However, there is no universal definition of the ischemic penumbra, and 
the operational definition depends on the way that the penumbra is evaluated 
(17). 
 
 
Figure 1. 3; A diagram showing the ischemic penumbra. 
 
  Classically, it relied on the electrophysiological and hemodynamic parameters, 
but more recently the concept has been widened to include metabolic, cellular 
and therapeutic parameters of ischemic penumbra(18). A broader definition by 
Hossmann has assumed that the penumbra is an ischemic tissue with limited 
blood supply and preserved metabolism (19). However, Ginsberg and Pulsinelli 
assumed that this metabolism could undergo intermittent compromise (20). A 
more relevant definition in relationship to therapeutic intervention was 
suggested by Hakim, who prescribed the penumbra as “fundamentally 
reversible” ischemic tissue(21). This definition gave the penumbra a 
considerable  clinical impact because it identifies the penumbra as a region of 
35 
 
potential reversibility which can be reactivated after arterial occlusion by 
increasing CBF (19). However, the penumbra is a dynamic and a transient area 
which develops over time. It is obvious that CBF reductions that characterize 
potential reversibility early after occlusion likely define irreversibility at later 
times. Moreover, several factors might affect the evolution of penumbra on an 
individual patient basis. Aside from the time since onset, these include residual 
blood flow, temperature, metabolic parameters (such as glucose) and the 
anatomical resolution of the technique applied. Therefore, the penumbra is 
unique for each individual patient. In this case, the time window for acute 
stroke treatment will differ according to each individual pathophysiological state 
(22). 
 
1.8 Viability thresholds  
Complete cessation of cerebral circulation causes loss of function at various 
flow thresholds. These were determined in different animal species with 
different reported flow values, but, when compared, a distinct rank order of 
susceptibilities can be established(19). In human beings, a flattening of EEG 
occurs directly after the hemispheric flow falls below 0.16-0.17ml/g/min, as 
evidenced by measurements of cerebral blood flow and EEG during clamping of 
one carotid artery in an endarterectomy (16). The evoked somatosensory 
potential is suppressed at local flows between 0.15and 0.23 ml/g/min. However, 
individual neurons vary in their functional threshold rates between 0.06 to 
0.22ml/g/min, which signifies selective vulnerability even within small cortical 
sectors. The functional threshold is determined when reversible paresis appears 
at the flow value of 0.23ml/g/min and irreversible paralysis occurs between 0.17 
and 0.18ml/g/min (19). 
Unlike electrophysiological function, which deteriorates immediately, 
histological damage needs more time to develop.  Whereas neuronal function 
ceases immediately if the flow drops below the threshold, the development of 
irreversible morphological damage depends mainly on duration of ischemia. It 
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starts at low flow values below 0.10ml/g/min after short duration of ischemia 
with a loss of cell function.  
Simultaneous recordings of cortical neuronal metabolism, local blood flow and 
cerebral perfusion pressure during and after ischemia of different degrees yield 
a curve which shows the worst possible pattern of residual blood flow and 
ischemia still permitting neuronal recovery figure1-4 (12).  
 
Figure 1. 4: A schematic drawing shows the  responses to the fall of CPP. 
Initially, CBF is maintained by vasodilatation. When CBF drops, OEF increases to 
maintain CMRO2.[ modified from M S Markus(23) and(24)] 
1.9 Pathogenesis of cerebral ischaemic 
injury. 
The brain tissue energy requirements are very high and depend mainly on 
oxidative phosphorylation for energy production, with glucose as its sole 
substrate. Therefore, sufficient delivery of substrates, particularly oxygen and 
glucose, must be constantly maintained. 87% of total energy consumed is 
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required by signalling, mainly action potential propagation and postsynaptic ion 
flux (5). Ischaemia triggers a complex chain of reactions which ends in neuronal 
death and consequent loss of neurological function (figure 1-5). Failure of high-
energy metabolism due to depletion of high-energy phosphate with 
overwhelming cellular electrolyte disturbance is the early mechanism 
responsible for evolving cerebral ischemic injury. Within minutes of ischemia, 
anaerobic glycolysis leads to the accumulation of acidic metabolites with 
resultant intra and extracellular acidosis.  This facilitates the release of free 
radicals, thus contributing to cell damage(25). The decreased pH and 
disappearance of substrate causes an inhibition of mitochondrial activity which 
augments the decline of high energy compounds (ATP). ATP depletion is 
associated with ionic-pump failure which results in massive release of 
intracellular K+ to extracellular space and marked increase of intracellular Na+. 
This induces persistent anoxic depolarisation which allows Ca2+ influx. 
Subsequently, many neurotransmitters are released at toxic levels, including 
amino acids, especially glutamate, exacerbating energy demand and disturbance 
of ion homeostasis. Ca2+ overload activates many injurious mechanisms which 
cause cell membrane degradation, the formation of free radicals and the release 
of cytochroms (released as a result of mitochondrial damage and most likely to 
initiate apoptosis). Additionally, it leads to the production of free fatty acids 
which end in the formation of irritant tissue substances including prostaglandins 
and thromboxanes, which can induce a strong inflammatory response and cause 
platelet aggregation, clotting, vasospasm and oedema(26). 
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Figure 1. 5: Mechanisms of ischaemic brain injury [Modified from Pusinelli (25)]. 
The amount of cellular damage is greater with increased glucose 
concentration, which is most likely due to its effect on lowering the tissue pH. 
All of these derangements depend on the degree and duration of ischaemia; in 
severe ischaemia (core region) they are propagated to necrotic cell death, while 
in moderate ischaemia (penumbra), energy is used to preserve cell viability at 
the expense of electrophysiological activity, and with a prolonged duration of 
ischaemia, either necrotic or apoptotic cell death may occur depending on the 
severity of the initial injury (11;25-27). 
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1.10 Development of ischaemic oedema 
Cerebral oedema is defined as an absolute increase of brain tissue water 
content. Oedema is damaging because it leads to swelling which aggravates 
ischaemic injury. Swelling indicates an increased volume of brain tissue because 
of the shift of water from one space to another. It accounts for the earliest 
markers of pathological changes associated with acute ischaemic stroke seen on 
imaging techniques(11). It appears as an area of low attenuation on non-contrast 
computed tomography scan (CT) due to the excess water content of tissue. In 
addition, signs of mass effect, including sulcal effacement and ventricular 
distortion, can be seen on magnetic resonance, and it appears earlier as a white 
region on T2-weighted images(28). However, very early oedema does not lead to 
tissue swelling because no new constituent is added to the intravascular space. 
Ischaemic brain oedema can be divided into three distinctive types: cytotoxic 
oedema, ionic oedema and vasogenic oedema(29;30); the last two of which 
require blood flow to cause swelling(5). 
1.10.1 Cytotoxic oedema 
This is the first to develop after the onset of ischaemia. Osmotically active 
solutes, mainly Na+, accumulate intracellularly, resulting in osmotic expansion of 
the cell. Failure of ATPase-dependent ion transport across cell membrane is 
accompanied by a Na+ influx, which drives chloride ions to enter the cell. The 
net influx of Na+ increases intracellular osmolarity, which generates an osmotic 
gradient that causes water movement from the extracellular into the 
intracellular space, causing cytotoxic cell swelling. Affected cells depolarize and 
become deformed. At this early stage, water is not replenished in the 
extracellular space and total brain volume remains unchanged, although cell size 
is increased. In brain imaging, this fluid shift is evident as a decreased apparent 
diffusion coefficient (ADC) of water, which is reflected in increased signal 
intensity on diffusion-weighted magnetic resonance imaging(31). Eventually, 
plasma membranes of swollen cells rupture and undergo oncotic or necrotic cell 
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death.  Cytotoxic oedema builds up a new gradient for sodium, chloride and 
water across the capillary of the blood-brain barrier between the intravascular 
and extracellular spaces, which creates a transcapillary driving force for the 
movement of water along with presence of appropriate capillary permeability. 
Thus, cytotoxic oedema supplies the driving force for the formation of ionic and 
vasogenic oedema and, eventually, brain swelling (11;29-32). 
1.10.2 Ionic oedema 
This heralds endothelial dysfunction. Capillary endothelial cell permeability is 
increased due to an increase in expression of transport proteins induced by 
ischemia and with the generated force in extracellular space (osmotic gradient), 
solute and water move from vascular compartment into interstitium of brain 
tissue, thus replacing them in the extracellular space that was consumed by the 
formation of cytotoxic oedema(29). The formation of ionic oedema occurs with 
the normal exclusion of macromolecules, because the blood-brain barrier 
remains intact. It precedes vasogenic oedema by 6 hours or more(30). Selective 
flux of Na+ across the blood-brain barrier can be attributed to two mechanisms, 
primary and secondary active transport. Secondary active transport mechanisms 
are determined by pre-existing electrochemical gradients. At this stage of 
oedema, hydrostatic pressure gradients are irrelevant in formation of oedema,  
Essentially, this is all due to intact capillary tight junctions, unlike osmotic 
pressure which is the main determinant of the driving force. The net tissue 
water content is increased and consequently brain volume also increases 
(29;30;33). 
1.10.3 Vasogenic oedema 
This is initiated when the blood-brain barrier disintegrates and serum proteins 
start to seep from the blood into the brain. This disturbance further amplifies 
accumulation of water in interstitium due to increases in its content of 
osmotically active molecules, including sodium and macromolecules. Capillaries 
function like fenestrated capillaries when the integrity of the blood-brain barrier 
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is lost and both hydrostatic and osmotic pressure gradients augment oedema 
formation. Several molecular mechanisms might be blamed on the permeability 
of changes during vasogenic oedema (29;33). The latter two types of oedema 
may reverse the narrowing of extracellular space caused by cytotoxic oedema 
and the progression of ischemia; it is rapidly enlarged causing marked increase 
in tissue pressure, which may in turn affect the surrounding tissue resulting in a 
reduction in regional CBF. The increased total water content of tissue is 
reflected by increased signal intensity on T2-weighted MRI (33). However, early 
hypodensity before mass effect on computed tomography scans may be used to 
distinguish ionic from vasogenic oedema(30). 
1.11 Progression and fate of ischemic injury 
Progression of ischaemic injury can be differentiated into three phases: the 
acute phase occurs within a few minutes after the onset of ischemia resulting in 
terminal depolarization of cell membranes and the establishment of an infarct 
core. Then comes the sub acute phase, in which the infarct core expands by 
means of peri-infarct spreading depression and molecular cell injury until it 
recruits the entire surrounding penumbra after 4-6 hours. Finally is the delayed 
phase, which may persist for several days or weeks. During this phase, secondary 
phenomena such as vasogenic oedema, inflammation and possibly programmed 
cell death may further advance progression of the injury(5). 
Recovery of the synaptic transmission and its connection with the severity and 
duration of ischemia is especially applicable to clinical management. Neuronal 
vulnerability varies significantly, but most neurons tolerate durations of 
ischemia of 1-2 hours, at flows only above 15 ml/100g/min, which indicates that 
a useful recovery of function after hours of ischaemia is only possible from flows 
in the penumbral range. Irreversible tissue damage can be caused by severe 
ischaemia below the penumbral range more rapidly than effective treatment can 
be performed. Within the penumbra, therapeutic intervention may lead to 
recovery and prevent infarction. As with functional recovery, the severity and 
duration of ischemia are important determinants of the development of 
infarction; therefore, failure to recover is correlated with the presence of 
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structural damage. The penumbra may persist for several hours, maintaining the 
tissue structure and giving the potential for function recovery(12). 
 
1.12 Thrombolysis 
To establish effective therapies for treatment of acute ischaemic stroke, 
there needs to be easily recognised targets. Logically, the target should be 
ischaemic tissue, as it is capable of responding to appropriate and timely 
treatment, meaning it is potentially salvageable and not irreversibly injured 
tissue which has no potential to recover function. This salvageable tissue is 
consistent with the ischaemic penumbra. Thus, distinguishing the penumbra 
from irreversible infarct core and determination of its existence and extent 
would benefit strategies of stroke therapy(34). Two approaches can be followed 
to direct treatment toward its primary purpose: a vascular approach, such as 
early reperfusion to limit ischaemia; and a cellular approach, such as 
interference with a pathochemical cascade to prevent further neuronal damage. 
However, since perfusion disturbance is the fundamental cause of progressive 
cellular death and infarction, fast and effective restoration of blood supply to 
flows above the critical threshold is crucial to secure ischaemic tissue(35). 
Because thromboembolism is responsible for the majority of strokes, 
thrombolytic therapy was suggested to lyse clots and reopen occluded cerebral 
arteries. Clinical gains of thrombolysis are related to reperfusion of tissue and 
limitation of stroke growth. A number of thrombolytic agents were used in 
clinical trials, including recombinant prourokinase (r-proUK), streptokinase and 
recombinant tissue plasminogen activator (rtPA) (alteplase)(36). However, rtPA 
is the only commonly-used thrombolytic agent and its efficacy, safety and 
feasibility in treatment of acute ischaemic stroke have been widely studied. It 
can improve neurological and functional outcomes when administered within the 
first 4.5 hours of symptom onset. While it is a highly effective treatment, it 
faces the challenge of a narrow therapeutic window and the possibility of 
developing a brain haemorrhage (37-39). 
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rtPA was first approved as treatment for acute ischaemic stroke by the US 
Food and Drug Administration in 1996 (40;41). This was based on results of a 
randomised controlled trial (NINDS) published in 1995 which found that 
administration of intra-venous t-PA within the first 3 hours of onset of stroke 
symptoms in selected patients, according to particular inclusion criteria,  
improves the clinical outcome at three months(42). Other trials were also 
conducted to prove the efficacy of thrombolysis in the treatment of acute 
stroke, the most important was by European Cooperative Acute Stroke Studies 
(ECASS I), which differed in that the dose of rtPA was higher than that used in 
NINDS, the time window was expanded to 6 hours instead of 3 (with median time 
to treatment of 4 hours), and the inclusion of a high proportion of patients with 
extensive pre-treatment computed tomography (CT) changes of ischaemia.  
These factors were the drawbacks of ECASS I which led to a higher mortality 
rate after one month and significantly increased the incidence rate of 
intracranial haemorrhage in rtPA-treated patients over placebo-treated patients 
(43). However, the target population analysis (per-protocol) showed significant 
differences in favour of the alteplase group.  In ECASS II the dose of rtPA was 
reduced and imaging selection criteria for the trial were more carefully defined, 
with inclusion of training for physicians to recognize the early ischaemic changes 
on CT. The results supported the efficacy of rtPA in treating acute ischaemic 
stroke within 3 hours, and probably within 6 hours, of the onset of symptoms, 
though only when re-analysed with a different primary end-point(44). The 
Alteplase Thrombolysis for Acute Non-interventional Therapy in Ischemic Stroke 
(ATLANTIS) study found no benefit in using rtPA beyond the first 3 hours of 
onset, but there was increased risk of symptomatic intracerebral 
haemorrhage(45). However, it added more evidence of its efficacy in the 
treatment of acute ischaemic stroke when it was given within the first 3 
hours(46). The SITS-MOST (Safe Implementation of Treatments in Stroke in 
Stroke-Monitoring Study) prospective registry further suggested its efficacy and 
safety in routine clinical use(47). Later, ECASS III proved its efficacy when 
administered within 3 to 4.5 hours after the onset of stroke with the same 
incidence rate of haemorrhage reported in previous trials(48;49), although with 
a less severely-affected clinical population. These results were also confirmed 
by the SITS-ISTR (Safe Implementation of Treatments in Stroke - International 
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Stroke Treatment Registry)(50). More recently, the third international trial (IST-
III); The Benefits And Harms of Intravenous Thrombolysis  with rtPA Within 6 
Hours of Acute Stroke Onset, approved the efficacy of thrombolysis in improving 
the outcome when introduced within the first 6 hours of acute stroke(51).The 
Echo Planar Imaging Thrombolytic Evaluation Trial (EPITHET) showed that 
alteplase had an insignificant effect on infarct growth, but a significant effect 
on reperfusion, and so supported the use of reperfusion as a surrogate for 
outcome in future proof-of-concept stroke trials. However, when baseline 
lesions of less than 5ml were excluded there was significantly lower growth of 
infarct in the alteplase group than in the placebo group(52). 
However, the use of rtPA is limited and although most neurologists 
recommend its use as emergency treatment for acute stroke, many clinicians in 
emergency departments, in the USA in particular, have concerns about its 
safety(53). The narrow therapeutic window, the increased possibility of 
developing brain haemorrhage, and the strict inclusion criteria are the main 
barriers that make accessible and practical use of thrombolysis difficult.  The 
majority of stroke patients do not meet the inclusion criteria for therapy 
because of delays in obtaining the treatment(54). These can result from factors 
related to the patient or the treating staff. Failure to recognize stroke symptoms 
and seek appropriate medical advice by patients or their families, consideration 
of stroke as a non-urgent event by emergency staff, delays in neuro-imaging and 
inefficiency of emergency stroke care were the main reported barriers(54;55). 
Studies and clinical trials to improve the efficacy of thrombolysis and widen the 
therapeutic window beyond 4.5 hours have been done. In the Diffusion Weighted 
Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study, MR 
imaging was used and the MRI characteristics that were most likely to 
significantly benefit from thrombolysis between 3 and 6 hours of onset were 
employed(54;56). EPITHET also used MRI to assess the infarct growth and 
reperfusion in patients who had a mismatch between DWI and PWI lesions(52). 
The Imaging-based Thrombolysis Trial in Acute Ischemic Stroke III (ITAIS III) is an 
ongoing study recruiting patients into thrombolysis by using CT scan(57). 
Desmoteplase is a thrombolytic agent which has a longer half-life and higher 
fibrin specificity than alteplase. It has shown promise when used up to 9 hours 
from stroke onset with the use of MR imaging as a baseline for treating 
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patients(57;58). Although the DIAS II trial showed no benefits of desmoteplase 
between 3-9 hours after stroke onset, the DIASIII/IV trials are currently 
recruiting patients with more careful selection criteria (59). 
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The main issue of this review is to shed light on the early signs of acute 
ischaemia which could be recognised by current imaging modalities, particularly 
computed tomography (CT) scans. The key words used to search for the 
appropriate literature were acute, ischaemic, stroke, penumbra, early, changes, 
sings, hypodensity, x-ray hypoattenuation, focal swelling, inter-rater agreement, 
computed tomography, scan, MR imaging, CT perfusion and angiography, 
diagnosis and hyperdense vessel. 
The tools for this search were the library data base by connecting to OVID, 
Pub med and Web of knowledge. Generally, I looked for literature published 
between 1990 and March 2012. Sometimes, older papers were included because 
of their relevance and reference to them in the more recent papers. There were 
around 300 papers reviewed, including clinical trials, observational studies, 
clinical and systematic reviews and editorial comments by authors. Of these, 
only the most relevant ones to the aim of this study were included. These were 
mainly papers which studied early ischaemic changes (EICs) on CT scan, 
specifically; the reliability of detection of these changes in early stroke and in 
particular those which aimed to approach the observer agreement on EICs 
comprehensively.. Also, papers which involved specific study of penumbra tissue 
in acute CT were included in this review. Other relevant papers were those 
which studied acute stroke CT techniques and compared it with MRI. However, 
papers which studied observer reliability using MRI or which used MRI alone in 
studying acute stroke were irrelevant to this review and also, papers which 
involved non-human subjects were excluded. 
Selected papers were then reviewed according to their relevance to the aim 
of the study. All papers which studied the observer reliability in detection of 
EICs were fully reviewed and compared with each other while other literature 
were either scanned in full or reviewed only by their abstracts.      
2.1 Neuroimaging in acute stroke. 
Advances in imaging techniques have revolutionised the overall approach to 
acute stroke management and put neuroimaging forward as its cornerstone 
(60;61). Previously, it was thought that the brain’s plasticity to recover from any 
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acquired injuries was limited and its ability to withstand oxygen deprivation only 
lasted a few minutes. Thus, a stroke was considered a hopeless disease which 
left patients with major disability or in extensive rehabilitation programmes and 
shortened their life span. Therefore, there was no need for imaging to provide 
detailed information about parenchyma and blood vessels in the early acute 
stages of a stroke, but mainly to exclude other differential diagnoses, 
particularly haemorrhagic stroke, and to follow up the patient. This nihilism 
around stroke management has changed since the introduction of thrombolytic 
therapy which converted acute ischaemic strokes into a treatable disease 
(62;63). A different range of imaging techniques has evolved that gives detailed 
information about the size, location and nature of an ischaemic lesion, the 
status of cerebral perfusion and the status of intra and extra cranial vasculature 
(64). Both functional and structural imaging have played a central role in 
deepening our understanding of strokes and documenting the differences in 
subjects’ response potential to therapy in relation to individual 
pathophysiological and hemodynamic states (22). Primarily, imaging in the acute 
phase of a stroke may be used to diagnose the stroke, rule out other diagnoses, 
define the site of arterial occlusion, determine the origin of the stroke by 
evaluating cervical arteries, assess the level of hypoperfusion, evaluate the 
viability and reversibility of brain lesions, detect early stroke complications such 
as cerebral herniation or haemorrhagic transformation and provide information 
about the possible clinical outcome. In routine clinical practice, the precise 
mapping of potentially salvageable ischaemic tissue is another goal of imaging. 
However, some of the constraints on the imaging approach include that it should 
be performed as fast as possible, availability, expense, duration and the ease of 
data acquisition, processing and interpretation and risks to the patient, such as 
exposure to contrast and radiation (65). Thus, familiarity with neuroimaging 
techniques and knowledge of what they tell us about pathophysiology is an 
essential requirement for all stroke professionals (63). The ideal neuroimaging 
method in acute strokes should be widely available, inexpensive and provide 
rapid non-invasive, multimodal information about tissue viability, perfusion and 
cerebral vasculature. Although no single imaging modality currently meets these 
criteria, a combination of more than one technique gives clinicians the critical 
information required to guide treatment decisions (65). However, the ongoing 
advances and multiplicity of imaging techniques have increased the complexity 
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of decision making in clinical practice. They are recommended to manage acute 
strokes on both a clinical and a pathophysiological basis (66). 
Recently, newer neuroimaging techniques have allowed evaluation of the 
haemodynamics of ischaemia and assessment of important pathophysiological 
variables. Although no single technique can fully investigate acute strokes, a 
multimodal approach with more than one imaging mode is suggested. The major 
structural neuroimaging tools are computed tomography (CT) and magnetic 
resonance imaging (MRI). Positron emission tomography (PET), xenon computed 
tomography (Xe-CT) and single-photon emission computed tomography (SPECT), 
diffusion and perfusion MRI and CT perfusion (CTP) are the touchstone of 
functional neuroimaging. In this review, I will focus on the CT scan’s role in 
acute strokes with some overview on MR imaging and other imaging techniques.  
2.2 Computed tomography (CT) scans. 
The acute stroke approach has been a giant leap since the introduction of CT 
scans in the 1970’s. The CT scan is considered the most widely used diagnostic 
technique for evaluation of patients with acute ischaemic stroke and it is highly 
recommended as the initial modality of choice for stroke investigation (67). This 
is because it is widely available, accessible, fast, and patient tolerable, i.e. 
critically ill, uncooperative and restless patients can be imaged. In addition, 
most thrombolysis trials were CT based (61;68;69). Basically, it is used to rule 
out non-vascular pathologies such as tumours and exclude haemorrhage with 
high sensitivity (70). Apart from this, early ischaemic changes can be detected 
by non-contrast CT scan in around 75% of patients with middle cerebral artery 
(MCA) stroke (71). These include hypodensity, focal swelling and the hyperdense 
vessel sign. Subsequently, there has been a growing interest in using CT scan to 
identify early ischaemic changes, particularly with the advent of alteplase 
thrombolysis. This has been involved in approaching strokes in the very early 
phase with the facilities to obtain more accurate, quicker and more 
comprehensive information about evolving ischaemic injury. Thus, besides the 
unenhanced CT scan as a structural imaging approach, there are the perfusion 
CT scan as a functional neuroimaging technique and CT angiography as an 
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imaging tool for intra and extra-cranial vasculature. All modern CT scanners are 
now using a helical CT scanning facility which shortens the scan time and allows 
coverage of the entire head, and with the advent of multi-slice helical CT 
scanners there has been an increase in the speed and amount of data collection. 
All of the mentioned modalities of the diagnostic CT scan are used in the initial 
investigation of early strokes. However, conventional CT contrast enhancement 
is not recommended in acute strokes and rarely helpful in subacute stroke stages 
either. Although concerns about extravasations of contrast and worsening of the 
stroke have arisen, there is as yet no supporting evidence of this (66;72). 
2.2.1 Unenhanced CT and early stroke. 
Plain CT or non-contrast CT (NCCT) remains the backbone of emergency 
neuroimaging in acute strokes, mainly to exclude brain haemorrhages and other 
non-vascular pathologies which are important in determining the further 
management of the patient. NCCT is typically performed in an emergency 
department using a multidetector helical scanner. In general, imaging 
parameters are adjusted to improve overall image quality and reduce the 
radiation dose, noise and artefacts. These include speed, pitch, rotation time, 
table speed, slice thickness, image spacing and field of view parameters. 
Physically, CT scans measure the X-ray beam attenuation through the region of 
interest using Hounsfield Units to express attenuation values. Hounsfield Units 
are a linear scale in which water has a value of zero. Thus, any tissue denser 
than water (high HU values) appears lighter than water on NCCT whereas low-
density tissues appear darker than water. Typically, grey matter has attenuation 
values of 30-35HU and white matter 20-25HU, and hence grey matter appears 
lighter than white matter on the NCCT. Ischaemic tissue on the NCCT appears 
with reduced radiolucency or hypoattenuated, due to the increased tissue 
content of water and decreased blood volume. The HU attenuation is directly 
proportional to the tissue content of the water; every 1% increase in tissue 
water content is associated with a 2.5HU drop in attenuation of the NCCT image 
(73). It can be difficult to see such small changes in HU on NCCT, and hence the 
subtlety of early ischaemic changes. This is in particular within the first 3 hours 
of time window for thrombolysis, when these changes might not be seen at all. 
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The rate of decline of tissue density depends upon the severity and duration of 
ischaemia. Therefore, the clarity of hypodensity on NCCT may help estimate the 
time interval since stroke onset. Early ischaemic changes on the NCCT represent 
different underlying pathological processes. Tissue hypodensity is associated 
with severe reduction of cerebral blood flow and volume compatible with infarct 
core and its extent can predict final infarction (74), while areas with isodense 
swelling are associated with increased cerebral blood volume and moderate 
hypoperfusion reflecting salvageable tissue (61;65;75). Thus, early ischaemic 
changes include elements of both core and penumbra [as illustrated in the 
previous chapter, Section 1.7) 
 
2.2.1.1 Role of NCCT in diagnosis of ischaemic infarction and 
exclusion of intra-cerebral haemorrhage. 
Identification of the signs of ischaemia on the NCCT is important for making a 
decision concerning thrombolysis. Early signs of acute ischaemic stroke on the 
NCCT, within the first 6 hours, are typically subtle and sometimes cannot be 
seen (Figure 2-2). Over the first few days, they become more obvious and well-
demarcated (68;76-78). Although the clinical evaluation represents the main 
diagnostic tool of strokes in patients presenting with acute neurological deficit it 
cannot confirm ischaemia and exclude haemorrhage.  
Distinguishing ischaemia from cerebral haemorrhage on bedside examination 
is difficult due to the lack of feasible differentiating clinical features (79-82). 
Therefore, imaging the patient using NCCT or MRI, to exclude haemorrhage is 
required. Acute haemorrhages are large enough to be seen on NCCT (83). They 
appear with increased density due to clotted blood (Figure 2-1). Much of the 
literature assumes that NCCT has high sensitivity for detection of ICH, and 
describes it as the diagnostic imaging technique of choice for exclusion of ICH in 
the hyperacute stage of strokes (68;70;82;84-86). However, there were no 
studies which evaluated the sensitivity of the NCCT for this detection (86;87). 
On the other hand, many authors argued that MRI is as sensitive as NCCT in the 
detection of acute haemorrhage and superior to NCCT for the detection of 
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chronic haemorrhages and it might substitute NCCT as the first line imaging in 
acute strokes to avoid use of two imaging techniques and save time and 
minimise costs (88-95). But the wide availability and easy access to NCCT, in 
addition to its limited contraindications, have made it preferred to MRI for 
exclusion of haemorrhage in most guidelines for acute stroke management 
(80;85;96-100). 
 
 
Figure 2. 1. Appearance of acute intracerebral haemorrhage by NCCT. The 3 
slices are from 3 patients post-thrombolysis; A-small area of ICH. B- ICH with 
ventricular extension. C- Massive ICH. 
  
2.2.1.2 Early ischaemic changes (EICs) on NCCT. 
The classic early ischaemic changes of acute stroke NCCT are manifested in 
three major ways: 1- decreased parenchymal density [Parenchymal 
hypoattenuation or hypodensity]; 2- tissue swelling without change in X-ray 
attenuation [isodense or isolated focal swelling], and 3- hyperattenuation of an 
occluded artery MCAT(101) (Figure 2-2). These changes are mainly described in 
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relation to ischaemia in the territory of the MCA. In this review, the EICs will 
refer only to parenchymal changes and HMCA will not be included. Apart from 
hyperdense vessel sign, parenchymal hypoattenuation seems to be the most 
frequently studied and reported early ischaemic change while focal swelling is 
less commonly seen and under-evaluated (102). In fact, the ways of reading 
these changes on the NCCT vary greatly among literature reports, with 
overlapping definitions and poor distinction between hypodensity and swelling 
(68).  
 
 
Figure 2. 2 Early ischaemic changes from three different patients presented 
within 6 hours from stroke onset. A- Isodense swelling B- Hypodensity C-
Hyperdense vessel sign. 
 
Authors universally identify two types of abnormalities on NCCT in early 
stroke: increased radiolucency of brain structures (hypoattenuation) and 
swelling, but how these two changes can be distinguished from each other is not 
clearly defined. In Table 2-1 is a list of terms which have been used for EICs in 
the literature, with the definitions of some of them when documented by 
authors. Generally, these are descriptive terms for the morphological and/or 
anatomical brain changes associated with early stroke. 
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2.2.1.3 Terminology and definition of EICs on NCCT. 
These signs are mainly described in MCA territory hence the anatomical 
references were mainly restricted to insula and basal ganglia. Loss of insular 
ribbon, obscuration of lentiform nucleus and cortical sulcal effacement were the 
most commonly used names for signs of early ischaemia on the NCCT in the 
literature(103) (Figure 2-3). Truwit et al. defined loss of insular ribbon as loss of 
definition of grey-white matter interface at lateral margins of the insula and 
stated that it is a reflection of oedema due to infarction (104). The same 
definition was given by Koga et al. and Wardlaw et al. (105;106). Some authors 
gave the same definition for obliteration of Sylvian fissure, as in Wardlaw and 
Mielke’s review, which includes an element of swelling. Despite insular changes 
being able to appear as narrowing or obliteration of Sylvian fissure, which is an 
indication of swelling, there was not enough clarification whether that always 
meant hypodensity or could also reflect isolated focal swelling (authors reported 
it as loss of insular ribbon only) (60;106;107). However, Scott et al. were more 
precise in defining the insular change by describing it as hypoattenuation of 
insular ribbon (108). Conversely, the obscuration of lentiform nucleus sign was 
frankly defined as decreased radiolucency of lentiform nucleus resulting in loss 
of its precise delineation (105;109). Also, disappearing basal ganglia sign has 
been attributed to decreased density (106;110). 
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Loss of insular ribbon; loss of definition of grey-white matter interface in the lateral margins 
of insula (104;106;111;112). 
Obscuration of lentiform nucleus; obscured outline or partial disappearance of the lentiform 
nucleus (109;111;112). 
Cortical Sulcal effacement; decreased contrast, loss of precise delineation of the grey-white 
interface in the margins of the cortical sulci, corresponding to localised mass effect (106;111-
113) 
Hemispheric sulcal effacement (72)  
Focal hypoattenuation; increased radiolucency of brain structures relative to other parts of 
the same structure or to contralateral counterparts (106) 
Obscuration of Sylvian fissure (106) 
The disappearing  basal ganglia sign; a loss of the normal delineation of the basal ganglia (110) 
Blurring of the clarity of the internal capsule (114) 
Parenchymal hypodensity; increased radiolucency of cerebral tissue relative to other parts of 
the same structure or to its contralateral counterpart (115) 
Cerebral oedema; circumscribed effacement of cortical sulci, compression of ventricles, and 
shift of midline structures (109;115-117) 
Loss of grey and white matter differentiation in the basal ganglia; decreased contrast, loss of 
precise delineation of the grey-white interface of the basal ganglia (106) 
Loss of cortical sulci or narrowing of Sylvian fissure (60) 
Compression of ventricular system and basal cisterns (60)  
Loss of grey–white matter differentiation in cortical gyri, basal ganglia, or insula (60) 
Lentiform nucleus hypodensity (72) 
Local compression of lateral ventricle (72) 
Focal brain swelling; circumscribed effacement of cortical sulci, compression of ventricles 
and/or shift of midline structures (94)  
Focal brain tissue swelling (118)  
Isolated focal swelling (102;107) 
Focal brain swelling; any focal narrowing of the cerebrospinal fluid space (e.g. effacement of 
cortical sulci or ventricular compression) (119).  
CT sign of brain swelling without concomitant parenchymal hypoattenuation; obvious 
asymmetric sulcal effacement was observed in more than one section and when there was no 
concomitant cortical hypoattenuation, including loss of grey-white matter distinction (120) 
Isodense brain swelling (72;75) 
Hypodense and swollen brain region, isodense and swollen brain region, hypodense brain 
region (75)  
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Severe/mild tissue swelling [mass effect]; mild; effacement of the ipsilateral cortical sulci or 
slight effacement of the lateral ventricle, and severe; complete effacement of the lateral 
ventricle or midline shift (121) 
Severe/mild hypoattenuation; mild; grey matter reduced to that of normal white matter 
attenuation; severe; grey or white matter attenuation less than normal white matter (121) 
Mass effect (122) 
Early infarction (68) 
Hyperdense middle cerebral artery sign; a part of the MCA that was denser than other parts of 
the vessel or of its counterpart and denser than any visualised vessel of similar size, as shown by 
unenhanced CT in which density could not be attributed to calcification (94) 
Dot sign; the hyperdensity of an arterial structure (seen as a dot) in the Sylvian fissure relative 
to the contralateral side or to other vessels within the Sylvian fissure (123) 
Table 2- 1: Terminology of EICs. 
 
 
     
Figure 2. 3: Early signs of acute stroke as seen within the first 4 hours. A; 
Loss of insular ribbon B- Obscuration of lentiform nucleus C- Cortical sulcal 
effacement. 
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All the other terms which have been used to describe ischaemic change in this 
area also indicated decreased density. For instance, blurring of internal capsule 
(114), lentiform nucleus hypodensity (72) and loss of grey-white matter 
differentiation in basal ganglia (60;106). The restriction of use of hypo 
attenuation in definition of these signs comes from the fact that it is difficult to 
assess focal swelling in subcortical areas (107). In contrast, authors used the 
hemispheric sulcal effacement sign to refer to both swelling and hypodensity. 
Wardlaw and Mielke defined the sulcal effacement sign as a reduction of 
contrast density with decreased definition of grey-white matter interface at 
margins of sulci with local mass effect features (106). The same definition had 
been given by Koga et al. (105). Earlier, Beauchamp et al. considered the sulcal 
effacement sign to be a morphological change which occurs due to accumulation 
of intracellular fluid causing swelling and loss of gyral infoldings and regarded it 
as distinct from attenuation changes which affect the grey-white matter 
interface, which were considered to follow later (114). On the other hand, Von 
Kummer et al. stated that sulcal effacement, like local compression of ventricles 
and midline shift, is a manifestation of focal brain swelling and not hypodensity, 
which is merely increased radiolucency (94;119). 
Hypodensity or parenchymal hypoattenuation was defined more clearly than 
swelling in most of the literature. In studies of EICs, authors used a general 
definition for parenchymal hypoattenuation which is decreased radiolucency of 
brain tissue relative to other parts of the brain. This can be seen in insula, basal 
ganglia and/or cortical areas and manifests as a loss of grey-white matter 
differentiation (60;73;74;115;117;119;124) (Figure 2-4). Wardlaw and  Mielke in 
their review used the previous signs for EICs beside focal hypoattenuation to 
refer to hypodensity affecting cortical areas (106). However, Grotta et al. were 
more specific in describing hypoattenuation. They stated that slight 
hypoattenuation might manifest as the loss of distinction between grey-white 
matter, while tissue hypodensity might manifest as marked hypoattenuation in 
which either the grey or white matter appears darker than normal (122). 
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Figure 2. 4: Examples of hypodensity (yellow arrows). 
 
In a similar way, Wardlaw et al. defined mild hypoattenuation as grey matter 
reduced to the patient’s normal white matter attenuation, and severe 
hypoattenuation as grey and white matter attenuation less than the patient’s 
white matter attenuation (101). This was not the case when swelling was 
defined in most publications. Von Kummer et al. defined focal brain swelling as 
circumscribed effacement of sulci, compression of ventricles (narrowing of 
cerebrospinal fluid spaces) and/or midline shift, but in their analysis of the 
results they mentioned seeing three patterns of focal swelling on the NCCT: 
swelling without hypoattenuation, swelling with small hypoattenuation and 
swelling with large hypoattenuation (Figure 2-5) (94;119). Other authors used 
the term cerebral oedema to refer to swelling and defined it as circumscribed 
effacement of cortical sulci, compression of ventricles, and shift of midline 
structures (115-117). Scott used cortical effacement to refer to swelling and 
defined it as subtle mass effect with sulcal effacement (108). Conversely, Grotta 
and his colleagues defined oedema as a brain tissue density less than that of 
white matter but higher than that of CSF, while mass effect was effacement of 
sulci and basal cisterns and compression of ventricles or Sylvian fissure (122). 
However, the previous definitions of swelling did not illustrate its importance 
and difference from hypodensity in regard to the pathophysiological background. 
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Basically, hypodensity is a reflection of ionic oedema on the NCCT and, 
originally, oedema results in tissue swelling which can also manifest as tissue 
shift, compression or effacement of CSF spaces. Subsequently, hypodensity and 
swelling should signify the same pathology according to the pathophysiological 
point of view. In an editorial comment by Von Kummer, he mentioned that  
brain tissue swelling is not closely associated with ischaemic tissue damage and 
it does not make sense to mix it with hypoattenuation and studying it on CT as 
one mixture (125). Na and his colleagues explained that CT signs of brain 
swelling without concomitant hypoattenuation might not represent severe 
ischaemic injury and they defined it as asymmetric sulcal effacement without 
presence of hypoattenuation including loss of grey-white matter distinction 
(120). The same definition for isolated focal swelling was given by Hirano and 
Parsons (102;126). In the study of the identification of penumbra on the NCCT by 
Muir and his colleagues, they mentioned two types of swelling, isodense and 
hypodense swelling. They categorised brain tissue into normal, isodense swollen, 
hypodense swollen and hypodense(75). In ACCESS study, Wardlaw distinguished 
brain tissue swelling by the absence of concomitant hypoattenuation change and 
used quanitative terms to differentiate two types of swelling: mild swelling to 
refer to sulcal effacement or slight effacement of ventricles and severe swelling 
to refer to the presence of complete ventricular effacement or midline shift 
(101).  
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Figure 2. 5: Examples of brain swelling in early acute stroke. A- Focal 
swelling with hypodensity (Both were within the first 4 hours post stroke onset). 
B- Focal swelling without hypodensity (isodense swelling) Right: at 4 hours post 
stroke. Left: at 2 hours post stroke. 
2.2.1.4 Systematic measurements of EICs on NCCT. 
Since EICs are subtle and difficult to recognise and their significance in 
predicting ischemic outcome was unclear, methods of systematic evaluation of 
NCCT for EICs to improve observer recognition, interpretation and agreement 
and estimate their volume with a standardised approach have been developed. 
The European Cooperative Acute Stroke Study (ECASS) suggested that 
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involvement of >1/3 of middle cerebral artery territory (MCAT) on early NCCT 
was associated with increased risk of parenchymal haemorrhage. Despite this, 
there were no guidelines on how to perform this estimate (43). The Idealise-
Close-Estimate (ICE) method was developed by the South-western Ontario Stroke 
Team to standardise the one third rule for measuring EICs in a systematic 
approach (127;128). It needs the observer to mentally estimate the affected 
area ratio to the whole MCAT. This is performed in the following steps: the 
observer idealises in their mind the area represented by the MCAT. The shape of 
the area is trapezoidal. Then, the observer looks for areas of asymmetry 
between the hemispheres which are typically represented in acute stroke by 
EICs. The observer then closes a geometric figure around the area or areas 
judged to be abnormal. In step three, the observer estimates the ratio of the 
geometric figure in step two to the trapezoid in step one.  
In their study of the detection of EICs in >1/3 of MCAT, Kalafut and colleagues 
designed a worksheet to make interpretation consistent and to optimise the 
performance of readers, by  incorporating Alteplase Thrombolysis for Acute Non-
interventional Therapy in Ischemic Stroke (ATLANTIS)/CT Summit criteria for 
involvement of >1/3 MCAT (129). The same worksheet was used by Mak et al. to 
reduce subjectivity with the ICE method (130). In 2000, some authors argued 
that the one third method was not reliable, and a reproducible grading system 
was needed to improve the overall reading of EICs on NCCT. They developed a 
quantitive CT score, the Alberta Stroke Programme Early CT Scoring (ASPECTS), 
and confirmed its reliability, validity and usefulness in estimating EICs. This 
score divides MCAT into 10 regions in two standardised axial cuts, the first at the 
level of thalamus and basal ganglia, and the second at the level of corona 
radiata (See Figure 1 Appendix). The regions are 3 subcortical (Caudate) 
(Lentiform) and (Internal capsule) and 7 cortical (Insula) (M1, 2, 3 representing 
anterior, middle and posterior branches of MCAT) and superior to this (M4, 5, 6 
representing anterior, lateral and posterior branches of MCAT). A single point is 
subtracted if an early ischaemic change is detected in a region of MCAT. A score 
of 0 indicates diffuse ischaemia. A normal scan has a score of 10 (71).  
Coutts and colleagues confirmed the reliability of ASPECTS when performed in 
real time (131). Pexman described ASPECTS as a reliable, robust and practical 
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method which can be applied to CT in acute stroke and he addressed a number 
of questions on ASPECTS use, including the determination of cortical M1-6 
regions boundaries, the number of ischaemic signs which need to be present in a 
region to lose a point and the size of the region which needs to be involved to 
lose a point (132). However, Phan et al. argued that the ASPECTS regions are 
unequally weighted, with the straitocapsular region having the greatest weight, 
which might imply that involvement of this region is likely to exclude eligible 
patients from thrombolysis. In their study, they used the infarct volume of MCAT 
to examine the internal structure of the ASPECTS template and they suggested 
incorporation of explicit weights based on the spatial pattern of infarcts (133). 
Similarly, Wardlaw et al. argued that the ASPECTS score and 1/3 rule do not 
localise the lesion to particular parts of MCAT (101). Additionally, ASPECTS does 
not take into consideration the Hyperdense vessel sign which is a major EIC on 
NCCT and might have prognostic importance. The ASPECTS score was also 
assessed for its ability to identify acute ischaemic patients who might benefit 
from thrombolytic therapy by PROACT-II Investigators who confirmed that a 
baseline ASPECTS score of < or = 7 is less likely to benefit from thrombolysis 
(134), which is the sameresult which was found by Barber et al.  (71). Another 
study showed increased risk of thrombolytic related parenchymal haemorrhage 
with low ASPECTS values (124). In a reanalysis of the NINDS trial by  baseline 
ASPECTS, there was no significant difference in the effect of intravenous rtPA 
given within 3 hours of onset in different strata of severity by ASPECTS score 
(113). More recently, Hirano and colleagues reanalysed the data from the Japan 
Alteplase Clinical Trial (J-ACT) using the ASPECTS system. They found that 
patients with low ASPECTS values (7 or less) have an increased risk of developing 
ICH (135).   
Both scoring systems, ICE and ASPECTS, were compared for their reliability in 
routine clinical practice. Mak found that in routine clinical practice the one-
third MCA method was more reliable than ASPECTS, which had higher potential 
in detecting more subtle EICs (130). On the other hand, Demaerschalk performed 
a head-to-head comparison of ASPECTS and ICE and concluded that both were 
reliable, comparable, easy to learn and quick. He found that ASPECTS allows for 
a conclusive estimation of the presence of 1/3 MCAT involvement (136). Other 
less commonly used scales are the International Stroke Trial (IST-3) scale and the 
63 
 
Boston acute stroke imaging scale (BASIS). They score the extent, location and 
swelling of an ischaemic lesion. The IST-3 scale was assessed in the ACCESS study 
along with ASPECTS and the 1/3 rule. It showed similar reliability to ASPECTS 
and the 1/3 rule (101). 
2.2.1.5 Significance of EICs on NCCT. 
The exact role of EICs in the NCCT in determining the patient’s suitability for 
thrombolysis and prediction of outcome has been debated (125;137). In a review 
of 14 studies by Wardlaw and Mielke, they found a consistent pattern indicating 
that presence of EICs was associated with poorer clinical outcome, but there was 
no evidence that, in the presence of EICs, thrombolysis worsened the functional 
outcome (106). In contrast, acute stroke patients with normal baseline NCCT 
seem to have a favourable outcome (74). In a detailed analysis of the relation 
between each early sign and outcome, Nakano et al. found that cortical sulcal 
effacement was significantly associated with increased post-thrombolytic leak of 
contrast with potential tendency to develop into haemorrhagic transformation. 
On the other hand, loss of insular ribbon and attenuation of lentiform nucleus 
were not correlated with the risk of haemorrhagic transformation (112). In the 
NINDS trial, the extent of EICs on the baseline CT was not included in the 
exclusion criteria for the trial. Investigators found increased risk of SICH in 
patients with visible signs of “oedema” on their baseline NCCT (42). However, 
later reanalysis of the NINDS trial with consideration of baseline NCCT 
prevalence of EICs showed no significant treatment modification effect, but 
there was a trend for decreased death rate and increased benefit of 
thrombolysis with favourable baseline NCCT (ASPECTS > 7) (113). The ECASS 
investigators introduced the concept of exclusion of patients from thrombolysis 
when they had early major infarct signs involving more than one third of MCAT 
within 5-6 hours from stroke onset. Although there was an increase in the risk of 
fatal ICH with an increase in the extent of EICs on pre-treatment NCCT (119), 
they did not prove the relation of EICs with thrombolysis and outcome (43). In 
reanalysis of data from ECASS II, authors found no influence of EICs on the effect 
of rt-PA on functional outcome, but there was substantial increase in the risk of 
thrombolysis related PH with low ASPECTS score (124). Despite the risk of sICH, 
the extent of EICs on baseline NCCT is not an independent predictor of outcome 
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and should not be the only reason to exclude a patient from treatment within 
the 3-hour window (57;138). The possible limitations of the use of EICs as a 
predictor of SICH might be due to a lack of agreement among physicians on a 
universal definition for EICs on NCCT and the old quality of CT scans on which all 
the reported studies were based (49). 
2.2.1.6 Detection of EICs on NCCT. 
EICs are prevalent on NCCT in the first few hours following stroke onset. The 
reported prevalence in the literature ranged from 60-80% (71;113;139). NCCT 
has shown poor sensitivity for detection of early ischaemia with values being 
around 75% (115;117;140-146). However, the specificity of these signs is 
generally good with values being around 90% (75;106;144). In general, it is 
difficult to determine the exact frequency of EICs because studied sets of scans 
were subjected to bias when they were selected. This is in part attributed to the 
relationship of stroke severity and time of admission which varied in the studied 
groups of stroke patients (bad strokes come to hospital faster and are more 
likely to be considered eligible for thrombolysis). Among the literature, the 
reported prevalence and sensitivity varied greatly. In the early 1990s, a study by 
Von Kummer et al. reported prevalence of 81.8% for hypodensity and CT 
sensitivity of 82% for ischaemic infarction within the first 6 hours of onset with 
lower values for shorter time intervals (94). Although this study used CT hard 
copies (precluding window adjustment by readers) and unclear patient selection 
methods, the pattern of results was similar to that reported by reanalysis of 
thrombolytic trials. In ECASS, where patients were enrolled within 6 hours, the 
prevalence of hypodensity was 46% while focal swelling was 21%. In contrast, 
patients who were involved in NINDS within 3 hours from onset of stroke had 
much less prevalence of any EICs at 30%. More broadly, Koga et al. studied the 
prevalence of each early abnormal sign separately and they reported 37% for loss 
of insular ribbon and 41% for both hypoattenuation of lentiform nucleus and 
hemispheric sulcal effacement (105). Similarly, a review by Sarikaya et al. 
showed the relation of frequency of these signs to the time interval from stroke 
onset. They found that loss of insular ribbon and attenuation of lentiform 
nucleus were the most prevalent signs in early stroke with frequency 77% and 
82% at 3 hours time interval respectively (103). However, lower prevalence 
65 
 
values were reported in some literature such as that reported by Aronovich et 
al., who found 28.7% for loss of insular ribbon, 20.7% for lentiform 
hypoattenuation and 41.3% for effacement of sulci (147). Unlike 
hypoattenuation, isolated focal swelling had much lower frequency values, such 
as the 13% prevalence reported by Na et al. (120). It was noted that the ability 
of observers to detect these changes depends on a number of factors including 
the time of first scanning, stroke severity, reader’s experience and scanner 
quality (74;94;126;148). A study of a stroke population consisting of 786 patients 
by Von Kummer et al. reported prevalence of hypoattenuation at 55% by expert 
readers and 34% by the study investigator. Along the same lines, experts 
attained a 64% sensitivity level, whereas study investigators achieved 40% only. 
Also, they found that sensitivity in the first hour of stroke onset was 58%, which 
is less than that achieved in the next hours (66%)(74). In contrast, a web study 
by Wardlaw et al. revealed that the speciality of readers and not years of 
experience was associated with improved detection of EICs. In addition, severe 
EICs were detected more frequently than mild signs by all readers (121). Suar 
and colleagues compared CT sensitivity to that of MRI and they found that EICs 
were present on 33 of 45 scans with sensitivity of 73%, which did not differ 
significantly from the sensitivity achieved with knowing the affected hemisphere 
(76%) (117). However, almost the same level of sensitivity had been reported by 
both Kalafut et al. and Barber et al. with a value at 78% (71;129). A study by Lev 
et al. sought the effect of using variable window sittings on the detection of EICs 
on NCCT and found that sensitivity increased from 57% to 71% when non-
standard soft-copy settings were used. On the other hand, reported specificity 
kept constant at 100% with different window settings (149). 
    2.2.1.7 Agreement in assessing EICs on NCCT. 
In clinical practice, thrombolysis decisions fortunately do not depend only on 
detection of EICs because no standardised approach to this issue has yet been 
agreed on. The ways of assessing the observer agreement on EICs varied greatly 
among publications in relation to many factors, including statistical analysis, 
observer’s speciality and experience, patient characteristics, clinical data 
availability, the definition and scoring systems for EICs and CT scan quality and 
the way of viewing it (Table 2-2).  
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Von Kummer et al. (94) assessed the inter-observer agreement among 
neuroradiologists to prove the presence and the ability to recognise EICs. They 
defined the changes, illustrated them by CT examples and asked readers to 
recognise them and only to determine the extent of hypodensity on NCCT 
according to a 20% scale: <20%, 20-40%, 41-60%, 61-80%, >80%. They calculated 
agreement in different situations, including percentage agreement on early signs 
of infarction among all readers and with the exclusion of readers in least 
agreement, percentage agreement with reference, chance adjusted agreement 
(kappa) for dichotomous ratings for HMCA, focal swelling and hypodensity, 
ordinal kappa for extent of hypodensity, pairwise agreement between each 
reader and another, and analysis of readers’ responses to determine the clear 
majority vote and number of agreements with reference. The multiple ways of 
manipulating data yielded more information on how observers agreed on EICs. 
For instance, unblinding did not change agreement significantly, exclusion of the 
least consistent reader improved overall agreement with reference and using 
large partitions of MCAT rather than smaller ones to estimate the volume of 
hypodensity increased agreement percentage considerably. In this study, they 
estimated agreement by 5 different statistical measures (Table 2-2) which 
resulted in different levels of agreement for the same variable under the same 
conditions. With exclusion of HMCA sign, kappa for multiple raters ranged from 
0.55-0.59 indicating moderate agreement according to the Landis and Koch 
scale. However, the pairwise weighted kappa ranged from 0.32-0.79 indicating 
fair to substantial agreement. When they estimated extent of hypodensity by 
rates, they attained low values although kappa values were indicating 
substantial agreement. Meanwhile, pairwise weighted kappa values were 0.37 to 
0.80 which might correlate with the low percentage of overall agreement 
percentage.
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Table 2- 2: Studies of EICs reliability. 
Study 
Statistics for assessing 
agreement 
Readers CT scans Clinical data EICs evaluated 
Von Kummer et al 1996 
-Kappa for –multiraters 
-Ordinal kappa 
-Pairwise weighted kappa 
-ICC. 
-Percentage of overall 
agreement 
6, 
-Neuroradiologists 
Reference neuroradiologist 
-Two sequential sessions  
-45, <6hrs 
-5-10mm slice thickness 
-Hard copy 
Blind\non-blind 
HMCA, parenchymal 
hypodensity, focal brain 
swelling. 
+ definitions. 
Extent ( increments of 20%) 
Lev et al 1999 
  
-Weighted kappa 
2, 
-Neuroradiologists 
-Two separate sessions 
(4wks) 
-Consensus  
-30,<6hrs 
-Standard window width and 
centre level(80,20 HU) 
-Variable soft copy 
settings(1-30HU window) 
(28-36 HU centre level) 
- imaging workstation 
Blind  
Focal hypodensity 
+ 1-5 scales 
Wardlaw et al 1999  
-Absolute numbers 
-Percentage of agreements. 
15, 
-Neuroradiologists E 
-Neurologists E+T 
-Stroke physicians E 
-General practitioner 
-Trainee physicians 
1 session 
14,<6hrs 
-  hard copy slides 
Blind\non-blind 
HDMCA 
LIR, loss of basal ganglia, 
hypodensity, sulcal 
effacement,  
Extent (1\3 rule) 
Grotta et al 1999  Balanced pairwise kappa. 
16, 
NINDAS investigators 
Neurologists 
Emergency stroke physicians 
Stroke fallows 
Radiology fallows 
Neuroradiologists(reference) 
One session 
70, 3hrs 
10mm slices 
Hard copies 
Non-Blind  
-Oedema 
-Mass effect 
-Loss of Gr-Wt  
Hypodensity 
Sulcal effacement 
Any early change 
-Extent (1\3rule). 
Definitions+ illustration 
course 
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Study 
Statistics for assessing 
agreement 
Readers CT scans Clinical data EICs evaluated 
Barber et al, 1999 kappa statistics? 
2, 
Neuroradiologists 
Consensus 
17,6hrs 
1-cm trans-axial slices 
Hard copies 
Blind 
HMCA 
Hypodensity 
Cerebral oedema 
Definitions 
Extent (1\3rule) 
Marks et al, 1999 
ICC 
Pairwise kappa 
 
3, 
Neuroradiologists 
 
50,<6hrs 
 
Blind 
Hypoattenuation 
Sulcal effacement 
HMCA 
Extent(1\3 rule) 
 
Kalafut et al, 2000 Percentage agreement 
3, 
Neuroradiologists 
2sessions 
25,3hrs 
 
Blind 
Non-blind for scans 
arising disagreement 
ATLANTIS criteria sheet 
Extent (1\3 rule) 
 
Pexman et al, 2001 Balanced pairwise kappa 
6, 
Stoke Neurologists 
Neuroradiologists 
2sessions 3wks 
 
 
156?, 3hrs 
10mm slices 
Hard copies 
Blind 
Non-blind 
 
Hypoattenuation 
Focal brain swelling 
Definition 
ASPECTS(<,>7) 
1\3 rule 
Fiebach et al, 2002 
Unweighted kappa 
Pairwise kappa 
9, 
Neuroradiologists 
Neurologist 
Residents 
2 sessions 
54,<6 
8mm slices 
 
blind 
HMCA 
LIR, OLN, cortical focal 
swelling 
Extent (1\3rule) 
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Study 
Statistics for assessing 
agreement 
Readers CT scans Clinical data EICs evaluated 
Saur et al, 2003 Kappa for multiple raters 
6, 
-Neuroradiologists 
-Neurologists 
2 sessions 
46, 6hrs(categorised) 
2mm 30\80HU 
6mm 35\50 HU 
Hard copies 
Blind 
Non-blind 
HMCA 
Hypoattenuation 
Cerebral oedema 
Definitions 
Regional classification 
Extent ( 1\3 rule) 
Mak et al, 2003 
Percentage agreement 
Pairwise kappa 
Prevalence adjusted 
kappa. 
5, 
-Neuroradiologists 
-Neurologists 
-General radiologist 
 
80, <6hrs 
5-10mm 
Hard copies on viewing 
box 
Blind 
6 EICs ? 
Extent (1\3rule) 
Extent ASPECTS(<,>7). 
Demaerschalk et al , 
2005  
Unweighted kappa 
ICC. 
4, 
Stroke neurologists 
40,<6hrs 
Hard copies with viewing 
boxes 
 
Blind  
Loss of Gr-Wt 
Sulcal effacement 
Subtle lucency 
1\3 rule 
ASPECTS 0-10 
Muir et al, 2007  
Cohen’s kappa statistic 
with the Fleiss-Cuzick 
extension for 
multirater analyses. 
5, 
Neuroradiologists 
Stroke neurologist  
Stroke physician  
32,<6hrs 
DICOM viewer software 
Blind  
Isodense swollen 
Hypodense swollen 
Hypodense 
Extent ASPECTS 0-10  
Wardlaw et al, 2010  
Calculating the area 
under 
receiver operator 
characteristic (ROC) 
curves (AUC) 
258, 
Neurologists, 
geriatricians, general 
radiologists, 
neuroradiologists, 
emergency physicians, 
family doctors 
Years of experience <>5, 
32 duplicated 63,<6hrs 
‘‘SMPTE’’ test 
Scans stored in digital 
jacket in jpeg format and 
uploaded to web site of 
study with advantage of 
SMPTE for monitor 
adjustment. 
 
 
Blind 
HMCA 
Mild\sever 
hypoattenuation 
Mild\sever swelling 
Definitions  
Extent 1\3 rule, 
ASPECTS0-10, IST-3 score 
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However, investigators did not take the patient’s characteristics into account 
when selecting scans for the study, and also they used a homogenous group of 
readers and standard CT characteristics, which could leave an open question 
about their effect on agreement. The short interval between the two viewing 
sessions might not be enough to eliminate the effect of subconscious memory in 
reading the unblinded set of scans which could affect the result of agreement 
too. In addition, estimation of swelling extent, which is more difficult than 
estimating the extent of hypoattenuation, was not included, and could have 
further lowered the agreement values. In subsequent studies of agreement, 
some of these factors were clarified. 
Lev and his colleagues sought the effect of changing the window settings of 
scans on detection of EICs by two neuroradiologists. Although detection 
improved significantly, agreement did not show the same pattern (0.48 to 0.50). 
Authors used weighted kappa for two raters to assess agreement on a diagnostic 
scale rated 1-5 with 1 indicating definite absence of stroke and 5 indicating 
definite stroke. The idea of this rating scale was different from other ways of 
rating EICs in that it did not assess the extent of ischaemic change directly. 
Consequently, the agreement level attained by Lev and his colleagues is difficult 
to compare with other studies. However, the main concern of the study was to 
determine the reliability and accuracy of detection of EICs rather than inter-
observer agreement (149). 
Wardlaw and colleagues considered the effect of speciality and experience in 
studying how good physicians were in detecting EICs. The authors expressed 
their results in absolute numbers of observations and the percentage agreement 
value on EICs was not recorded in the study. They found that inexperienced 
doctors failed to recognise EICs, while experienced observers missed hypodensity 
frequently. This might have been due to the poor definition of EICs and their 
extent in the context of this study. However, the ability of readers to reproduce 
their results regarding coding scans as normal versus abnormal was good (150). 
Grotta and his group provided a broader analysis of agreement between 
different specialities including a number of physicians who had participated in a 
NINDS trial. A short training course for readers, stroke severity consideration 
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when selecting scans and the use of balanced kappa and repeated sampling were 
all tried to optimise agreement. Even so, the agreement was only fair and not 
affected by the speciality and experience of readers. This might be related to 
the low prevalence of EICs in selected scans which affects the values of kappa 
significantly. Moreover, the compared groups of physicians were small and 
unequal, which could make comparison questionable (122).  
In the studies where the main aim is not to assess the agreement between 
readers on EICs on the NCCT, the values obtained would be less reliable than 
those of well-designed studies of agreement. For example, Barber et al. (115) 
reported kappa value at 0.44, while Kalafut et al. reported 96% agreement on 
involvement of >1/3 of MCAT. In the Kalafut et al. study, there were no clear 
definitions for EICs involved in the study and it was left up to the reader’s 
discretion (129). Marks et al. (144), in a full approach to EICs on NCCT, reported 
a similar level of agreement to Barber et al., the results between 3 readers with 
pairwise kappa values being 0.44, 0.50 and 0.65. Both studies tested 
neuroradiologists and looked for almost the same EICs but with different 
definitions and the total number of scans involved in each study. 
When Pexman et al. assessed the ASPECTS score versus 1/3 MCAT rule, they 
reported pairwise kappa values between different specialities ranging from 0.56 
to 0.89 for ASPECTS and 0.20 to 0.64 for 1/3 rule. However, when the same 
speciality was considered, the highest agreement was between neuroradiologists 
(0.89) when using ASPECTS and the lowest agreement again between 
neuroradiologists (0.52) when using the 1/3 rule (132). In a study comparing CT 
and MRI, Fiebach et al. calculated the agreement between experts and novice 
physicians with results ranging from 0.42 to 0.52 for detection of each infarct 
sign on NCCT by experts, while novices showed lower agreement in detection of 
early infarction signs with kappa at 0.38 (151). A similar study was conducted by 
Saur et al. but with a different way of analysing the data. They reported 
moderate agreement on EICs with kappa value of 0.57 for the blinded set and a 
substantial level of agreement with 0.67 for an unblinded set of scans. However, 
both values had no significant difference statistically. The agreement did not 
differ significantly between both groups of readers, with 0.65 and 0.60 for 
neuroradiologists and neurologists respectively. In separate analysis for scans 
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obtained in the first 3 hours, interrater agreement fell to 0.36. In addition, Suar 
et al. assessed the intrarater agreement and found that raters did not change 
their readings of the same scans when presented for the second time with kappa 
of 1 for each rater and 0.67 to 0.90 for different regions (117). Mak et al. did not 
specify the EICs which they were assessing and the calculated agreement was for 
the extent of these changes by comparing 1/3 MCAT rule and ASPECTS scoring 
systems. Paired kappa ranged from 0.10 to 0.88 by using aspects with an average 
of 0.44 and from 0.31 to 0.72 by using 1/3 MCAT rule with an average of 0.49. 
Readers consisted of different specialities and they had a brief training in 
reading the scans before commencing the study (130). In contrast, Demaerschalk 
et al. reported a substantial level of agreement (0.72) between stroke 
neurologists when they used ASPECTS and ICE. Observers scored NCCT from 0-10 
using ASPECTS. Hence the ICC was calculated for ASPECTS (0.79). However, 
investigators did not illustrate EICs and their definitions (136). Muir et al. 
calculated both interobserver and intraobsever agreement on each sign of early 
infarction independently. Although observers agreed on hypodensity and 
isodense swelling poorly, with kappa values 0.15 and 0.08 respectively, the 
intrarater agreement between individual readers was good (75). The ACCESS 
study presented more details on observer reliability in the detection of EICs. 
This was by involving a large number of observers [258] from different 
specialities and scientific backgrounds, and assessing all the factors related to 
observers, scans and patients on a changing level of agreement. These included 
presence of ischaemic sign, time to scan, brain background appearance, 
speciality, years of experience and time to read the scan. Additionally, they 
used web technology to present compressed images to readers who had the 
ability to adjust the screen for better visualisation of scans. The agreement with 
a reference standard was only reported by using AUC and odds ratios. However, 
the agreement between readers was not assessed (101). 
2.2.1.8 Analysis of agreement variables. 
Most of the studies which were conducted to assess the agreement level on 
EICs had different approaches. Many authors were concerned with how the 
observers would agree in the presence of a number of variables related to scans, 
the patient and the readers themselves.  
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A- Speciality and experience of readers. 
Expert neuroradiologists were one of the most tested groups. They generally 
showed moderate to substantial agreement with almost the same values of 
kappa reported in several papers, ranging from 0.44 - 0.79 (94;115;129;144;149). 
Although fair agreement levels with kappa values at 0.32 and 0.35 were reported 
in some studies, these findings were blamed on the involvement of inconsistent 
observers, with improved agreement when excluded (94). In ACCESS, 
investigators found that the highest agreement level with reference standards 
was achieved by neuroradiologists and followed by stroke physicians. However, 
they did not assess agreement among the different groups of readers or the 
totality of participants in the study. The exclusive approach in repeating studies 
of agreement among expert neuroradiologists might be pointless since other 
specialties are more frequently involved in taking the rapid treatment decisions, 
including stroke physicians, general radiologists and emergency physicians. 
Among stroke physicians, agreement was substantial to perfect in three studies: 
0.60, 0.72, 0.85 (117;132;136). However, the studies which involved more than 
one or two specialties showed only fair to moderate agreement: 0.22-0.43 by 
Grotto, and 0.44 by Mak (122;130). According to the ACCESS study (101), years 
of experience in reading stroke scans seem to have no effect on agreement 
level, but a longer time being spent on assessing the EICs was the main 
determinant of increasing the odds of agreeing. However, experience in reading 
stroke scans makes a big difference between experts and novices when agreeing 
on EICs (151).  
In many papers where the readers had a poor performance in reading EICs, 
authors suggested that training observers on how to recognise EICs would 
improve overall agreement. A study by Von Kummer et al. showed a significant 
increase in the number of correct estimates by trained participants. They found 
that the trained ECASS II investigators reduced the number of falsely included 
patients in the trial to an extent similar to that found in the study, and the 
proportions of patients with large infarctions or ICH reduced to 50% in 
comparison with ECASS I (152).  
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B- Patient characteristics. 
Factors related to patients, such as age, gender, morbidity and NIHSS score, 
were not considered in the majority of agreement on EICs studies and patients 
were included in these studies based on their scan findings. Although authors 
mentioned the age and gender in some studies, they rarely assessed their effect 
on agreement on EICs on NCCT. However, NIHSS scores were involved more 
frequently in the inclusion criteria of patients, but also were not correlated with 
agreement on EICs. In the ACCESS cohort, investigators studied the relation of 
NIHSS and age with EICs and they found that increasing age increased both 
detection of EICs and agreement with reference standard, whereas NIHSS scores 
had no effect (101).  
C- Scan quality. 
Generally, authors found no effect on agreement level in the presence or 
absence of clinical data with scans. However, other intrinsic factors related to 
CT technology were less often mentioned although it was common to blame poor 
performance on early generations of CT scanners regarding depiction of early 
signs of infarction. In studies where the effects of scan quality (in terms of 
noise) and window settings were tested there was no significant effect on 
agreement, although the sensitivity might change significantly (101;149). The 
study of effect of matrix size on detection of EICs by Ogura et al. showed the 
effectiveness of applying reasonable matrix size in the examination of EICs 
(153). The other intrinsic factor which might affect detectability is the slice 
thickness of scans. In most studies of agreement by using multidetector 
scanners, the slice thickness was 5-10mm. Tanaka et al. found that using greater 
slice thickness improves the detectability of hypoattenuated objects 
significantly (154). However, the use of both thin and thick slices was 
recommended by some neuroradiologists to increase diagnostic accuracy in early 
strokes with offset against the additional time to evaluate (155). In contrast, a 
longer time to scan, severe ischaemia and old stroke lesions were all associated 
with increased agreement on EICs. However, white matter changes had a 
negative impact on agreement (101). More recently, use of modern Digital 
Imaging and Communications in Medicine (DICOM) image viewers has allowed the 
readers to manipulate the scan window level and adjust the best view of scan 
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slices. Moreover, advanced Web tools have helped to save scans in optimal 
sittings and use them for large-scale studies (75;101;121).  
On the other hand, there has been no proof of the superiority of using DICOM 
technology over hard copies and viewing boxes in practical and research sittings. 
D- Statistics of agreement. 
Kappa statistics (chance-adjusted-index of agreement) were used 
predominantly to measure inter-observer variability in assessing EICs on NCCT 
with reference to Landis and Koch’s scale for agreement level in Table 3.4 
[Chapter III]. Percentage of agreement, intraclass correlation coefficient (ICC) 
and ROC analysis were used to a lesser extent. Kappa exists in various forms 
which should be taken into consideration when analysing data for assessment of 
agreement. For instance, weighted kappa penalises disagreements in terms of 
their seriousness (i.e. the degree of disagreement in grading – e.g. two observers 
scoring a region as a 1 and a 5 respectively is weighted more heavily than two 
observers scoring a 4 and a 5), whereas unweighted kappa treats all 
disagreements equally. Consequently, values obtained by the two measures will 
differ dramatically. Scharf et al. reported a value of 0.19 by unweighted kappa 
and 0.35 by using weighted kappa which changed agreement from slight to fair 
(156). In addition, there are different weighting schemes for weighted kappa 
which produce different values from the same data, including linear and 
quadratic weightings. The linear weighting is used when the difference between 
rated categories is significant, whereas quadratic weighting is applied when the 
difference is not so important. However, the magnitude of kappa along with its 
interpretation is influenced by other factors which differ markedly among 
various studies. Among these are prevalence of EICs, bias and non-independence 
of ratings. Prevalence and/or bias adjusted kappa (PABAK) scores were used in a 
number of studies shown in Table 2-2. Nevertheless, balanced kappa values 
should be displayed alongside true kappa values because the former reflect a 
hypothetical situation in which no prevalence or bias effects are present. For 
example, Mak et al. calculated both kappa and PABAK with higher values for the 
second one, e.g. 0.72 to 0.90 respectively.  
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The previous implementations of kappa are used for two raters, but in the 
presence of more than 2 raters, Fleiss’s kappa for multiraters is employed to 
assess overall agreement among raters. Generally, there are two forms of kappa 
for multiraters: fixed-marginal kappa and free-marginal kappa. Unlike Cohen’s 
kappa, there are no weightings; hence the results might be less reliable in some 
situations when kappa values are low in the presence of good agreement. In this 
case, the calculation of pairwise weighted kappa for each pair of readers with 
total average could help to better reflect the true agreement level among 
raters. In the study conducted by Von Kummer et al. (94), they applied varied 
forms of kappa to assess the true agreement among raters.  
Percentage of agreement does not take into account agreement that would be 
expected purely by chance. Consequently, the overall agreement rate may be 
high in the absence of intrinsic agreement between raters. Kalafut et al. applied 
percentage agreement solely, and the interpretation of results was rather 
ambiguous in the absence of an appropriate scale (129).  
Intraclass correlation coefficient is used with continuous data and it takes into 
account the variance between observations. ICC may be preferred over Fleiss’s 
kappa to asses multiple raters agreement because it gives more favourable 
levels of agreement. Marks et al. and Von Kummer et al. used ICC to calculate 
overall agreement between multiple readers beside weighted kappa for 
individual pairs.  
The Receiver Operator Characteristics (ROC) curve is used mainly to evaluate 
how accurate a diagnostic test is, whereas the Area under Curve (AUC) evaluates 
the test’s effectiveness. However, this requires a reference standard (“gold 
standard”) to estimate agreement. In the ACCESS cohort, AUC with odds ratios 
were used to measure the agreement of each group of observers against a gold 
standard. However, this method is not suitable to assess agreement among 
raters. In brief, whatever the statistical method used by authors to assess 
agreement on EICs, it should be interpreted and compared cautiously. 
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D- Early signs being assessed. 
Since the emergence of the concept of early signs of infarction there has been 
increased interest in their evaluation with concomitant multiplicity in the terms 
being used to describe these changes. The calculated agreement for early 
changes varied according to the main focus in individual studies. For instance, 
Lev et al. measured agreement on focal parenchymal hypoattenuation only, 
whereas Mak et al., who reported similar results, did not mention that 6 signs 
were assessed because the main purpose of their study was to compare ASPECTS 
and the 1/3 rule.  
In more than two studies, authors tended to assess two categories of EICs - 
hypodensity and brain swelling - simultaneously (94;101;115;117;132;144). 
However, some authors gave different definitions to each category and others 
used synonyms for brain swelling, such as cerebral oedema (115;117). They 
measured agreement either for each change alone, or altogether. In other 
studies, authors adopted a broader evaluation of early infarction signs on the 
NCCT by involving more than the usual two parenchymal changes 
(122;136;150;151). For instance, Grotta et al. measured both agreements on and 
extent of loss of grey-white matter interface, hypodensity and cerebrospinal 
spaces compression, aiming to assess the performance of experts in reading each 
change separately. In contrast, Demaerschalk et al. did not record the 
agreement on each sign they explained to readers because the main focus was 
on comparing ASPECTS with the ICE method in quantifying EICs. 
 
2.2.1.9 Detection of Penumbra on NCCT. 
Imaging of brain ischaemia with positron emission tomography (PET) revealed 
the physiological characteristics of penumbra. Along the same lines, magnetic 
resonance diffusion-perfusion mismatch and perfusion CT demonstrated the 
existence of both grey and white matter penumbral tissue. Basically, penumbra 
is a hypoperfused tissue with compensatory vasodilation or early post-ischaemic 
hyperperfusion which was proved to correspond to an area of tissue swelling 
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without change in X-ray attenuation on NCCT (Figure 2-5B) (75;102;120). 
Moreover, unlike parenchymal hypoattenuation, isodense focal swelling is less 
likely to progress into infarction with major reperfusion (102). CT attenuation of 
brain swelling caused by cerebral vasodilatation does not decrease (isodense) 
and theoretically it might increase due to the relative increase in the blood 
content of the tissue (increased attenuation on CT). Conversely, brain swelling 
due to ischaemic oedema causes reduction in CT attenuation as a result of the 
increased tissue content of water (120). The prevalence of isodense swelling in 
many studies was not reported and, when assessed, it was very low. For 
instance, Von Kummer et al. reported a prevalence of 2%, whereas Na et al. 
reported 13% (119;120). Overall, the depiction of penumbra on NCCT and its 
distinction from infarct core appearance has been under-evaluated in most of 
the literature. Detection of this sign in the first few hours after stroke onset on 
the NCCT seems to be more difficult than the recognition of subtle hypodensity 
itself. Moreover, estimation of its extent and its separation from hypodensity 
appears to be complex.  
Von Kummer et al. (94) estimated the extent of parenchymal hypodensity 
alone without the involvement of focal swelling and suggested that brain 
swelling and hyperdense segments of arteries should not be included in the 
estimation of the extent of EICs on baseline NCCT to decide eligibility for 
thrombolysis because of their different pathophysiological background (125). 
Subsequent studies on isodense brain swelling recommended its exclusion from 
the ASPECTS score (107). However, studies of EICs and clinical outcome did not 
exclude the sign of brain swelling from the overall estimated extent of EICs on 
baseline NCCT (113;124;134). This might be attributed to a number of factors, 
such as considering tissue swelling and hypoattenuation as a manifestation of the 
same underlying pathology which is oedema, non-separation between the two 
forms of swelling associated with early stroke, and the infrequency and subtlety 
of isolated focal swelling (124). In addition, scoring systems like ASPECTS and 
1/3 rule do not differentiate these findings unless the investigator discriminates 
them on baseline evaluation (119). However, mixing up these two findings when 
estimating the extent of EICs on pre-treatment NCCT may explain the dramatic 
recovery from apparently extensive baseline EICs in some cases (134;157). On 
the other side, some cases with marked isodense swelling without concomitant 
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hypodensity on baseline NCCT progress to infarction despite successful 
reperfusion (107). 
2.2.1.10 Hyperdense middle cerebral artery sign (HMCA). 
This sign is a marker of intraluminal thrombus, most often seen in the MCA, 
but also reported in other intracranial vessels. It can be seen in the MCA M1 
segment as hyperdense linear streaks following the course of M1 from its origin 
toward the Sylvian fissure (Figure 2-2c). Additionally, the MCA dot sign is seen 
as a circular hyperdensity in M2 and M3 segments as result of occlusion of distal 
branches of MCA (158) (Figure 2-6). Also, occlusion of the internal carotid artery 
may be displayed on NCCT as a hyperdense ICA sign indicating thrombus within 
the supracliniod segment of the distal ICA. Other arteries were also reported as 
hyperdense PCA (159). 
Reported prevalence varied among reports. Barber et al. found it in 5% of 
patients, while Ozdemir et al. saw it in 35% of NCCT scans (123;160). The HMCA 
sign has high specificity (100%) but low sensitivity ranging from 24% to 54% 
(161;162). This might be attributed to the effects of a number of factors, 
including slice thickness, experience of readers and haematocrit level. For 
instance, a study by Kim et al. revealed that thin-section slices had higher 
sensitivity and specificity (up to 100%) for detection of acute thrombus 
compared to 5-mm slices(163). An added value to thin-slice CT is the ability to 
assess the length and volume of acute thrombus and quantification of the extent 
of vascular obliteration (164). In most studies assessing the agreement on early 
parenchymal changes, authors also reported agreement on the HMCA sign. 
However, agreement swung from fair to perfect among papers (106). Generally, 
it has been found that the HMCA sign is associated with severe stroke and poor 
functional outcome (106;161;165) and sometimes with large embolic infarcts 
(166). However, there is no evidence to exclude those patients from 
thrombolysis (161;165). Kharitonova et al. found that the risk of symptomatic 
ICH after thrombolytic therapy was similar in HMCA and non-HMCA groups of 
patients (161). In a cohort study of patients who were registered in (SITS-ISTR), 
there was a good outcome in patients with disappearing HMCA sign after 
thrombolysis twice as many as patients with persistent sign. Additionally, 
81 
 
authors found that HMCA predicted functional independency and survival 
independently and the early NIHSS improvement predicted HMCA disappearance 
(167). Comparably, the HICA sign was found to be associated with severe initial 
neurological deficit and worse prognosis than HMCA sign even in the presence of 
thrombolysis (160). On the contrary, the MCA dot sign appeared to be associated 
with better outcome than HMCA sign (123). All of this was consistent with the 
sign indicating only the site of occlusion, rather than independently indicating 
severity. 
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Figure 2. 6: Examples of hyperdense vessel sign in NCCT and tissue fate on 
follow up (>24 hours) scans. A-MCA “Dot” sign (arrow); seen after154 minutes 
after stroke onset in a 41-years-old woman. Patient received rtPA with 
recanalisation and disappearance of HVS and good outcome after 3 months. B-
HICA sign as seen in a 76-years-old woman who presented after 137 minutes 
from onset with sever stroke and had poor outcome. Follow up scan showed 
infarction of the whole left hemisphere. C-HMCA sign as seen in a 76-years-old 
woman after 164 minutes from stroke onset. There was no recanalisation and 
patient had poor outcome. 
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2.2.2 Perfusion Computed Tomography (PCT) in 
acute stroke. 
    Conventional NCCT is still the primary imaging modality preferred by most 
emergency departments for the initial evaluation of strokes. However, for 
detection of early ischaemic changes and stratifying patients for thrombolysis, 
NCCT faces the problem of the subtlety of EICs. Hence, it has been suggested 
that the evaluation of cerebral perfusion might aid selection of stroke patients 
suitable for thrombolysis. In other words, it might help in distinguishing 
salvageable tissue which is at risk of infarction from that with extensive 
irreversible ischaemia. PCT imaging has the potential to improve the overall 
performance of CT for management of early stroke because it visualises the 
underlying pathophysiology rather than structural signs of brain damage. Thus, it 
enables depiction of the perfusion deficit on the tissue level. PCT is considered a 
relatively new technique which allows quantitive and qualitative assessment of 
cerebral perfusion. It has been found that PCT is useful for non-invasive 
diagnosis of cerebral ischaemia and it complements NCCT and CT angiography 
(168). In general, the perfusion technologies are of two major branches, a 
diffusible tracer technique which relies on the rapid passage of a lipophilic 
agent across the blood brain barrier (BBB) into the brain tissue. Determination of 
perfusion flow requires determination of the agent’s amount intravascularly and 
in parenchyma. The second branch is the non-diffusible tracer technique which 
involves the use of an agent which remains inside blood vessels and does not 
pass into brain parenchyma assuming intact BBB. Quantification of perfusion 
parameters is done through analysis of time-density curves. The last branch 
represents the technology of perfusion CT(169).  
2.2.2.1 PCT technique. 
PCT is a rapid add-on examination which takes only a few minutes to perform. 
PCT generates maps of cerebral perfusion parameters, typically cerebral blood 
flow (CBF), cerebral blood volume (CBV), mean transit time (MTT) and time to 
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peak (TTP) (Figure 2-7). CBV is defined as the total volume of blood in a given 
unit volume of brain. This includes blood in large vessels and in the tissue. It is 
measured by millilitres of blood per 100g of tissue. CBF is defined as the volume 
of blood moving through a given unit of tissue per unit of time. It is measured by 
millimetres per 100g of tissue per minute. MTT is defined as the average transit 
time of blood via a given brain region and it is measured by seconds. TTP is the 
time from the beginning of contrast injection to maximum enhancement within a 
region of interest (164;170). 
 
Figure 2. 7: PCT perfusion parameters from patient with acute stroke with left 
side perfusion defect at 5 hours from symptoms onset showing CBV\CBF or MTT 
mismatch [ ASPECTS areas are plotted on the maps]. 
Perfusion studies are obtained by tracking transient changes in blood vessel 
and brain parenchyma during the first pass of intravenously injected iodinated 
contrast agent (non-diffusible perfusion technology), which causes a transient 
increase in the Hounsfield Units in linear relationship with its concentration in 
the perfused tissue. Perfusion parameters can be obtained from pixel-to-pixel 
analysis of density changes over time. These changes can be graphed as regional 
time-attenuation curves (TAC) for each voxel and from which perfusion 
parameters can be calculated (Figure 2.8). The evolving of high-speed 
helical/spiral CT scanners having solid-state detectors and a gantry-design (a 
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high gravitational force generated by fast rotation) with the advantage of 
software facilitated the accurate measurement of perfusion parameters with 
rapid analysis and pushed up perfusion CT to the current state. Two tracer 
kinetic models were described for calculation of the perfusion parameters. 
These techniques are based on the indicator dilution principle in which the 
concentration of a known amount of injected contrast material is measured 
against the time in intracranial vessels. The first one is the central volume 
principle which describes CBF as simply related to CBV and MTT. The accuracy of 
this method requires an intact blood-brain barrier to preserve contrast material 
to intravascular spaces. Any leakage to extra-vascular tissue causes spuriously 
high values of flow parameters. The mathematical approach involved in the 
calculation of perfusion parameters is called the “deconvolution” operation. 
This method, however, has to meet some conditions to derive perfusion 
parameters, including a need for a gamma variate fit to evaluate the bolus first 
pass only to avoid the violation of simple-voxel compartment assumption, and 
the determination of arterial input function (AIF) to isolate the true tissue 
response function from the measured parenchymal density curve by 
mathematical deconvolution. 
 
 
   Figure 2. 8: Time attenuation curve plotted from perfusion data of normal 
brain tissue [modified from Tomandle et al.]. 
86 
 
 
The true AIF into the tissue voxel of interest cannot be measured directly and 
is usually estimated from a major artery, such as MCA, assuming that this vessel 
represents the input to the tissue of interest. Any delay or dispersion of bolus 
will cause errors in the estimation of CBF. However, the potential effect of 
multiple collateral vessels in maintaining residual perfusion in ischaemic 
compartments may affect the AIF by the creation of multiple inlets equal to 
ischaemic voxels which violates the underlying perfusion model assumption. 
The second approach is the maximum slope model technique, in which CBF is 
calculated from the maximum slope of TAC, and CBV from the maximum 
enhancement of TAC in a voxel of interest compared with that of superior 
sagittal sinus. This is to avoid arterial partial-volume averaging effects. Because 
the model necessitates that the bolus should be retained temporarily by the 
capillary network in order to obtain valid values of blood flow, the contrast 
material is injected at very high rates in this model to achieve rapid arterial rise 
time within a few seconds. Otherwise, CBF will be underestimated. The 
mathematical method involved in the calculation of perfusion parameters is 
called the “non-deconvolution” operation which assumes venous outlet to be 
equal to zero. This simplified and sped up the calculations by this model 
compared to the “deconvolution” operation, which is more demanding and 
involves complicated and time-consuming processes. Hence, the interpretation 
of results which relied on the “non-deconvolution” method may be less reliable 
than those reliant on the “deconvolution” operation. The very short time span 
for each curve to peak eliminated the need for gamma variate fitting for 
calculation of perfusion parameters. Therefore, this approach is insensitive to 
motion and does not require recirculation correction or operator decisions. On 
the other hand, due to partial volume effects inherent to 5-10 mm slice 
thickness, the selective calculation of absolute perfusion parameter values might 
be inaccurate and  comparesion of CBV and CBF values in both ischaemic and 
non-ischaemic hemisphere would be a safer approach. Both illustrated models 
represent the basis of current multiple software applications for brain CT 
perfusion (169;171-173). The quantification of CBF by perfusion CT has been 
tested and studied extensively in animals and humans. In humans, it has been 
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validated against other functional imaging techniques, such as XeCT, PET and 
MRI (174-178). 
  Image acquisition in perfusion CT occurs for a total of 45-60 seconds and up 
to 90 seconds in a multiphasic approach with scanning at 80kV. However, these 
parameters have been adjusted to minimise a patient’s exposure to radiation. 
The coverage of brain tissue depends on the width of the CT scanner detector 
which is limited in the craniocaudal direction in many scanners (but not all) and 
therefore typically does not allow whole brain assessment. Hence, it is 
important to pre-determine the target tissue of interest to be covered before 
starting PCT acquisition (168;179;180). Following data acquisition, the source 
images are processed in workstation for generation of parametric maps and data 
processing is accomplished by using special software packages. These tools 
generate colour-coded maps and time-attenuation curves from which perfusion 
parameters can be calculated for any area of interest which could be chosen 
manually by the operator (as was described above). Non-cerebral tissues can be 
removed by masking using semi-automated “image segmentation” which 
depends on using thresholds based on attenuation measurements. Calculation of 
perfusion parameters might be subject to delay and dispersion which can result 
in underestimation of CBF and overestimation of MTT which can be overcome by 
the deconvolution technique or by using local AIF estimated from smaller vessels 
close to ischaemic tissue (168;180). Quantitative analysis may aid the use of 
threshold values to determine infarct core, penumbra and normal tissue. One 
suggested operationally defined penumbra is the volume of tissue contained 
within the region of CBF/CBV mismatch on PCT maps (180). On the other hand, 
the core has reduced both parameters, CBV and CBF. Quantitative assessment is 
done by placing regions of interest (ROIs) in suspected ischaemic areas and 
corresponding locations in the contralateral hemisphere. Relative and absolute 
values of perfusion parameters in these regions can be obtained. Thresholds 
were determined for both penumbra and core using relative and absolute values 
of CBF and CBV. Most papers referred to thresholds derived by Wintermark et al. 
which assumed cut-off values greater than or equal to a 34% reduction from 
baseline CBF for penumbra and less than or equal to 2.3-2.5ml\100g  CBV for 
core, while relative MTT above 145% of the normal hemisphere outlined all at-
risk tissue (178). Later on, they studied 130 patients having acute stroke and 
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found that relative MTT was the most accurate parameter characterising the 
penumbra and absolute CBV the parameter most accurately describing the 
infarct core (181). However, other parameters with different thresholds might 
be applied in some centres. Hence, validation of optimal postprocessing and 
image interpretation procedures is needed (168).  
 
2.2.2.2 Reliability of PCT and its prediction of clinical 
outcome. 
To date, the only imaging technique required before administration of 
thrombolytic treatment is NCCT. However, the narrow time window has 
constrained the use of thrombolysis in a larger portion of acutely presenting 
stroke patients. Hence, there has been increased interest in understanding the 
core/penumbra mismatch concept by using advanced imaging techniques such as 
PCT and MRI to extend the time-to-treatment window.   
The PCT technique is considered relatively new when compared to MRI, 
therefore its clinical applications are less thoroughly reported in the literature. 
Hamberg et al. found that PCT had the potential to provide the earliest 
indication of vascular occlusion and its distribution and it might be easily applied 
in the clinical studies concerned with vascular pathophysiological changes. In a 
study of post-cardiac surgery patients in intensive care units to evaluate PCT 
feasibility in hyperacute stroke, Bisdac et al. found greater sensitivity of PCT in 
detecting and mapping of ischaemic stroke in ICU patients in whom NCCT 
findings were inconsistent with the severity of clinical condition (182). Similarly, 
the use of visual interpretation of PCT maps in clinical sittings was validated by 
Muir et al. (183). The diagnostic accuracy of PCT in the detection of secondary 
infarction to vascular spasm following aneurismal subarachnoid haemorrhage was 
assessed and demonstrated high sensitivity for prediction of clinically relevant 
spasm (184;185). Bisdas et al. compared the performance of PCT with diffusion-
weighted MR imaging (DW-I) in hyperacute strokes and they found sufficient 
assessment by both with good correlation with admit ion and follow up scores 
(186). Earlier, Wintermark  et al. compared quantitive PCT with qualitative 
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diffusion and perfusion MRI in emergency settings and found equivalence in both 
imaging modalities regarding identification of penumbra in acute stroke patients 
(187). Similarly, Na et al. investigated multiphasic PCT (covering the whole or 
most of the brain) by comparison with DWI and PW-I in regard to the prediction 
of tissue outcome and final infarct volume, infarct growth and clinical severity. 
They found that the PCT mismatch was highly specific for tissue at risk and 
strongly predictive of infarct growth and concluded comparable utility to DW-I 
and PW-I in early stroke assessment (188). Eastwood et al. studied the 
correlation of abnormalities seen on PCT with their volumes as seen on DW-I and 
PW-I in acute stroke patients. They reported good correlation of CBF and MTT 
parameters on PCT with the full volume of abnormality, however CBV had lower 
correlation with full volume on PW-I(189).   
Although PCT has shown the ability to predict clinical outcome and final 
infarct volume, the accuracy and validity of PCT parameters in estimating the 
extent of ischaemic tissue in acute stroke patients is debated (Figure 2-9). In 
addition, the decision about the best perfusion parameters to estimate 
ischaemic tissue volume and predict its outcome has not yet been agreed. 
Nonetheless, there have been continuous efforts in evolving post-processing and 
interpretation of perfusion maps. Schaefer et al. sought the usefulness of PCT 
maps in predicting final infarcted tissue and found that PCT was able to 
distinguish hypoperfused tissue likely to infarct from tissue likely to survive. 
They suggested that CBF was a good parameter in differentiating penumbra into 
two compartments: penumbra that infarct and penumbra that recover with 
reported values of 0.19, 0.34, 0.46 for core, infracted penumbra and recovered 
penumbra respectively. In other words, independent of recanalisation status, 
ischaemic tissue with >66% reduction in CBF was predicted to infarct, whereas 
ischaemic tissue with< 50% reduction in CBF was predicted to survive and >75% 
reduction in CBF corresponded to the core. They called for avoidance of 
overestimation of tissue that is going to infarct depending on visual estimation 
of TTP/CBV ratios.  However, CT/CBV lesions were typically non-reversible and 
had a strong correlation with final infarct size (190). Similarly, Dr Konstas and Dr 
Lev in their commentary review, stated that salvageable penumbra was 
overestimated by benign oligaemia by using the traditional cut-offs for MTT and 
CBF (173). Muir et al. reported the relation of recanalisation to the fate of 
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ischaemic tissue by using TTP and CBV on PCT maps and found that in 
recanalised patients the final infarct volume was correlated with initial CBV 
volume but not with TTP, while in patients in whom there was no recanalisation 
the final infarct volume correlated with initial TTP and not CBV (183). Along the 
same lines, Gasparrotti et al. found that patients with large TTP/CBV mismatch 
ratio and small core on baseline PCT had a favourable outcome and the core size 
was the strongest predictor of clinical outcome as was measured by CBF on 
perfusion maps (191). 
Among thrombolysis trials which used the mismatch concept to assign patients 
to thrombolysis was the Desmoteplase in Acute Ischemic Stroke (DIAS II) trial. 
This trial was the only one reported to date that used PCT along with MRI to 
select patients based on core/penumbra mismatch with inclusion of scans which 
showed at least 20% penumbra (59). However, the DIAS II trial did not confirm 
the results from the preceding DIAS I and DEDAS trials that selected patients 
based only on MRI mismatch (58;192). In the DIAS II trial investigators reported 
some inconsistent results between MRI and PCT. One of these was because of the 
limited brain coverage by PCT which caused profound differences in mismatch 
volumes with MRI. In addition, PCT showed a reverse change in core lesion 
volume at day 30 compared to MRI in which a median percentage increase in 
core lesion volume on MRI was seen compared with a similar decrease on CT.   
PCT parameters have high sensitivity and specificity to predict infarction. 
Murphy et al. reported the sensitivity and specificity of CBV and CBF for 
infarction at 97% (193). Nabavi et al. reported higher predictive values for PCT 
than CTA and NCCT in testing MOSAIC score (defined later) (194). Similarly, Lin 
et al. sought ASPECTS accuracy on PCT maps for MCA stroke patients with 
evidence of complete arterial recanalisation and found that ASPECTS delineated 
perfusion maps with higher accuracy and sensitivity than CTA and NCCT (195).  
However, in another study by Fiorella et al. there was insufficient agreement 
between 3 CT technologists to include quantitive values of perfusion parameters 
into clinical decision making despite the high degree of correlation between the 
parenchymal regions of interest derived from CBV, CBF and MTT maps. 
Therefore, they recommended that with optimisation of post-processing 
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parameters, the degree of variability between assessors might be improved 
(196). 
 
 
Figure 2. 9: Perfusion maps with baseline NCCT and 33-hours follow-up scans 
showing EICs in a 65 years-old patient with acute stroke. Scanning was done 
within 3 hours of symptoms onset and accomplished in 17 minutes and rtPA was 
infused and recanalisation approved. Visually, MTT delineates a total ischaemic 
area of >2\3 of right hemisphere [M1-M3] areas with different levels of CBV\CBF 
ratio. Areas with severe reduction of both CBV and CBF and areas with a slightly 
decreased CBF and normal CBV ended in infarction while areas with normal CBF 
and normal or increased CBV recovered. 
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2.2.2.3 Comparison of PCT with PMR. 
Because the general principles underlying the computation of perfusion 
parameters are the same for both PCT and PMR, the overall clinical applicability 
of both is similar (168). However, PCT has benefits over PMR in that it has 
widespread availability and relative ease of scanning, particularly in the 
presence of attendant monitors or presence of absolute contraindications to MRI 
scanning. Speed of scanning, which adds no more than 5 minutes to NCCT 
scanning, and low cost are other pros of PCT (86). The most important potential 
advantage is the linear relationship between contrast concentration and 
attenuation on PCT, which allows quantitative measurement of perfusion 
parameters. In PMR maps, the contrast concentration is not linearly related to 
T2 effect which makes absolute measurements of perfusion parameters difficult 
(168). In addition PMR has susceptibility effects from adjacent tissue, whereas 
PCT has greater spatial resolution (180).  
Being widely available with simpler methodology and greater degree of 
quantification, PCT has the potential to increase patient access to new 
treatment and clinical trials (86). Unlike PMR, PCT has relatively limited 
coverage, which must be sufficient in making treatment decisions in acute 
strokes. However, source images from CTA, which depict core tissue, cover 
entire brain volume and are available immediately at scan completion (180). A 
second disadvantage of PCT is its low sensitivity to detect microbleeds which are 
easily seen by MRI, although the relevance of the latter has not been proved 
either. In addition, the patient is exposed to risk of radiation (increased risk of 
cancer and genetic effect and skin burns) and there are adverse effects of 
iodinated contrast (contrast-induced nephropathy and increased risk of 
hyperthyroidism) (168;180).  
Despite the fact that post-processing of PCT and CTA images may be manually 
demanding, they can still be rapidly and reliably constructed (180). However, 
the role of MRI in acute stroke triage has been evaluated more than PCT. 
Therefore, although PCT seems to be promising in the treatment of acute 
strokes in many small studies, its validation in clinical practice is not yet been 
proved in large patient cohorts. 
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2.2.2.4 Multimodal evaluation of acute stroke 
A multimodal approach incorporating the three modalities of CT - NCCT, PCT 
and CTA - may offer advantages for early imaging of stroke patients. Despite 
this, NCCT is still the preferred modality for initial evaluation of patients 
presented with acute stroke [for the reasons illustrated earlier in this chapter]. 
Nabavi et al. evaluated a score system based on a multimodal approach to 
patients in the acute stage using a scoring system termed the MOSAIC score (0-
8), which sums scores from each of the 3 CT components: presence and amount 
of early signs of infarction on non-contrast CT (NCCT; 0 to 2 points),  stenosis 
(>50%) or occlusion of the distal internal carotid or middle cerebral artery on 
CTA (0 to 2 points), and presence and amount of reduced cerebral blood flow on 
2 adjacent PCT slices (0 to 4 points). The predictive value of this score was 
evaluated in respect to final infarct size and 3 months clinical outcome by use of 
mRS and BI scores. Throughout the analysis, MOSAIC’s score was superior to all 
single CT components with respect to the various outcome measures (194). 
Similarly, Kloska et al. reported higher sensitivity of 78.9% when using the 
multimodal approach than each single CT component alone (197).  Along the 
same lines, Scarif et al. found that, although the PCT and CTA increased the 
scan time from onset to diagnosis from 2 minutes to 10 minutes, the sensitivity 
to detect ischaemia increased significantly among observers. Moreover, the 
inter-observer agreement, which was fair to moderate when using NCCT, rose to 
a substantial level (156). More recently, a larger study which recruited 191 acute 
stroke patients by Hopyan et al. showed that the addition of PCT in approaching 
acute stage patients improved stroke diagnosis even by inexperienced scan 
readers over that achieved with NCCT alone or a combination of NCCT and CTA. 
Furthermore, it improved intra- and inter-observer agreement up to a 
substantial level (69). However, the diagnostic performance of the multimodal 
CT approach has not been evaluated against the performance of MRI for infarct 
detection.  
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2.2.3 Computed Tomography Angiography (CTA) in 
acute stroke 
An important  aspect in acute stroke is the evalution of intra- and extra-
crainial vasculature status. Vascular imaging helps localisation of the site of 
arterial occlusion, thrombosis or stenosis which may be crucial to determine the 
type of therapy. It has been found that intravenous thrombolysis appeared more 
efficacious for distal than proximal thrombus and that mechinical thrombectomy 
and intra-arterial thrombolysis might be more efficacious for treatment of large 
vessel occlusion (198). CTA can be defined as a fast, volumetric CT examination 
performed with a time-optimised bolus of contrast material for the opacification 
of vessels (199). It relies on continous scanning while the patient is moving 
through the X-ray beam. In addition to the aquisation of axial cuts, surface or 3-
D rendering, multi-planar reformating and maximum intensity techniques can be 
performed. CTA scanners can cover the entire region from common carotids up 
to the ciricle of Willis in a single data aquisation. 
Wildermuth et al. evaluted the feasiblity of CTA in acute ischaemic stroke 
patients and they reported a high diagnostic accuracy compared with digital 
substraction angiography (DSA) and doplar ultrasonography (DU). They stated 
that patients with autolysed thrombi, occlusion of the internal carotid artery 
bifurcation, and poor leptomeningeal collaterals may have little potential for 
benefit from thrombolytic therapy (200). The sensitivity of CTA for detection of 
extracranial carotid artery stenosis ranged around 90%. A study by Berge et al. 
found that CTA was comparable to DSA, which is the gold standard for diagnostic 
vascular imaging, in the diagnosis of significant carotid artery disease (201). CTA 
has been found to be very sensitive for detection of very-high-grade stenosis 
which should be distinguished from the total lumen occlusion because of 
different therapy plans (202). However, single-slice CTA were found 
insufficiently robust concerning plaque composition with moderate predictive 
value for detection of plaque ulceration (203). In addition to its vascular 
visualisation, CTA source images (CTA-SI) were suggested as a useful added-on 
examination tool in the assessment of ischaemic tissue status. It can be rapidly 
obtained after NCCT in emergency settings, and, unlike PCT, it covers the entire 
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brain and does not require postprocessing. Scharman et al. found that a 
combination of NCCT, CTA and CTA-SI were comparable to DWI by MRI in 
predicting final infarct volume (177). Camargo et al. compared the reliability of 
both NCCT and CTA-SI, and they found that CTA-SI was more sensitive in 
detection of early ischaemia and more accurate in the prediction of final infarct 
volume (204). The reliability of CTA for the detection of intracranial occlusions 
was also very high in several studies with reported sensitivities up to 100% in 
some papers. In contrast, it has lower sensitivity for detection of intracranial 
stenosis than those for occlusion which might be due to its low estimation of 
heavy atheromatous calcifications (205;206). However, Bash et al. stated that 
CTA sensitivity was not compromised by extensive atheromatous calcifications 
when appropriate window settings were used. In the same study, CTA appeared 
superior to MRA with a higher sensitivity and positive predictive value than 3D 
TOF MRA for both intracranial stenosis and occlusion(207). Additionally, CTA 
spatial resolution is twice that for MRA because it is less susceptible to motion, 
pulsation, slowness and other artefacts. Post-processing time is similar in both 
methods. 
In general, vascular imaging at an early phase of the stroke is recommended 
to triage patients to the best therapy and to determine prognosis (208). Sims et 
al. have found that thrombus location on CTA influenced subsequent patient 
outcome and recommended that CTA can safely and rapidly support the 
stratification of stroke patients based on location, degree and presence of 
vascular occlusion (209). More recently, Gonzalez et al. argued that lack of 
arterial occlusion information in several stroke classification systems might have 
contributed to the poor progress in stroke treatment and there was a need for a 
refinement of stroke evaluation instruments, particularly the NIHSS and ASPECTS 
scores which did not involve the occluded vessel assessment. They claimed that 
current thrombolytic trials (DIAS III and DIAS IV) support this suggestion because 
they use CTA as a critical component of patient selection. In their study, they 
evaluated the performance of a combination of Boston acute stroke imaging 
scale (BASIS), which includes arterial occlusion evaluation, and NIH stroke scale 
(NIHSS). They found that the combined instrument was substantially more 
powerful in predicting outcomes of acute stroke patients than any single 
classification method (210). Although CTA is a non-invasive approach with high 
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levels of accuracy it has some disadvantages related to the use of substantial 
amounts of intravenous contrast material which may limit its use in patients with 
contrast allergy and renal dysfunction. In addition to this, there is the risk of 
exposure to ionising radiation.    
 
2.3 Magnetic resonance imaging (MRI) in early 
stroke 
Since the emergence of thrombolytic therapy as a treatment for acute stroke, 
MRI has offered an alternative to CT for the evaluation of acute stroke. MRI is 
used to image the intensity of the cerebral parenchyma and its anatomic 
structure. Similar to CT, MRI is employed in acute stroke to exclude 
haemorrhage and stroke mimics, and detect ischaemic tissue. To meet this 
demand and perform a thorough evaluation of ischaemia, a combination of 
conventional MRI, MR angiography (MRA) and diffusion- and perfusion-weighted 
MRI techniques can be used. The conventional MRI sequences typically used in 
acute stroke include T1-weighted spin-echo, T2-weighted fast spin-echo, fluid-
attenuated inversion recovery, T2*-weighted gradient-echo, and gadolinium-
enhanced T1-weighted spin-echo sequences. In the first few hours after stroke 
onset, conventional MRI is less sensitive than DW-MRI and it may result in false 
negative findings. Conventional MRI (two T2-weighted sequences, a T1-weighted 
sequence, and a "balanced" pulse sequence with the use of a high-resolution 
data acquisition matrix) techniques were insufficient to detect EICs until 8-12 hrs 
after symptom onset (140;211). However, subsequent development of fast-echo 
gradient technique and diffusion imaging along with clinically available echo-
planar imaging which is resistant to patient motion, have permitted a rapid and 
very sensitive MR imaging protocol in early stroke. 
The appearance of ICH on MRI depends on its age and the MRI sequence used. 
Conventional MRI T1 and T2-weighted sequences are sensitive to detection of 
subacute and chronic blood and less sensitive to acute haemorrhage within the 
first 6 hrs. As blood is extravasated into the brain parenchyma, haemoglobin 
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becomes deoxygenated. Deoxyheamoglubin is a paramagnetic substance which 
produces a non-uniform magnetic field causing signal loss and darkening on T2 
sequence images.  in a study by Kidwell and collegues, the gradient recalled 
echo (T2*-Sensitive) sequence was found to be equivalent to NCCT in detecting 
acute haemorrhage . On the other hand, DWI has unproven reliability in the 
detection of early parenchymal haemorrhage. Kidwell et al. sought the 
reliability of MR GRE in detecting acute cerebral haemorrhage and found that 
MRI was superior to CT in detecting chronic microbleeds which were not 
visualised on NCCT (92). More recently, a study by Boulanger et al. found that 
patients with < 5 micro haemorrhages were not at increased risk of developing 
symptomatic ICH (without thrombolysis). However, they were at increased risk 
of recurrent disabling or fatal stroke (212). Despite this, NCCT is still considered 
the gold standard for exclusion of haemorrhage by most clinicians (as illustrated 
earlier in section 2.2.1.1). 
The most important sequence of MRI for demonstration of acute ischaemia is 
DWI. It is based on the detection of restricted diffusion as water moves from 
extra- into intra-cellular spaces. Ischaemic tissue on DWI is readily visible as 
brighter areas than normal brain tissue. DWI has the ability to detect very small 
infarcts and those in the posterior fossa: it also shows changes within minutes of 
stroke onset. Numerous authors consider DWI as the most sensitive and specific 
technique for imaging acute ischaemic stroke. Current DWI employs an echo-
planar technique with very short image acquisition time and high sensitivity to 
signal changes (213). Gonzalas et al. sought the accuracy of DWI in the diagnosis 
of stroke in the first 6 hours of stroke onset and reported very high sensitivity 
and specificity up to 100% in comparison to conventional MRI and NCCT (18% and 
45% respectively). The very high sensitivity reported by Gonzalez et al. might be 
due to unadjusted time interval between conducting the CT and MRI (214). 
However, Fiebach et al. performed a randomised crossover comparison of DWI 
and NCCT and demonstrated a higher sensitivity and specificity for DWI than 
NCCT (151). Other conditions which cause restricted diffusion, such as infection 
and inflammatory diseases, may mimic ischaemia on DW images. Additionally, 
areas with reversible ischaemia and increased blood volume appear normal on a 
DWI map. Therefore, perfusion-weighted MRI was recommended along with DWI 
to detect areas with reversible ischaemia (penumbra). 
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Warach et al. combined DWI and PWI during same session to report the 
presence of penumbra within the mismatch area between the two maps. Thus, 
the acute hyperintensities on the DWI represented ischaemic core areas, 
whereas surrounding areas of perfusion deficits corresponded to penumbral 
tissue, according to the postulation of Warach et al. (215). Lovblad et al. found 
a strong correlation between the DWI lesion and stroke severity, clinical 
outcome, and final infarct volume which means that the larger perfusion deficit 
than DWI lesion could be a qualitative marker for potential infarct expansion 
(216). Despite this, it cannot predict how much expansion actually occurs and 
the inability to truly quantify MRP restricts its ability to define accurate 
thresholds (107). However, MRP remains very sensitive to ischaemic lesions 
which makes it useful as a triage technique for patient management, but its 
specificity in accurately predicting tissue outcome and final infarct volume is 
poor (217;218). Moreover, most MRP investigations have not resulted in 
consensus as to which perfusion parameter is the most accurate predictor of 
tissue fate. On the other hand, several authors suggested the visual mismatch 
estimation rather than using a quantitive method. Luby et al. compared the 
performance of qualitative mismatch evaluation against the quantitive method 
and they reported no difference. In addition, qualitative mismatch selection had 
high sensitivity, specificity and positive predictive values among neurologists 
(219). In (Desmoteplase in Acute Ischemic Stroke–phase II) DIAS II trial, 
investigators used MRI as the mismatch concept by visual inspection for the first 
time as an entry criterion to thrombolyse patients and as a primary efficacy end 
point and they reported a significant difference between treated and untreated 
patients up to 9 hours post ictus (192). These results were approved later on by 
investigators of DEDAS (58). In general, despite these different methods applied 
by using MRI in the acute stage of strokes and their effectiveness in predicting 
tissue fate and clinical outcome, there has been a lack of definitions of 
ischaemic changes and clinical outcome on which the accuracy of MRI 
parameters is based. Additionally, time to reperfusion has not been taken into 
account when evaluating MRI methods. 
As part of the MRI protocol for stroke, MR angiography (MRA) is a helpful tool 
for the detection of intra- and extra-cranial vasculature. Unenhanced MRA 
showed sensitivity of up to 93%, while enhanced MRA had higher sensitivity of up 
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to 97%. However, MRA showed a high sensitivity for the detection of cerebral 
aneurysms > 3mm (220). The MRI protocol for the evaluation of acute stroke 
patients consists of conventional MRI, DWI, PWI and MR angiography which 
usually takes 15 minutes, a bit longer than CT protocol. However, the two 
modalities were proven to be useful to approach acute stroke patients, and 
currently both have a role in patients’ evaluation depending on local clinical 
circumstances and constraints, such as available technology and staff experience 
(221). 
 
2.4 Other functional imaging techniques are 
used for evaluation of acute ischaemia 
 
 2.4.1 Positron Emission Tomography (PET). 
PET is the gold standard for the quantification of CBF and cerebral tissue 
oxygen consumption. Penumbra tissue appears on PET as an area of reduced CBF 
and increased oxygen extraction fraction (OEF). Heiss et al. found a significant 
correlation between the volume of hypoperfusion areas on PET and patients’ 
clinical outcomes (35). However, PET is confined to research with limited 
clinical application because of the arterial sampling techniques required for 
absolute quantitative CBF values are relatively contraindicated with standard 
systemic thrombolysis (70).  
2.4.2 Single-photon emission computed tomography 
(SPECT). 
This technique depends on injected radioisotope which binds to certain blood 
compounds and diffuses through the intact blood brain barrier and can be 
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metabolised by brain tissue. Acquisition of data takes a bit of a long time in 
comparison with standard techniques of stroke evaluation which renders SPECT 
unsuitable for clinical settings (72). SPECT provides semiquantitive 
measurements of CBF which can be performed rapidly. However, its limitations 
include tracer preparation, expense and low spatial resolution in comparison 
with CT and MRI (64). Additionally, the subtracted data is physiologic and not 
anatomic like MRI and CT. 
 
2.4.3 Xenon-enhanced computed tomography scan 
(Xe-CT). 
This technique depends on inhalation of the inert gas Xenon in a known 
concentration and tracing the subsequent changes in tissue density. This 
technique was approved in both animal and human models for accuracy in the 
detection of ischaemia with strong correlations(222). A study by Firlik and 
colleagues reported sensitivity to detection of EICs up to 100%. Additionally, 
they found that CBF values less than 15ml were associated with the development 
of severe oedema and poor outcomes (223). Generally, there has been little 
literature relating to XeCT imaging, which limits the involvement of the 
technique in routine clinical settings. In addition, Xenon has anaesthetic effects 
which might affect its administration in acute patients. 
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Chapter III : Methodology 
 
 
 
 
 
 
 
 
 
102 
 
3.1 Study design 
This study was conducted retrospectively on CT scans of stroke patients, who 
were recruited to ongoing studies at an academic stroke centre. The study 
consisted of three stages: stage I, the consensus stage, and stage II. Finally, an 
analysis of perfusion parameters of scans and the fate of tissue compartments on 
follow-up scans was done (figure 3-1). CT scans were categorised into two 
separate groups: the first set of scans for stage I, and a second set of scans for 
stage II. In addition, there was a small set of CT examples for the consensus 
stage. 
 
 
Figure 3. 1: Study design. 
3.2 Patients 
The target population was patients with acute ischaemic stroke recruited to 
one of two studies at an academic stroke centre, namely the Multicentre Acute 
Stroke Imaging Study (MASIS / Wyeth) and Post Stroke Hyperglycaemia (POSH). 
Study inclusion and exclusion criteria for both studies are listed in table 3.1. 
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Demographic data, including age, gender, domestic circumstances, alcohol and 
smoking status, were collected from eligible patients. On admission, time of 
onset of symptoms, time of hospital arrival and time of first scanning were 
reported and the patient’s risk factors and concomitant medications were also 
assessed. The pre-morbid modified Rankin Scale (mRS) and NIH Stroke Scale 
(NIHSS) for each patient were taken. Almost all eligible patients had acute 
multimodal CT scanning, including NCCT, CTA and PCT, and repeat scanning at 
24-72 hours after a stroke. 
 In MASIS, patients had MRI and MRA as the main follow-up imaging technique, 
while CT modalities were seldom used. Conversely, NCCT and CTA were the main 
follow-up imaging tools for POSH patients, In both studies, the time of onset of 
acute NCCT, perfusion and angiography scanning were all recorded. In addition, 
patients had outcome assessments on day 7 with the NIHSS, and day 30 with the 
mRS.  
Eligible patients were those who presented within 6 hours of stroke onset and 
had acute NCCT, perfusion imaging and follow-up NCCT and angiography. 
Patients were not stratified according to age, gender and NIHSS score. 
Prevalence of EICs on CT was not taken as a determinant for involving patients in 
the study.  
Inclusion criteria Exclusion criteria 
Presented within the first 6 hours Non-stroke diagnosis 
Proven diagnosis of acute stroke Inability to lie in a recumbent position 
 Intercurrent illness limiting surviving 
up to a month. 
 Coma 
 Renal failure 
 Known allergy to contrast media 
Table 3. 1: Inclusion and exclusion criteria for both; MASIS and POSH studies. 
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3.3 Readers 
Targeted observers were stroke neurologists and neuroradiologists with 
different levels of experience. They were invited to the study by e-mail or by 
meeting face to face to illustrate the study purpose, and their role in it (See 
Appendix; tables 1,2,3). The study set out to include observers of varying 
experience and professional background. No trainee neuroradiologists were 
available to participate at the time of the study. All readers except one were 
either medical staff or members of research teams at Southern General Hospital. 
When the consensus was ready, all were sent invitations to read the consensus 
set of scans and further their participation in the second stage of study. Only 5 
readers agreed to continue, while the other 4 apologised. Six new readers 
responded positively to the consensus invitation and agreed to participate in the 
second stage.  All participants except two were either member of medical staff 
or research teams at Southern General Hospital.  
3.4 CT Scans 
Scans of eligible patients, including acute and follow-up NCCT, PCT and CTA, 
were loaded into the MiStar software package [Version 3,2,63 DICOM 3.0 
Conformance software] for processing. Each scan was anonymised and coded by 
serial numbering according to their groups starting from number 01. Coding of 
scans was arbitrary and was not randomised. Acute NCCT scans were saved in 
Joint Photographic Experts Group (JPEG) format for the purpose of gathering the 
targeted slices, which contain the 10 ASPECTS regions only. These slices were 
collected in one image of a maximum 6 slices by loading onto the Paint program 
and resaved as (JPEG) file (figure 3-2). The size of the slices was adjusted at 
about 400*400 as measured by the program, for equalisation of appearance. The 
slices of one scan were reduced to be shown in 2-4 images. Scan resolution for 
providing the best viewing window for readers was optimised for grey-white 
matter differentiation on MiStar software before being formatted by Paint. PCT 
scans were all processed by MiStar using Stroke Mode and slices of interest 
(ASPECTS areas) were all saved in (JPEG) format. Follow-up NCCT scans were 
viewed on MiStar and stored in (JPEG) files for revision. 
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Figure 3. 2: Recollection of CT scan slices in one image maximum 6 slices and 
minimum 3 slices. 
3.5 Reading the scans 
Targeted changes to be read were isodense swelling and hypodensity. The 
ASPECTS score anatomical template was used to read EICs in this study (see 
Appendix; figure 1). The Hyperdense vessel sign was not included in the 
detailed assessment in this study, but was added as extra information with 
assessments in the first stage of the study. Therefore, EICs hereafter always 
refer to isodense swelling and hypodensity but not the Hyperdense vessel sign.  
Readers were asked to classify the ischaemic changes into 10 areas according to 
ASPECTS template. In the first set, the posterior and anterior cerebral artery 
territories were added to ASPECTS areas. However, this study mainly included 
scans from patients with middle cerebral artery occlusion; hence, the posterior 
and anterior areas were rarely involved in any ischaemic changes and their 
incorporation in analysis of agreement caused misleading results i.e very high 
values of free marginal kappa although readers were not agreeing on the 
presence of abnormality in the area. Therefore, responses to these areas were 
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excluded from the analysis of first stage results and they were not involved in 
the second stage of the study. A reference standard for the presence or absence 
of EICs in each region was not done in this study for purpose of comparing these 
classifications with their correspondent areas on PCT in the next stages of the 
study and finding out how the perfusion changes of acute ischaemia on PCT be 
interpreted by observers on NCCT. The classification as hypodense, isodense, 
both, or normal was defined by the majority interpretation of readers.  The 
cortical and subcortical white matter was all considered in reading each 
ASPECTS area.   
 
 
Figure 3. 3: Scans on Survey Monkey. 
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Figure 3. 4: Responses of readers to one survey (one scan). 
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3.6. Presentation of scans to readers 
Presentation of scans to readers was done by the creation of the web-based 
survey tool Survey Monkey. A basic account was the model used for loading the 
set. It permits a limited number of questions (up to 10 per survey) with a limited 
number of responses. Therefore, the scan slices were gathered in one image 
with priority to slices containing the ASPECTS template regions. An example of 
scans loaded to the survey with the questionnaire is shown in Appendix figures 
2 and 3. Images on Survey Monkey have no adjustment exposure tool; therefore, 
changing contrast to enhance the grey-white matter interface was not possible 
and readers couldn’t change the window settings of loaded slices for best 
viewing of EICs.  Each scan had its own survey with a web link.  
Each survey was named with its scan number. The order of surveys and their 
links was not correlated with their numbers (figure 3-3). A total of 40 surveys 
were created on Survey Monkey, with 40 web links for all scans of the first set. 
They were organised in an arbitrary way but avoided repeating similar scans in 
adjacent places. Thirty two surveys were created for second set scans. Readers 
were sent survey links via e-mail together with ASPECTS template as a PDF file 
(Appendix figure 1). Each link connects to a scan in the set. Responses from all 
readers to each scan were collected by survey collector tool with the possibility 
of browsing each response individually (figure 3-6). The survey does not match 
the responses to each reader’s e-mail, but it gives the time of starting response 
to scan and the time last modified. However, the time at end was dependent on 
the last second the reader closed the survey, so the whole interval is not always 
indicative of the real time spent by the reader on reading the scan. 
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3.7 Stage I of the study (First Set of Scans) 
 
 
Figure 3. 5: Schematic drawing of repetition process with scans coding [C\D 
Clinical Data]. 
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The aims of this stage of the study were:  
1- To assess the effect of the number of variables on reading EICs: 
hypodensity and isodense swelling on NCCT. 
2- To assess intra-observer agreement. 
3- To assess the untrained group of readers. 
4- To evaluate Hyperdense vessel sign. 
In the first stage, scans from 19 patients were used to assess inter- and intra-
observer agreement. Two out of the total number of patients had non-stroke 
diagnosis at the final evaluation. They were added to the first set in order to 
assess the ability of readers to recognise normal appearing brain tissue from an 
ischaemic one at the time of the presentation. Therefore, 17 scans were only 
involved in all subsequent analyses of agreement, perfusion and fate.  
All 19 scans were repeated, making a total of 40 scans, and presented to 
readers as the first set of scans. Readers were not informed of any duplicate 
scans. Seventeen scans were presented twice, and two scans were presented 
three times within the set.  The repetition process aimed at changing the slice 
thickness and clinical information with scans. Additionally, some scans were 
repeated without change to assess intra-rater reliability. Readers were not given 
any training or illustration of EICs before their participation in the study. 
3.7.1 Study Variables 
In this stage of the study, 4 main variables were assessed for their effect on 
reading EICs on acute NCCT. These include slice thickness of scans, knowing 
clinical information, readers’ experience and readers’ speciality. Other 
situations, such as affected hemisphere, normality of scans, intra-rater 
agreement and Hyperdense vessel sign were also measured with this set of 
scans. The effect of other factors on reading the scans like old infarcts, white 
matter diseases and atrophic and atherosclerotic changes, which are intrinsic 
factors related to brain parenchyma, were not assessed in this study though they 
were found to affect the observer reading of EICs. This was because this study is 
mainly concerned with seeking agreement on isodense swelling among group of 
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readers rather than seeking the agreement on hypodensity or both changes 
together which have been more likely to be mixed with other chronic brain 
changes. Additionally, this study introduces defining criteria for isodense 
swelling and hypodensity which differentiate them from each other and 
recognise each one as a separate entity from any other change. And for porpuse 
of testing the defined criteria before and after training these factors were 
cancelled and readers were asked to focus on acute ischaemic changes.       
A- Slice thickness 
Scans were adjusted to two levels of slice thickness: 5mm (thick) and 0.9mm 
(thin). For scans which were stored in thin slices, MPR reformatting by MiStar 
was done to generate thin slices. In total, there were 20 scans with thick slices 
and 20 scans with thin slices. Of these, 4 scans were presented twice within the 
set with fixed clinical information, changing their slice thickness from thin to 
thick. Figure 3-6 shows an example of these scans in thick slices and thin sliced 
forms. 
B- Clinical information 
Observers read the scans with and without any knowledge of the patient’s 
presentation. In total, 20 scans were shown without concomitant clinical 
information, which means that readers should judge normality of scan and 
recognise the affected side before they look for EICs. The other 20 scans were 
presented with their clinical information, which states that readers know the 
affected hemisphere and they just need to distinguish ischaemic changes. From 
the total number of these scans, there were 8 scans shown without clinical data 
and then repeated with clinical data with fixation of their slice thickness. Scans 
with clinical information were further subdivided into two groups according to 
the amount of provided clinical information: scans with full clinical data and 
scans with minimum clinical data.  
Full clinical data show the detailed symptoms and signs of the patient on 
presentation, whereas minimum clinical data is just a hint of the affected 
hemisphere. Examples of these are as follows: 
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Example 1; full clinical data 
Scan-10. A 76-year-old woman with breast cancer presents with partial left 
facial paralysis, left upper limb weakness, mild sensory loss and severe hemi-
inattention.  
Example 2; minimum clinical data 
Scan-02. A 79-year-old woman presents with left side symptoms.  
 
 
Figure 3. 6: Same scan with thick slices(A) and thin slices(B). In both situations, 
the ganglionic and supraganglionic levels of ASPECTS template are only shown. 
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In total, 11 scans were with minimum clinical data and 9 scans with full 
details. Categorisation of scans regarding the amount of clinical data available 
was not stratified according to the prevalence of EICs or severity of stroke, and 
the number of scans which had full or minimum C\D was according to the 
availability of clinical details from the studies’ files.  
C- Readers’ experience and speciality. 
Two specialities and two experience levels were investigated in this study to 
seek their effect on agreement. Specialities which were involved in acute stroke 
management were mainly targeted in this study, including stroke neurologists 
and neuroradiologists. Their experience was classified into two categories: 
expert readers, who are consultant doctors who have spent many years in 
reading scans from stroke patients, and trainee readers, who are doctors still 
training to read scans from stroke patients. In total, there were 7 stroke 
neurologists, 2 neuroradiologists, 5 experts and 4 trainees.  
 D- Affected side and normality of scan 
Because this set included normal scans and scans without clinical information, 
the ability of readers to agree on the normal scans and the ischaemic 
hemisphere was also assessed. Two scans from non-stroke patients were 
included within the set. Both presented without any clinical information, but 
one was with thick slices and one was with thin slices. Both were duplicated and 
hence there were 4 normal scans within the first set of scans. Readers’ 
agreement on the affected hemisphere for all abnormal scans (36) and for scans 
without clinical information (16) was assessed separately. 
E- Intra-observer agreement 
For assessment of intrinsic reliability of readers in reading EICs, the number of 
scans with different presentations was repeated without change. There were in 
total 5 scans and with repetition they were shown 10 times within the first set. 
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Table 3. 2; First set 
questionnaire. 
 
This CT is : 
 Normal 
Abnormal 
 
2. The affected side is : 
Left 
Right 
 
3. Hyperdense vessel sign is seen in the : 
 
 MCA 
M2 Segment Sylvian "dot" Sign 
ACA 
PCA 
Intracranial ICA 
Other vessel 
None 
 
4. The following area shows: 
 
                            Focal Swelling               Hypoattenuation 
Caudate                                     
Lentiform                                             
Internal capsule                                     
Insula                                                 
M1                                                 
M2                                         
M3                                         
M4                                              
M5                                         
M6                                                 
A(lower slice)                              
P(Lower slice)                                 
A(Upper slice)                                     
P(Upper slice)                            
Done
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3.7.2. First set questionnaire 
Readers were asked to answer 4 questions on each scan in the first set. The 
questionnaire template is illustrated in table 3-1. If they answered yes to any of 
choices, they had to tick the corresponding box of choice. An absence of a tick 
mark means that the reader thinks the choice is absent and the scan is normal. 
In the first two questions, readers had to decide whether the scan was normal or 
abnormal and, if abnormal, which side was affected? The next two questions are 
related to ischaemic changes which they have to detect when the scan is 
abnormal. They had to look for a Hyperdense vessel sign and localise it to a 
cerebral artery. Then they had to recognise isodense swelling and hypodensity 
and localise them to each ASPECTS region. Readers were asked not to report any 
changes which were not related to acute ischaemia. The time required to 
complete the whole set of scans was open but with a maximum of 4 weeks. 
Thereafter, readers were sent regular reminders. Time recorded by the survey, 
together with contact e-mails from readers, helped to identify each reader 
personally.  
 
3.8 Consensus stage (consensus set of scans). 
The aims of this stage were as follows: 
1- To seek consensus among readers on definitions of isodense 
swelling and hypodensity. 
2- To build up general steps in reading EICs on NCCT. 
3- To distinguish clearly between isodense swelling and hypodensity.  
Scans which had the highest level of agreement on EICs were used to illustrate 
the appearances of isodense swelling and hypodensity and were employed to 
derive definitions for thee appearances. Other scans from stroke studies were 
also used to give examples of these changes. The definitions of isodense swelling 
and hypodensity and their signs on NCCT were taken from previous litrature, 
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mainly puplications from Von Kummer et al. and Wardlaw et al. These 
definitions were collected and organised for the purpose of illustration and 
differentiation between both changes (see Appendix; figures 4a-e). 
3.8.1 Appearances of EICs 
Scans which attained good agreement in the first stage were analysed on 
MiStar software. During this stage, the NCCT and PCT of each case were 
analysed. Their NCCT and PCT scans were both loaded to the viewer at the same 
time for the purpose of matching the appearances of EICs on NCCT with 
penumbra-gram on PCT. MiStar’s “penumbra gram” [the generation of 
“penumbra gram” will be described with PCT later] displays areas with 
penumbral perfusion thresholds in a green colour, while areas with core 
perfusion are in red. Because the axial orientation of some patients differed 
between the NCCT scan and PCT scan, NCCT slices for these cases were 
reformatted by the MPR tool to match the axial orientation of PCT slices.  
Visual comparison of areas was the main method of analysis. Additional 
methods included: 
1- Densitometry; measurement of Hounsfield Units for areas on NCCT 
corresponding to core and penumbra. On MiStar, this is displayed as 
statistical information for each ROI( region of interest) pixel. The mean 
HU value of each ROI was reported for the comparison process. However, 
the determination of the exact difference in HU readings between 
isodense swelling and hypodensity is not the main purpose of study and 
the reported values were mainly to support the visual comparison 
findings. 
2- Histogram; this is displayed dynamically for the chosen ROIs. It is a 
plot of pixels against HU values. Thresholds can be adjusted according to 
the desired range to minimise artefact and obtain clearer curves for 
comparison.  
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On the penumbragram slice, ROIs were drawn on penumbra areas 
automatically by choosing the “Grow by Threshold” button and on core areas 
too, and then copied onto the NCCT corresponding slice, and finally mirrored 
onto the contralateral hemisphere. This was done to find out how penumbra 
appeared on an NCCT scan. Structural changes within ROIs were compared with 
normally appearing contralateral tissue in respect to: changes in radiolucency, 
narrowing and loss of CSF spaces, and loss of grey-white matter interface. Areas 
which showed deviation from normal appearance had densitometries and 
histogram measurements. ROIs were also drawn manually when the 
automatically generated ROIs were large and disorganised or when samples were 
from abnormal regions, and normal and abnormal white matter were tested. 
For purposes of comparison, and because there were few scans with good 
agreement on either isodense swelling or hypodensity from the first set, other 
scans from ongoing studies with large core or penumbra, and with mixture of 
both, were also added to the analysis. Figures 3-7,8,9 and 10 show examples of 
a scan with large penumbra, a scan with large core and a scan with mixed core 
and penumbra tissues. The way of visual comparison was also illustrated in those 
figures with reference to densitometry readings and histogram appearance in 
normal and abnormal hemispheres. Other examples of consensus analysis are 
shown in appendix figures 7,8,9,10.  
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Figure 3. 7: Core appearance analysis. Upper: from left to right; Penumbra-
gram, ROI, Acute NCCT, Histogram thresholds. Lower; Right: densitometry 
readings with averages of HU units in each ROI. Left: Histogram. 
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Figure 3. 8: Penumbra appearance analysis. Upper: from left to right penumbra 
gram, ROIs, NCCT, Histogram thresholds. Lower; Left; Histogram Right; 
densitometry readings. 
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Figure 3. 9: Appearance of areas with mixed penumbra and core tissues. Red 
arrows indicate on NCCT and green arrows indicate penumbra areas. 
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Figure 3. 10: Scan with mixture tissue. Samples from affected areas show low 
HU for core areas and similar HU values for penumbra and normal tissue. Green 
arrows show areas of penumbra (isodense), Red arrows show areas of core 
(hypodensity). 
 
 
3.8.2 Definition of isodense swelling and 
hypodensity 
Definitions for both isodense swelling and hypodensity were derived from the 
above analysis and from the definitions given by Von Kummer et al. and Wardlaw 
et al, as well as publications from Na et al, Muir et al. and Koga et al.   
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Hypodensity; Increased radiolucency of brain structures relative to other 
parts of the same structure, or to its contralateral counterpart that could be 
recognised visually. 
Hypodensity signs on NCCT scan are; 
1- Complete loss of differentiation between grey-white matters 
(CDGW); complete loss of cortical ribbon due to decreased attenuation of 
grey matter. There should be no distinction between density of cortex 
and underlying white matter, and the density should be equal to, or less 
than, contralateral white matter. 
2- The disappearing basal ganglia sign (DBG) and Obscuration of 
lentiform nucleus (OLN); loss of the normal contour of basal ganglia, or 
decreased attenuation of parts, or whole, lentiform nucleus, with loss of 
precise delineation of the area and blurring of its margins so that its 
differentiation from contiguous white matter structures is impossible. 
3- Loss of insular ribbon (LIR); loss of the usual slightly increased 
attenuation of insular cortex with reduced precision in delineation of 
grey-white interface at its lateral margins.  
4- Cortical sulcal effacement (CSE); decreased contrast density with 
loss of precise delineation of grey-white matter interface at the margins 
of the cortical sulci. 
Isodense swelling; brain swelling without concomitant hypoattenuation. 
This might be associated with the following signs on the NCCT: 
1- Partial loss of differentiation of grey-white matter interface 
(PDGW); loss of grey-white matter interface. Cortical ribbon is not well 
recognised if compared to contralateral hemisphere; however, the cortex 
is still brighter than subcortical tissue and is less dense than contralateral 
white matter. 
2-  Cortical sulcal effacement (CSE); a localised mass effect. It can 
appear as a reduced number of sulci and the straightening of brain outer 
contour in affected areas. 
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3-  Obscuration of Sylvain fissure (OSF); narrowing or obliteration of 
Sylvain fissure. 
4- Loss of insular ribbon (LIR); reduced precision in delineation of 
grey-white interface at its lateral margins. 
The reading of both on the NCCT depends on recognising two signs: 
1- The changes in the grey-white matter interface; complete 
disappearance with hypodensity and partial disappearance with isodense 
swelling. 
2- Brain swelling; local swelling with normal density is isodense 
swelling and not hypodensity. 
The signs which are stated for each change were gathered in this way in order 
to lessen any confusion which might arise with regard to the many names for 
EICs. The appearance of these signs with each change is illustrated with 
definitions. 
3.8.3 Consensus between readers 
Definitions of EICs with their signs and with illustrative examples were 
collected in a PowerPoint presentation and saved as a PDF file (see Appendix for 
the complete consensus presentation). The appearances of the changes were 
generally categorised into two: hypodensity and brain swelling. Then, more 
specific definitions were stated on presentation.  Readers were also given an 
illustration of how to use these definitions when reading the scans. 
Readers who agreed to participate in the study were sent an e-mail and the 
PDF file of consensus presentation. They were asked to go through the 
definitions and the illustrative examples and, if they agreed to participate 
further in the study, they would be sent the second set of scans. Readers who 
disagreed with any element of the proposed definitions were able to reply for 
clarification of any issue.  
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Most the readers who had a positive reply were satisfied with the consensus 
set. Two readers sought clarification of the partial and complete loss of gray-
white matter. 
3.9 Second stage of the study (second set of 
scans) 
The aim of this stage was to: 
1. Assess trained group of readers. 
2. Assess the effect of training on reading EICs. 
3. Assess the effect of training in relation to experience and 
speciality. 
In this stage, NCCT scans from 32 patients were involved. There was no 
repetition of any of the scans within the set. All scans were presented with 
similar variables: thick slices (5mm) and minimal clinical information. An 
example of minimum data is as follows: 
A 90-year-old man presented with RIGHT SIDE symptoms. 
3.9.1. Second set questionnaire 
In this stage, the questionnaire consisted of one question, as illustrated in 
table3-2, which shows the questionnaire template. Readers were asked to read 
each ASPECTS region and categorise it as normal, isodense swollen or 
hypodense. A tick at an area in any box for hypodensity or isodense swelling 
means that the reader saw the change at that area. Absence of any tick for an 
area means it was normal. If they thought the scan was normal, they had to tick 
the next icon as designed in the questionnaire. For the purpose of identifying 
each reader, they were given codes and were asked to sign their codes at the 
end of each scan. Additionally, readers were asked not to report any changes 
which were not related to acute ischaemia. The time required to complete the 
reading of the whole set of scans was determined at 15 working days and readers 
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were offered a £10 Amazon voucher if they completed reading the scans in time! 
The identity of each reader was known from the code. 
 
The following area shows: 
 
                   Hypodensity         Focal swelling 
Caudate nucleous                      
Lentiform nucleus                   
Internal capsule                      
Insula                                    
M1                                    
M2                                    
M3                                    
M4                                   
M5                                    
M6                                      
 
In this SCAN: 
 There is no Hypodensity or Focal swelling. 
 
 
Reader code is : 
 C E F N K H M T Z 
 
Table 3. 3; Second set questionnaire.  
 
3.10. Analysis of perfusion parameters for all 
scans 
The aims of analysing the perfusion scans are to: 
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1- Compare CBF, CBV and MTT for all ASPECTS regions of an affected 
hemisphere with those of the normal hemisphere. 
2- Correlate NCCT appearances as categorised by readers with 
perfusion categories.  
3- Compare perfusion parameters of the three NCCT appearances. 
  3.10.1 Perfusion CT scans 
PCT scans of all cases from both first and second stages were loaded onto 
MiStar for analysis.  
Each scan was loaded onto the CT perfusion analysis programme/ stroke 
module. Viewer image parameters were all adjusted automatically except for 
the time interval, which was entered manually for each scan at 2 seconds. 
Arterial input (AIF) and venous output functions (VOF) were also adjusted 
manually and penumbra map processing then applied. Displayed perfusion maps 
on the main screen are: CBF, CBV, MTT, Delay Time, raw CTA image, function 
curves, penumbra gram, mean arterial and venous enhancement maps, mean 
arterial and venous phase maps and mean baseline map. Maps of interest for 
ROIs analysis in this study were MTT, CBV, CBF and penumbra gram.   
Perfusion thresholds for penumbra and core were set in relative values (given 
as percentage of normal tissue of contralateral hemisphere).  The programme 
calculates this automatically. However, penumbra MTT threshold (minimum) was 
adjusted manually to 145% of normal tissue MTT, and then applied to all scans 
automatically. Core CBV threshold was also adjusted manually to be 2ml/100g 
and then it was applied automatically to all scans. Other perfusion parameters’ 
thresholds were kept constant as measured by the programme. 
To avoid the presence of blood vessels on the true values of perfusion 
parameters, adjustment of maps by ‘Masking by Threshold’ effect was used. The 
highest threshold value for the CBV map was set at 90 in order to exclude all 
pixels with absolute CBV > 9ml\100g, this in turn excluded all blood vessels from 
the map prior to any analysis.  
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3.10.2 Measurement of perfusion parameters 
ROIs corresponding to each ASPECTS area were selected manually from two 
slices selected to correspond to the ganglionic and supra-ganglionic ASPECTS 
templates. Sizes of penumbra and core as displayed by the penumbra-gram were 
also considered when choosing these slices with preference of the largest one. 
Loading the slice into the ROI analysis was done with “all maps of current slice” 
choice for the purpose of measuring all parameters of the same area at once. 
The first step in the analysis was the determination of core and penumbra 
readings for each scan, which was done using the penumbra-gram. A manually-
drawn ROI on penumbra was grown automatically using the “grow by threshold” 
choice from the menu. The same was done with the core area (figure 3-12). 
Subsequently, the programme displays readings from all perfusion maps of the 
same slice. Secondly, ASPECTS regions were drawn manually on both 
hemispheres using the contrast CTA map as anatomical reference. Data from 
those areas were exported to a folder and saved as a text file. The exported 
statistical information for each parameter per ASPECTS region included: median, 
mean, standard deviation, maximum and minimum values. They were all 
absolute values. Calculated mean was the measure used for comparing areas in 
this study. In addition, each perfusion map was saved as a jpeg file. 
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Figure 3. 11; Perfusion maps with ASPECTS regions. 
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3.11. Cerebral angiography 
The aim of the angiography was to assess a vessel’s patency after 24 hours 
from the onset of a stroke. Recanalisation was determined from either study-
specific database information, or from neuroradiology clinical reports.  
3.12. Follow-up NCCT scan 
The aims of assessing follow-up scans were to: 
1- Determine fate of ASPECTS regions on acute NCCT. 
2- Compare fate of perfusion categorised compartments with fate of 
NCCT appearances as categorised by readers. 
A total of 49 follow-up NCCT scans were loaded onto the MiStar DICOM and 
exported to a folder as jpeg files. The comparison process was carried out 
visually for each ASPECTS area on acute NCCT, which was compared directly 
with its corresponding area on the follow-up scan and categorised as either 
normal or infarcted. Examples of this are illustrated in figure 3-13. 
Each ASPECTS region was classified into three compartments:  
1- Baseline (<6h) NCCT appearance: normal, isodense swelling, 
hypodense or both (hypodensity and isodense swelling).  
2- Perfusion CT categorisation; normal, core, penumbra or both 
(penumbra and core). 
3- 24 Follow-up NCCT; normal or infarcted and mixed fate (part is 
infarcted and part is normal). 
Comparison between the three classifications was carried out for the purpose of 
determining the fate of each ASPECTS area categorised by perfusion or readers. 
 
 
130 
 
 
 
Figure 3. 12: Correlation of ASPECTS area’s categories with their fate on follow 
up NCCT scan. In this example parts of lentiform nucleus and insula ended in 
infarction. 
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3.13. Statistical analysis 
Data analysis was carried out by using MedCalc Statistical Software Package 
Version 12.2.1(224). Microsoft Excel was used to collect all data in a 
spreadsheet. Online calculations for some measures were done with StatTool 
Programme(225) and Online Kappa Calculator (Randolf stat)(226). 
3.13.1 Collection of data 
All collected data were stored in spreadsheets and created by Microsoft Excel. 
These included: 
1- Readers’ responses to each scan on Survey Monkey from both sets 
of scans. These were loaded as the response from individual readers for 
each single scan and each category of ASPECTS regions (isodense swollen 
or hypodense). Absence of response to any category meant a normal 
appearance and was shown as = 0. Positive response=1.    
2-   ASPECTS score of each scan; this was calculated as total score 0-
10 and trichomatous score, 0-2, 3-7, 8-10.  Responses of readers were 
categorised by ASPECTS into three categories as follows: 
  Total ASPECTS score; the overall response of readers to EICs 
which they see on each scan, e.g. the total score given by a reader 
to a scan considers only the normality of an area, regardless of the 
type of change in it. If the area was normal it was given 0 and if it 
was abnormal it was given 1. In other words, this category 
represents the value of ASPECTS score when there is no 
differentiation of isodense swelling from hypodensity, which is 
currently used to read the scans. 
 Hypodensity; responses to the presence of hypodensity were 
the only responses considered in calculating the total ASPECTS of 
the scan. Areas with positive hypodensity were given 1,and areas 
that were normal or had isodense swelling were given 0. 
 Isodense swelling; responses to seeing isodense swelling in 
ASPECTS areas were the only responses used to calculate the total 
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ASPECTS of the scans. Areas which showed isodense swelling were 
given 1, while areas with hypodensity or isodense swelling were 
given 0. 
 Further classifications of scores according to experience, speciality, slice 
thickness of the scans, clinical information was also carried out. 
3- Counts of readers’ responses; number of responses to ASPECTS 
areas categories (either isodense swelling or hypodensity) were summed 
separately. Further classification according to experience, speciality, slice 
thickness of the scans, and clinical information was also done. 
4- Responses to Hyperdense vessel sign; positive=1 absence 
response=0. 
5- Tissue compartments; ASPECTS areas as categorised by readers; 
normal, isodense swelling and hypodensity, and by perfusion parameters; 
normal, penumbra and core. 
6- ASPECTS areas fate; for each scan, either normal or infarcted. 
Added canalisation status for each scan. 
7- The mean value of CBF, CBV and MTT for each area was categorised 
as isodense swollen or hypodense and with their contralateral counter 
area. 
3.13.2 Agreement 
Kappa statistics were the main tool of measuring inter-observer agreement. 
The percentage of total agreement and intraclass correlation coefficients was 
used to a lesser extent for the purpose of comparison of agreement levels.  The 
main analysis of agreement was done by pairwise kappa, which converted 
agreement into measurable data for statistical testing. 
Weighted Cohen’s kappa (quadratic weights) was used to calculate pairwise 
kappa for each pair of readers. This is because the study used ASPECTS scoring 
0-10, which has different levels of importance between its categories. Pairwise 
Kappa was measured with readers’ responses to total ASPECTS, hypodensity and 
isodense swelling, and for first stage and second stage data separately. For the 
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first set of variables, pairwise kappa was further calculated for each pair of 
readers by dividing data according to experience, speciality, slice thickness of 
scans, clinical information, and for the three categories of ASPECTS. Average 
pairwise kappa was used to evaluate the agreements by individual readers. 
Fleiss's Kappa for multiple raters was used to measure inter-observer 
agreement among all readers on each EIC category. It was employed in two 
forms: fixed marginal kappa [XMK] and free marginal kappa [FMK]. . XMK or 
intraclass correlation coefficient were used to add clarification of the agreement 
level. Trichotomised ASPECTS scores and the count of responses to each ASPECTS 
area were used. Some 95% confidence intervals for FMK and XMK were 
calculated; however, CI of FMK was very wide and not included in the results.  
Weighted Cohen’s kappa (linear weights) for two raters with 95% confidence 
interval was used to calculate intra-observer agreement in two situations:  
 On all ASPECTS areas using trichomtous scoring; kappa was 
calculated for total ASPECTS, hypodensity and isodense swelling. 
 On each single area using count of responses. Kappa was calculated 
for isodense swelling and hypodensity. 
Level of agreement was determined by using Landis and Koch’s scale for 
agreement level Table 3.4.  
 
Table 3. 4: Landis and Koch’s scale for agreement level. 
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Intraclass correlation coefficient ICC was calculated with ASPECTS scores 0-10 
and with trichomatous ASPECTS.   
The percentage of overall agreements (POA) was used for measuring agreement 
on Hyperdense vessel sign with XMK.  
Pairwise kappa was calculated by using the MedCalc programme(224), while 
linear Cohen’s kappa, XMK and ICC, were calculated by using the online StatTool 
programme(225) [http://www.stattools.net/StatToolsIndex.php].  FMK was 
calculated by  Online Kappa Calculator [http://justusrandolph.net/kappa/]      
(226). POA were calculated by Microsoft Excel.  
3.13.3 Tissue compartments and fate 
Absolute numbers with proportions were used to express the results of tissue 
fate and the matching of NCCT appearance with perfusion category. Prediction 
statistics included calculation of sensitivity and specificity, likelihood ratios and 
predictive values. They were calculated for the whole set and for trained and 
untrained groups of readers. Odds ratio was used for hypodense versus isodense 
swollen areas, and for recanalized versus non-recanalized isodense areas. 
   3.13.4 Statistical significance testing 
All tests of significance were calculated by using the MedCalc programme. 
The t-test for independent samples and for paired samples was used to evaluate 
the significance in difference in agreement level for most compared samples. 
However, the Mann-Whitney test (independent samples) and Wilcoxon test for 
paired samples were used instead of the t-test when samples were small or were 
not normally distributed. Testing the significance of a difference in agreement 
among more than two samples was done by ANOVA. One-way analysis of variance 
was used with normally distributed samples and Kruskal–Wallis test for samples 
which were not normally distributed. 
Chi-square tests were used to test the statistical significance of categorical 
data in relation to the fate of different compartments in relation to 
recanalization status. One-way analysis of variance was used to test the 
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difference between the three perfusion parameters: CBF, CBV, MTT for EICs and 
normal tissue. 
3.13.5 Study graphs 
Almost all graphs were generated by the MedCalc programme. Descriptive 
graphs of agreement results were done by using three types of graphs. Multiple 
line graphs were used to plot the data from compared groups, such as pairwise 
kappa values and average pairwise kappa values. Mean in the graphs were 
plotted either as red dots or as a horizontal line. Multiple variables graphs were 
used to plot all paired agreements for each reader and also to plot all paired 
agreements for the same reader before and after training. Agreement among all 
readers in each set of scans by kappa for multiraters was plotted by graphs 
generated on Microsoft Excel. A line trend graph was used to present XMK 
reported on each ASPECTS area by trained and untrained observers. A column 
chart was used to present the results of HVS as a comparison between thin and 
thick slice scans. 
Tissue compartment categorisation and fate results were presented as stacked 
columns generated by Microsoft Excel. Each stack column represented the 
frequency and proportion of each classified group within each category. A data 
comparison graph was used to present a comparison of each perfusion parameter 
across the three NCCT appearances. The box and whisker with minimum and 
maximum value plot was used to represent data.  
3.14 Ethical considerations 
Ethical approval from the Multicentre Research Ethics Committee for Scotland 
had already been given for the MASIS (REC reference; 07\MRE00\96) and POSH 
studies. Study consent included use of anonymised imaging data for further 
analyses. Patients in both studies were coded and the identity of each patient 
was not provided.  
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Chapter IV (Results): Agreement. 
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4.1 Epidemiology data 
1- Patients’ Data. 
Data Frequency Mean Standard 
deviation 
Interqurtile 
range 
Number of patients 49 patients - - - 
Patients’ average age  70.2 years 11.5 years - 
Number of males 28  patients 72.3 years 8.3 years - 
Number of females 21 patients 67.8 years 14.5 years - 
Heart disease 22 patients - - - 
NIHSS (Median)15 - - Lower=9 
Upper=19 
Diabetes Mellitus 9 patients - - - 
Average onset of scanning - 174min - - 
Average onset of perfusion 
scanning 
- 187 min - - 
Treated patients. 36 patients - - - 
Onset of follow up - 30 hours - - 
Table 4. 1 Patients’ data. 
2- ASPECTS Areas Data. 
Data 
Frequency of 
isodense 
swelling 
% 
Frequency 
of 
Hypodensity 
% 
Mixed 
EICs 
% Normal % 
All Scans 20 40.8% 24 48.9% - - - - 
1st set 
Scans 
5 29.4% 8 47.1% - - - - 
2nd set 
Scans 
15 46.8% 16 50% - - - - 
ASPECTS 
Areas on 
NCCT 
38 7.7% 49 9.7% 14 2.8% 390 79.5% 
Table 4. 2: frequency and proportion of EICs as categorised by readers on all 
scans and in each set. And frequency and proportion of ASPECTS areas as 
categorised by patients on NCCT. 
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Data Frequency 
of 
Penumbra 
% Frequency 
of 
Core 
% Mixed 
core and 
penumbra  
% Normal % 
ASPECTS 
Areas on 
PCT 
86 17.5% 94  19.1% 27  5.5% 283  57.7% 
1st set 
Scans 
30 17.6% 25 (14.7%) 3 (1.7%) - - 
2nd set 
Scans 
56 17.5% 69 21.5%) 24 7.5%) - - 
Table 4. 3: frequency and proportion of ASPECTS areas as categorised by 
perfusion CT. These are for the whole set and for each set. 
 
Data Total infarcted 
areas 
Total normal 
areas 
Mixed fate 
All  ASPECTS areas 154 (31.4%) 336(68.5%) 23*(14.9%) 
Areas with mixed 
EICs 
10 (71.4%) 2 (14.3%) 2 (14.3%) 
Areas with mixed 
core \ penumbra 
9(34.6%) - 17(65.7%) 
Table 4. 4: frequency and proportion of ASPECTS areas fate on follow up 
NCCT [ * this is the percentage from totally infarcted areas and not from all 
areas]. 
A total of 51 patients from both studies, MASIS and POSH, were included in 
this study. Table 4.1 represents epidemiological data of 49 patients who were 
included in the subsequent analysis of this study. All had a final diagnosis of 
acute middle cerebral artery ischaemic stroke except five patients, in whom; 
acute posterior ischaemic infarction was the final diagnosis. In the first stage, 
there were nine readers involved: three expert stroke neurologists, four trainee 
stroke neurologists, and two expert neuroradiologists. 11 readers participated in 
reading the second set of scans after they were trained on the consensus set. 
Among the 11 readers, there were four expert stroke neurologists, four trainee 
stroke neurologists, two expert neuroradiologists and two trainee 
neuroradiologists. In total, 47 PCTs were included in the analysis. Two scans 
from the first set were excluded because they were normal, and two scans from 
second set had perfusion MRI and not perfusion CT which were analysed by 
different mode. 
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Tables 4.2, 3 and 4 demonstrate all information on ASPECTS areas as were 
categorised by readers and PCT with their final fate.   
 
3- Hemispheric Involvement of the Scans. 
Data Total  % of 
correctly 
detected  
Overall 
kappa 
Added 
clinical 
information  
Normal scans 4 (10%) 36% 0.08 - 
Abnormal scans 36 (90%) 76% 0.42 78% 
Right hemispheric 
stroke 
42% 67% 0.56 K 0.64 
Left hemispheric 
stroke 
58% 77% 0.46 K 0.61 
Table 4. 5: statistics of involved scans and hemispheres [ K; kappa]. 
The data on normality of scans in total and percentage of readers who were 
correctly recognising the abnormality is demonstrated in Table 4.5.  The effect 
of addition of clinical information on correct answers of readers is also 
presented.   
4.2  Intraobserver Agreement 
ASPECTS category Kappa ( COHEN’S) 95% CI 
Total score 0.96 0.73 to 1 
Hypodensity  0.84 0.49 to 0.99 
Isodense Swelling 0.74 0.59 to 1 
Table 4. 6. Intraobserver agreement for individual readers using 
trichotomised ASPECTS. 
Area Hypodensity 
 
Focal swelling 
 
Basal ganglia Kappa=0.9446    Kappa=0.6341    
Insula 
 
Kappa=0.9275    
 
Kappa=1.0000    
 
MCA Territories 
 
Kappa=0.9275    
 
Kappa=0.9091    
 
Table 4. 7:  Cohen’s kappa for intraobserver agreement on regions of 
ASPECTS template using tables of counts. 
 
140 
 
As can be seen from Tables 4.6 and 7, the intrinsic agreement of individual 
readers on the three categories of ASPECTS and on ASPECTS areas by using the 
repeated scans within the whole set was substantial to perfect agreement.  
 
4.3 Effect of Scan’s Factors on Interobserver 
Agreement 
 
Free marginal kappa for multi-raters 
(FMK) 
Intra-class correlation coefficient (ICC) 
 Total score 
Isodense 
swelling 
Hypodensity Total score 
Isodense 
swelling 
Hypodensity 
Blinded 0.52 0.69 0.59 0.48 0.20 0.45 
Unblinded 0.38 0.60 0.55 0.41 0.11 0.37 
Full C\D 0.36 0.49 0.51 0.49 0.11 0.44 
Minimum 
C\D 
 
0.40 0.69 0.58 0.34 0.093 0.33 
Thick slices 0.45 0.68 0.54 0.54 0.13 0.50 
Thin slices 
 
0.60 0.61 0.60 0.38 0.15 0.32 
Table 4. 8 Overall interobserver agreement among the nine readers on each 
category of EICs by using trichomotous ASPECTS. 
ASPECTS 
category 
Total score Hypodensity 
Isodense 
swelling 
 APK 
P 
Value 
APK 
P 
Value 
APK 
P 
Value 
Blinded 0.45 0.34 
 
0.39 
0.53 
0.14 0.08
9 Unblinded 0.38 0.35 0.05 
Full C\D 0.46 
0.05 
0.42 
0.16 
0.11 
0.26 
Minimum C\D 
 
0.32 0.32 0.05 
Thick slices 0.50 
0.01 
0.46 
0.01 
0.06 
 
0.55 
Thin slices 
 
0.34 0.31 0.1 
Table 4. 9: Comparison of average pairwise kappa (APK) of each group of 
variables across the three ASPECTS categories. [ significance level is at P < 0.05]. 
[ C\D clinical data] 
As can be seen from Table 4.8, overall interobserver agreement among the 
nine readers by using free marginal kappa for multiraters was different from 
that by ICC across the three ASPECTS categories.    
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Analysis of agreement between each observer, [ Appendix tables 15, 16 and 
17] yielded paired agreements ranging from very poor to perfect agreement. 
Linear distribution of paired agreements in blinded and non-blinded sets of scans 
showed closely related curves with crossing over at some points as it is 
illustrated in Figure 4.1. In Table 4.9, the average kappa across the three 
categories of changes ranged from poor to moderate for blinded set and from 
poor to fair for non-blinded set. The values of APK were higher in the blinded set 
than the non-blinded set. Despite this, it can be seen that there is no 
statistically significant difference.  
In Figure 4.2, the linear distributions of paired agreements in both sets 
appeared close to each other for isodense swelling and hypodensity while they 
were separated in a large area for Total score. As is reported in Table 4.9, 
average pairwise kappa for set with full data indicated moderate agreement for 
Total score and hypodensity and poor agreement for isodense swelling. In 
contrast, the set with minimum clinical data had fair agreement on Total score 
and hypodensity and very poor agreement on isodense swelling. Although the 
detailed clinical information on patient presentation seemed to enhance 
interobserver agreement, the difference in level of agreement between the two 
sets of scans along the three categories is statistically not significant. 
It is clear from Table 4.9 that average pairwise kappa declined from 
moderate for scans with thick slices to fair for scans with thin slices when 
readers agreed on Total score and hypodensity, whereas it was poor for both 
sets when readers agreed on isodense swelling. In figure 4.3 curves in Total 
score and hypodensity categories were separated apart with thick slices set in 
positive direction and thin slices set in negative direction whereas in isodense 
swelling category they overlapped with each other. The agreement level on 
Total score and hypodensity for scans with thick slices shows a statistically 
significant difference from that for thin slices. However, agreement on isodense 
swelling did not change significantly when thick slices were used instead of thin 
slices scans. When scans had thick slices, readers agreed more consistently than 
when the set were with thin slices where readers showed very poor agreements 
and even no agreement at all. In case of isodense swelling, the great portion of 
agreements was in the no agreement zone and the few remaining pairs deviated 
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greatly from the average in a positive direction [full statistical measures for the 
variables are presented in [ Appendix Table 18]. 
 
Figure 4. 1:Linear distribution of pairwise kappa in relation to clinical data for 
each category of ASPECTS. 
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Figure 4. 2: Linear distribution of pairwise kappa in relation to amount of 
clinical data for each category of ASPECTS. 
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Figure 4. 3: Linear distribution of pairwise kappa in relation to slice thickness 
for each category of ASPECTS. 
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4.4 Effect of Training on Interobserver 
Agreement 
 
4.4.1 Trained Group Versus Untrained Group 
In this section, the interobserver agreement will be calculated in relation to 
training by dividing the groups into trained and untrained 
A-Comparison of Interobserver Agreement on EICs Between 
Trained and Untrained Groups of Readers 
 
 
 
Group Trained group Untrained group 
parameter Total score 
Isodense 
swelling 
Hypodensity Total score 
Isodense 
swelling 
Hypodensity 
FMK 0.39 0.50 0.57 0.44 0.63 0.57 
XMK 0.26 0.20 0.29 0.26 0.10 0.25 
ICC 0.42 0.055 0.37 0.42 0.40 0.15 
Table 4. 10. Overall interobserver agreement on each category of ASPECTS. for 
trained versus untrained readers as measured by free marginal kappa (FMK), 
fixed marginal (Fleiss’s Kappa) (XMK) and intraclass coeffiecient (ICC). 
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Group Trained group of readers Untrained group of readers 
Significance 
P<0.05 
Parameter APK CI* SD** variance APK CI* SD** variance 
t-
test 
P 
value 
Total score 0.42 
0.38-
0.45 
0.14 0.021 0.41 
0.32-
0.49 
0.25 0.066 0.16 0.87 
Hypodensity 0.37 
0.31-
0.43 
0.21 0.046 0.37 
0.29-
0.45 
0.24 0.06 0.15 0.88 
Isodense 
swelling 
0.30 
0.25-
0.35 
0.18 0.033 0.093 
0.019-
0.16 
0.21 0.047 4.77 0.0001 
Table 4. 11: The difference of average pairwise kappa of each category of 
ASPECTS for trained and untrained groups of readers [* Confedince interval, ** 
standard deviation]. 
From Table 4.10 it can be seen that calculation of overall agreement by three 
different agreement measurements yielded different results among the two 
groups of readers. FMK gives the highest values of kappa whereas using XMK 
gives a very low agreement levels. In contrast, by using ICC, agreement had 
similar trend to pairwise kappa analysis. 
 In reference to average pairwise kappa in Table 4.11, trained and untrained 
readers agreed moderately on Total score and fairly on hypodensity. However, 
trained readers agreed fairly on isodense swelling whereas untrained readers 
agreed very poorly on isodense swelling. The difference in agreement on 
isodense swelling between the trained and untrained readers was statistically 
significant. In Figure 4.4 the linear curves represents the paired agreements 
given by observers in each group; red boxes are trained readers and blue circles 
are untrained readers. The vertical axis represents the ascending values of 
kappa. In the first figure; each red sequer represent paired agreement of two 
trained observers on total aspects score and each blue circle represents  paired 
agreement of two untrained readers on total aspects score. Paired agreements 
in each group were sorted in descending order to exhibit the points of crossover 
between both groups.AS it can be seen, the linear curves crossover when readers 
were agreeing on Total score and hypodensity, whereas they were separated 
from each other when readers agreed on isodense swelling with trained readers’ 
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agreements were in positive direction of kappa scale. However, both curves 
widened apart from each other as they slopped down kappa scale for Total score 
and hypodensity with a higher level of agreements given by the trained group. 
Paired agreements that were given by trained readers appeared more consistent 
with less variation than those given by untrained readers across the three 
categories of ASPECTS. A great portion of paired agreements given by untrained 
readers was poorer than predicted to occur by chance, which reflects the 
absence of agreement among a considerable number of untrained readers on 
isodense swelling. On the other hand, agreements by the trained group had 
considerable portion above the average level with agreements up to a 
substantial level [  Appendix table 19]. 
 
Figure 4. 4: Linear distribution of pairwise kappa in each group of readers for 
each ASPECTS category. 
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B- Does the effect of training differ among individual readers ? 
Group 
Trained group of 
readers 
Untrained group of 
readers 
Significance P<0.05 
Parameter 
Mean 
APK 
variance 
Mean 
APK 
variance 
Mann-
Whitney 
test 
P value 
Total score 0.42 0.006 0.41 0.03 109 0.65 
Hypodensity 0.37 0.02 0.38 0.02 114 0.94 
Isodense 
swelling 
0.30 0.009 0.09 0.02 4.04* 0.0012 
Table 4. 12: Comparison of average pairwise kappa (APK) for each reader in the 
trained and untrained groups across the three studied categories[ * t.test ].  
 
As is reported in Table 4.12, the overall average agreement on Total score 
was moderate in both groups with a statistically insignificant difference between 
trained and untrained readers (P>0.05). In Figure 4.5, paired agreements of 
untrained readers showed wide variation across kappa scale whereas paired 
agreements of trained readers appeared more consistent and less variable. Only 
one untrained reader had strong consistency of agreements with others with 
good agreement level except for one odd value. One untrained reader showed a 
cluster of very poor agreements with others. This can be also extracted from 
Figure 4.8, which shows an almost linear relationship between APK of trained 
readers with a very steady decline in the level of agreement and a steep drop of 
APK of untrained readers after an almost linear steady course. This sudden drop 
in the untrained group occurred because of two readers who showed much less 
than the average level of agreement than others in their group. The distribution 
of average agreements of readers around their mean in each group had the same 
explained pattern.  
 The pattern of paired agreements on hypodensity by each reader in both 
groups appeared as that given to Total score. This is illustrated in Figure 4.6. 
However, as can be seen in Figure 4.4, the almost linear steady course showed 
steep decline in agreement for both groups, this time with deviation of one 
untrained reader and two trained readers. The average agreement of five 
untrained readers was moderate while three others had fair average agreement 
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and the last reader agreed poorly on average. In the trained group, seven 
readers had moderate average agreement while three had fair agreement and 
only one agreed poorly. Even so, it is clear from Figures 4.8 that the 
performance of readers in both groups tended to be similar. This can be 
explained by the absence of a statistically significant difference in agreement 
between the two groups as seen in Table 4.12. 
 Untrained readers agreed in general very poorly or did not agree at all with 
each other on isodense swelling when compared with trained readers, who 
showed a range of agreement up to a substantial level. This can be noted from 
the distribution of agreements of each reader in Figure 4.7. In the untrained 
group, there were three clusters of no agreement or very poor agreement with 
wide variation in agreements given by other readers. In contrast, trained readers 
showed variability in their agreements except for one reader who showed 
clustering at a very poor level of agreement.  In reference to APK, there were 
three untrained readers who had no agreement with others on average, and 
three untrained readers showed fair average agreement with borderline kappa at 
0.22. The last three readers showed poor average agreement with a various 
range from 0.09 to 0.20. Therefore, it is clear that all APKs of trained readers 
are higher than those of untrained readers. This can be seen in Figure 4.8, 
which shows higher values of APK for trained readers with an almost linear 
relationship and very steady decline across the kappa scale. Agreements of 
untrained readers were below those by the trained group and although it started 
constant for the first three readers, it showed a rapid decline in agreement for 
all subsequent groups. Unlike the untrained group, all the trained readers had 
fair average agreement except two readers; one showed moderate and one 
showed poor agreement on average. Therefore, it can be said that, in general, 
untrained readers agreed poorly on isodense swelling whereas the trained group 
agreed fairly. The difference in the level of agreement between the two groups 
is statistically significant as seen in Table 4.12 [ pairwise kappa and APK by each 
reader in each group and for the three categories are in Appendix tables 20-
25]. 
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Figure 4. 5: Plot distribution of pairwise kappa on both changes of each reader 
in trained and untrained group. 
 
Figure 4. 6: Plot distribution of pairwise kappa on hypodensity of each reader in 
trained and untrained group. 
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Figure 4. 7: Plot distribution of pairwise kappa on isodense swelling of each 
reader in trained and untrained group. 
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Figure 4. 8:  Linear distribution of APK of each trained and untrained reader on 
each studied category of EICs. 
 
C- Comparison of Interobserver Agreement of Trained and 
Untrained Groups After Exclusion outliers. 
Four untrained readers and six trained readers were excluded because they 
had the least average agreement in their group. Therefore, the two new groups 
to be compared consist of five readers each. 
 
 
153 
 
Group Trained group of 
readers 
Untrained group of 
readers 
Significance P<0.05 
Parameter 
Mean 
APK 
variance 
Mean 
APK 
variance 
Mann-
Whitney test 
P value 
Total score 0.60 0.005 0.62 0.002 23 0.42 
Hypodensity 0.48 0.002 0.48 0.003 27 1.0 
Isodense 
swelling 
0.50 0.001 0.40 0.004 2.29* 0.021 
Table 4. 13: Comparison of average pairwise kappa (APK) for each reader in the 
trained and untrained groups across the three studied categories [ * t.test ].   
 
The most noticeable change after exclusion of outliers is that the average 
agreement increased in both groups [Appendix tables 27-31 ]. Although 
untrained readers had a higher average kappa value than trained readers when 
agreed on Total score, they did not differ significantly as is shown in Table 4.13. 
It is also clear from Figure 4.10 that the readers in both groups agreed in an 
almost identical line. The pattern of agreements given by readers in both groups 
is similar as is illustrated in Figure 4.9 despite trained readers showing 
variability in their agreements more than untrained readers.  
The agreement level on hypodensity in both groups improved from fair to 
moderate with the preclusion of inconsistent agreements. All readers in the two 
sets agreed moderately with different variability, which appeared to be higher 
for untrained readers. This is illustrated in Figure 4.9, where agreements of 
trained readers appeared more consistent than agreements of untrained readers. 
However, only one untrained reader showed good consistent agreements with a 
good moderate level. Comparing the difference between the two groups yielded 
no statistical significance and assumed high similarity between the means of 
both as illustrated in Table 4.13.   
Agreement on isodense swelling rose from very poor to moderate agreement 
among untrained readers and from fair to good moderate among trained readers. 
However, the difference in agreement between trained and untrained groups is 
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still statistically significant even with the exclusion of inconsistent readers. This 
can be explained by the pattern of agreements given by readers in both groups. 
In Figure 4.10 the curves of APK in both groups are separated from each other 
and there is no overlap with higher values for trained readers. Moreover, the 
variations in agreement among untrained readers are also higher than variations 
among trained readers. This can be also noted from Figure 4.9. 
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Figure 4. 9: Plotting of pairwise kappa of each reader in trained and untrained 
groups after exclusion of outliers for the three categories of EICs. 
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Figure 4. 10:  Linear distribution of average pairwise kappa of each reader in 
the trained and untrained groups for the three categories of EICs after exclusion 
of outliers. 
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4.4.2 Pre- and Post-Training Groups of Readers 
(same readers). 
A- Comparison of Pre- and Post-Training Interobserver Agreement 
on EICs for the Whole Group. 
 
Scan’s set Pre-training Post-training 
Significance 
P<0.05 
Parameter APK CI SD variance APK CI SD variance t-test 
P 
value 
Total score 0.61 
0.52-
0.72 
0.13 0.017 0.36 
0.23-
0.48 
0.17 0.030 13.12 0.0001 
Hypodensity 0.42 
0.28-
0.58 
0.20 0.041 0.34 
0.15-
0.52 
0.25 0.067 2.2 0.06 
Isodense 
swelling 
0.20 
0.008-
0.49 
0.28 0.078 0.19 
0.077-
0.30 
0.15 0.025 0.40 0.69 
Table 4. 14: Comparison of average kappa before and after training across the 
three ASPECTS categories.  
As is illustrated in Tables 4-14, readers who participated before and after 
consensus generally had better performance before they were trained on 
recognising EICs. Their average agreements were substantial on Total score 
before training and dropped to fair after training with a significantly different 
level of agreement. This is demonstrated in Figure 4.11. In addition, there was 
a higher variation of agreements when readers were trained.  
For hypodensity, readers agreed moderately before training and fairly after 
training. Despite this, the difference in pre-and post-training performance is 
statistically insignificant as shown in Table 4.14.  In Figure 4.11, it is clear that 
there was an overlapping in the pattern of agreements in the two situations with 
higher values for the pre-training set. The paired agreements showed less 
variability before the consensus.  
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Readers agreed poorly on isodense swelling before and after training with no 
statistically significant difference as seen in Table 4.14. However, readers 
agreed more consistently on isodense swelling after training [see Appendix 
Tables 32 and 33, for pairwise kappa for each reader]. 
 
Figure 4. 11: Linear distribution of pairwise kappa before and after training for 
each category of ASPECTS. 
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B- Comparison of Pre- and Post-Training Interobserver Agreement 
on EICs for Each Reader. 
READERS 
Total score Hypodensity Isodense swelling ANOVA 
Pre Post 
Sig-
level 
Pre Post 
Sig-
level 
Pre Post Sig-level F-ratio 
P 
value 
READER-A 0.71 0.45 P>0.05 0.51 0.41 P>0.05 0.32 0.31 P>0.05 1.6 0.25 
READER-B 0.49 0.19 P<0.05 0.37 0.057 P<0.05 0.18 0.14 P>0.05 5.2 0.004 
READER-C 0.66 0.45 P>0.05 0.49 0.42 P>0.05 0.31 0.22 P>0.05 2.8 0.044 
READER-D 0.58 0.34 P>0.05 0.43 0.41 P>0.05 -
0.096 
0.05 P>0.05 7.8 <0.001 
READER-E 0.64 0.42 P>0.05 0.34 0.41 P>0.05 0.33 0.23 P>0.05 1.9 0.13 
Table 4. 15: ANOVA analysis of each reader response before and after training 
with reference to average pairwise kappa of each ASPECTS category. 
 
Scan’s set Pre-training Post-training 
Significance 
P<0.05 
Parameter APK APK P value* 
Total score 
0.70 
 
0.48 
 
0.0312 
Hypodensity 
0.46 
 
0.54 
 
0.3125 
Isodense swelling 0.22 0.22 0.8438 
Table 4. 16: Comparison of average kappa pre- and post- training after 
exclusion of reader B. [* Wilcoxon test].  
From Table 4-15, it is clear that all average agreements on Total score were 
higher before training. Agreement on hypodensity showed less change, with a 
moderate level for most readers before and after training. However, one reader 
had fair agreement before training and dropped to very poor after training. Most 
readers agreed on isodense swelling similarly before and after training with 
levels ranging between fair and poor agreement.  Changes in pre- and post-
training agreements of each reader on each ASPECTS category are illustrated in 
Figure 4.12. As seen in Table 4.15, the changes in agreement level before and 
after training has no statistical significance for all readers except for reader B, 
who showed a significant change in agreement on both changes and hypodensity 
before and after training. 
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Figure 4. 12: Distribution of pre- and post-training pairwise kappa of each 
reader for the three EICs categories. 
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When reader B was excluded from analysis, the resulted levels of agreements 
is shown in Table 4.16 with reference to average pairwise kappa of paired 
agreements for Total score isodense swelling and hypodensity.   
 From Figure 4.13, it is clear that curves in hypodensity and isodense swelling 
categories crossed each other whereas those for Total score separated apart 
widely. The pre-training agreements for hypodensity and isodense swelling 
showed wide variability, and the post-training agreements appeared more 
consistent with fewer variables. 
 
Figure 4. 13: Linear distribution of average pairwise kappa of pre and post 
trained readers after exclusion of reader B across the three EICs categories. 
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4.5 Effect of Speciality and Experience on 
Interobserver Agreement 
4.5.1 Readers’ Speciality 
 
Group Neuroradiologists 
Stroke 
neurologists 
Significance P<0.05 
Parameter APK APK P value* 
Total score 0.30 0.49 0.09 
Hypodensity 0.33 0.45 0.09 
Isodense 
swelling 
0.24 0.36 0.09 
Table 4. 17: Comparison of average pairwise kappa of neuroradiologists and 
stroke neurologists (* Kruskal-Wallis test). 
 
 Neuroradiologists* Stroke neurologists** 
Parameter Trained Untrained 
P 
Value 
Trained Untrained P value 
Total score 11.67 21 0.13 0.46 0.51 >0.05 
Hypodensity 11.50 20 0.13 0.41 0.45 >0.05 
Isodense 
swelling 
8.33 0 0.13 0.35 0.30 >0.05 
Table 4. 18: Comparison of average pairwise kappa of neuroradiologists and 
stroke neurologists before and after training for each ASPECTS category (* 
Kruskal-Wallis test, ** one-way ANOVA). 
 
 Table 4-17 presents comparison of interobserver agreement between 
neuroradiologists and stroke neurologists. Generally, neuroradiologists agreed 
fairly on the three categories whereas stroke physicians agreed moderately on 
Total score and fairly on isodense swelling. Although stroke physicians performed 
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better than neuroradiologists, this has no statistical significance with P>0.05 
across the three categories of ASPECTS. Table 4.18 presents the comparison in 
relation to training in each speciality. It is clear that the performance of each 
speciality before training had no statistically significant difference from the 
performance in the post-training group.  
 
4.5.2 Readers’ Experience. 
 
1- Interobserver Agreement Comparison Between Experts and 
Trainees. 
 
Untrained Experts Trainees Significance P<0.05 
Parameter APK Median variance APK Median variance MWT* P value 
Total score 0.61 0.58 0.021 0.26 0.16 0.056 30 0.02 
Hypodensity 0.55 0.60 0.066 0.30 0.30 0.055 35 0.09 
Isodense 
swelling 
0.04 -0.068 0.25 0.096 0.17 0.028 75 0.31 
Table 4. 19: Comparison of average pairwise kappa of untrained experts and 
trainees (* MWT Mann-Whitney test). 
 
Trained Experts Trainees Significance P<0.05 
Parameter APK SD variance APK SD variance T test P value 
Total score 0.36 0.15 0.023 0.44 0.12 0.015 1.44 0.16 
Hypodensity 0.28 0.25 0.062 0.44 0.17 0.031 1.82 0.08 
Isodense 
swelling 
0.24 0.20 0.04 0.30 0.17 0.029 0.18 0.42 
Table 4. 20: Comparison of average pairwise kappa between trained experts and 
trainees (MWT Mann-Whitney test). 
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Tables 4.19 and 20 demonstrate comparison between experts and trainees 
when they were untrained and trained. Generally, experts had better 
performance than trainees in untrained group with the only statistically 
significant difference in agreement on Total score. On the other hand, in the 
trained groups, trainee readers had better performance than experts. However, 
these differences were statistically insignificant across the three categories. 
2- Interobserver Agreement Comparison Between Trained and 
Untrained readers in relation to experience. 
 
Experts APK ANOVA 
Parameter Untrained Trained P value F ratio P value 
Total score 0.61 0.36 <0.05 10.37 P < 0.001 
Hypodensity 0.56 0.29 <0.05 10.37 P < 0.001 
Isodense swelling 0.04 0.24 <0.05 10.37 P < 0.001 
Table 4. 21:Comparison of average kappa of trained experts with that of 
untrained experts across the three categories of ASPECTS. 
 
Trainees APK 
Kruskal–Wallis one-way 
analysis* 
P value 
Parameter Untrained Trained Untrained Trained 
Total score 0.26 0.44 26.5 39.8 >0.05 
Hypodensity 0.30 0.44 28.8 39.9 > 0.05 
Isodense swelling 0.096 0.30 11.50 27.7 < 0.05 
Table 4. 22: Comparison of average kappa of trained with that of untrained 
trainees across the three categories of ASPECTS [* values are the average rank by 
Kruskal–Wallis]. 
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Tables 4-21 and 22 present the average pairwise kappa values of untrained 
and trained experts and trainees with test of significance. 
Untrained experts agreed substantially on Total score and moderately on 
hypodensity whereas trained experts agreed fairly on both categories. These 
differences in performance had statistical significance as is illustrated in Table 
4.21. However, trained experts agreed fairly on isodense swelling whereas 
untrained experts agreed very poorly. This showed statistical significance as is 
clear in Table 4.22. 
In general, trained trainees performed better than the untrained trainees. 
The average agreement of trained trainees were moderate on Total score and 
hypodensity and fair on isodense swelling, while the untrained trainees had fair 
agreement on Total score and hypodensity and very poor agreement on isodense 
swelling. These differences in trainees’ performance were only statistically 
significant regarding agreement on isodense swelling as is clear from Table 
4.22. 
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4.6 Overall Interobserver Agreement on Each 
Area of ASPECTS. 
 
 
Isodense Swelling 
 
Hypodensity 
 
ASPECTS AREA 
Untrained 
readers 
Trained readers Untrained readers Trained readers 
FMK XMK FMK XMK FMK XMK FMK XMK 
Caudate Nucleus 0.78 0.01 0.92 0.008 0.66 0.29 0.68 0.21 
Lentiform Nucleus 0.70 -0.003 0.81 0.02 0.47 0.34 0.395 0.23 
Internal Capsule 0.85 -0.003 0.95 0.06 0.72 0.09 0.62 0.03 
Insula 0.71 0.01 0.46 0.10 0.43 0.19 0.359 0.24 
M1 0.60 0.006 0.51 0.14 0.63 0.34 0.67 0.30 
M2 0.50 0.08 0.28 0.14 0.56 0.10 0.511 0.28 
M3 0.65 0.08 0.41 0.19 0.66 0.11 0.586 0.20 
M4 0.65 0.12 0.51 0.18 0.66 0.24 0.643 0.13 
M5 0.50 0.12 0.33 0.20 0.56 0.13 0.5272 0.15 
M6 0.59 0.12 0.40 0.23 0.66 0.18 0.72 0.18 
Table 4. 23: Overall agreement on isodense swelling for each ASPECTS region 
among all readers in the trained and untrained groups [free marginal kappa 
(FMK) and Fleiss’s kappa (XMK)].  
 
 
Figure 4. 14: Linear distribution of overall Fleiss’s kappa (XMK) values on 
isodense swelling for each ASPECTS area in untrained (first set) group and 
trained (second set) group. 
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Figure 4. 15: Linear distribution of overall Fleiss’s kappa values on hypodensity 
for each ASPECTS area in untrained (first set) group and trained (second set) 
group. 
 
The overall agreement on isodense swelling and hypodensity for each ASPECTS 
area by using FMK and XMK with 95% confidence intervals are presented in Table 
4.23.  
Figures 4-14 and 15 show the trends of agreement on areas of ASPECTS 
template. In Figure 4.14 it is clear that agreement on isodense swelling 
appeared to improve gradually in both groups as it moves out from subcortical 
areas toward cortical areas. In Figure 4-15, agreement on hypodensity showed 
improvements and worsening in both subcortical areas and cortical areas. 
However, in upper cortical areas agreement on hypodensity dropped in both sets 
when compared to the other ASPECTS areas. In both figures, readers showed 
very poor agreement or no agreement on the internal capsule area. However, 
agreement on isodense swelling for the second set appeared to be better than 
that for the first set, whereas agreement on hypodensity overlapped in both 
sets. 
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4.7 Hyperdense Vessel Sign (HVS) 
Parameter Presence 
Category 
of HVS 
Thick slices scan Thin slices scan 
Overall MCA 
Dot 
Sign 
Overall MCA 
Dot 
Sign 
Fleiss’s 
kappa 
0.42 0.58 0.25 - - 0.31 - - 
% of positive 
responses 
38.9% 
0.3-
19.8% 
25% 0.1% 83% 52% 71% 16% 
Table 4. 24: Fleiss’s kappa (XMK) and percentage of positive responses for 
presence of hyperdense vessel sign and its categorisation and in relation to thick 
and thin slices scans. 
Table 4.24 summarises some data collected on HVS. However, of the positive 
responses on HVS, 51% were on MCA, 38% on “Dot” sign and 11% on the rest of 
the intracranial arteries including PCA, ACA and ICA. The responses of observers 
varied with changing the scans’ slice thickness.  The positive responses on MCA 
sign on thick slices were very low in comparison with thin slices scans. In 
contrast, positive responses on “Dot sign” were low on thin slices scans and 
soared on thick slices scans. Differences in responses on HVS categories are 
illustrated in Figure 4-16 with reference to absolute numbers of responses on 
each category in both sets of scans. 
 
 
Figure 4. 16: Number of responses on each HVS category on thick and thin slices 
scans.  
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Chapter V (Results): Tissue fate 
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5.1 Consensus results 
 5.1.2 Notes from comparison of acute NCCT and 
PCT in consensus analysis*1 
The comparison process yielded the following findings; 
 
1-  Areas with core appeared uniformly hypoattenuated on NCCT, 
with radiolucency equal to or less than that of normal white matter. On 
densitometry and histogram, they were different from normal tissue 
too. Samples from these areas had lower HU values than contralateral 
areas. Graphically, curves from normal and hypoattenuated areas were 
separated from each other on the histogram (figure 3-7). 
 
2- Areas with penumbra appeared isodense with an equivalent 
radiolucency to that of normal tissue. These areas had similar 
densitometry readings and histogram to that of normal areas. HU values 
were almost the same in normal and isodense areas, and curves 
overlapped on each other (figure 3-8, 9 Basal ganglia). 
 
3- When penumbra and core occurred in the mixture, which was the 
commonest finding on penumbra grams, they appeared in a patchy 
manner (figure 5.1). When core tissue predominates, penumbra tissue 
appears as normal or hyperattenuated areas surrounding or dispersed 
across hypodense areas, and when penumbra tissue predominates, core 
areas appears as dark patches within isodense areas (figure 3-9).  
 
4- In the case of mixed findings, the ROI of the whole ASPECTS area 
gives slightly deviated curves from normally appearing tissue (figure 3-9 
M2). HU values of affected ASPECTS area are difficult to judge because 
of the interrelationship between core and penumbra within these areas. 
However, if hypodense patches and isodense patches were compared 
                                         
1 -* Some of Figures in the next two sections are found in chapter III.  
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with contralateral normal areas, they have values similar to that 
described in point 1 and 2 respectively (figure 3-10).  
 
 
Figure 5. 1: Scans with mixed penumbra and core tissue. Green arrows: 
penumbra [ isodense swelling] red arrows [ hypodensity]. 
 
5- Structural changes within ROIs, regardless of radiolucency changes, 
included narrowing or obliteration of CBF spaces. This might appear as 
complete obliteration, reduction of the number of sulci and cisterns, 
decreased depth of cortical sulci and partial or complete effacement. 
For example, in figure 3-7, there is complete effacement of cortical 
sulci; in figure 3-10, there is narrowing of some cortical sulci; in figure 
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3-8, there is narrowing of Sylvian fissure; and in figure 3-9 there is 
obliteration of Sylvian fissure and cortical sulci. Straightening of the 
brain outer contour, as in figure 3-8, might also occur in conjunction 
with underlying swelling. 
 
 
Figure 5. 2:Obscuration of lentiform nucleus[ black arrows]. 
 
 
6- Another structural change was distortion of the normal delineation 
of grey-white matter. Hypodensity compatible with the core was 
associated with complete loss of differentiation between grey and white 
matter, with decreased radiolucency as in figure 3-7. In contrast, areas 
with penumbra showed incomplete loss of delineation, which appeared 
as mixing of bright and dark areas together, as in figure 3-9 and figure 
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5.1 A. Penumbra areas might also retain the grey-white matter 
interface as normal, as in figure 3-8 and some areas in figure 3-10, or 
with its deviation in an outer direction as in figure 3-9.  
 
7- The same distortions in cortical grey-white matter can occur in 
insular ribbon. Loss of insular ribbon might be complete as in figure 3-9 
or partial as in figure 5.1 A. 
 
8- Distortion of the normal contour of basal ganglia, mainly the body 
of lentiform nucleus. The borders between lentiform nucleus and 
adjacent structures become blurred and it is difficult to differentiate its 
contour. In figure 5.2 A, it is difficult to draw borders between the 
insula and lentiform nucleus. In figure 3-9, there is incomplete loss of 
shape with retained brightness. In figure 5.2 B, there is complete 
distortion with hypodensity. 
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Figure 5. 3: Example of loss of insular ribbon sign A; With evident core by PCT. 
B; With evident Penumbra by PCT. 
 
5.1.2 Conclusions from comparison process 
Core tissue on NCCT appeared in all examples as dark areas in comparison 
with ipsilateral normal tissue and the contralateral hemisphere, i.e. decreased 
radiolucency [hypodensity, hypoattenuation]. The degree of density on the grey-
scale seemed to be in level with normal white matter or lower. This change in 
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radiolucency might be associated with the manifestation of brain swelling as a 
narrowing of CSF spaces, e.g. sulcal effacement. In other words, if hypodensity 
occurs as a uniformly dark area, it will very likely be core tissue. When core 
occurred in lentiform nucleus, it caused distortion of its shape making it difficult 
to differentiate it from contagious structures. It might appear as a uniform dark 
patch, or a uniform loss of its lighter appearance (figure 5.2). Core in the insula 
caused loss of its characteristic ribbon shape. This might include loss of the 
small area of light  and the zigzag path of insular region with increased darkness, 
and it can be associated with local swelling manifestations, such as the 
narrowing of Sylvian fissure when compared with contralateral hemisphere 
(figure 5.3 A). 
Penumbra tissue appears on the NCCT as similar in appearance to normal 
tissue, or is slightly lighter when compared with contralateral hemisphere. The 
slight hyperattenuation occurs in a mixture with isodensity and not solely in all 
examples; however, it is not very common and cannot be used to distinguish 
penumbra from adjacent normal tissue. Appearance of penumbra can be 
distinguished on the NCCT by evidence of local swelling. In figure 3-8, isodensity 
is associated with the narrowing of Sylvian fissure. In figure 3-10, isodensity is 
associated with effacement of cortical sulci. These findings can be applied on 
insular ribbon, which shows isodensity with a narrowing of Sylvian fissure, as in 
figure 5.3 B. In some instances, the characteristic zigzag of insula might be 
distorted when compared with contralateral insula, as in figure 5.3 B [left and 
middle slices].  Penumbra affecting basal ganglia is difficult to recognise, 
although partial isodense distortion of lentiform nucleus contour might indicate 
penumbra rather than core, as in figure 3-9. 
Predominance of core or penumbra alone seems to have a distinguishable 
appearance on NCCT as a uniform dark area and isodense swollen area 
respectively. Moreover, determination of their extension is attainable. However, 
when they occur in a mixture, the appearance also becomes a mixture of 
normally appearing tissue, isodense swelling and hypodensity; its reading on the 
NCCT also becomes rather confusing because of its similarity with normally 
appearing contralateral hemisphere. In this situation, foci of hypodensity might 
be difficult to recognise, particularly in cases with diffuse atherosclerotic 
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changes that had a similar density to acute ischaemic changes. However, 
hypodensity patches will most likely be surrounded by penumbra rather than 
normal tissue in this case. 
Brain swelling, which is associated with acute ischaemia, occurs with both 
hypodensity and isodense swelling. Penumbra on the NCCT is always associated 
with swelling, whereas the core may or may not be associated with swelling on 
NCCT.  
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5.2 Fate of tissue categories 
5.2.1 Fate of Tissue Compartments as Categorised 
by Readers 
 
 
Figure 5. 4: The proportion and frequency of each NCCT appearance category in 
relation to fate and recanalisation [I.F. swelling, isodense swelling; REC, 
recanalisation]. 
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EICs Chi-square Contingency coefficient Significance level 
Isodense swelling fate 27.2 0.22 P < 0.0001 
Hypodensity fate 110.3 0.42 P < 0.0001 
Normal appearance fate 96 0.40 P < 0.0001 
Table 5. 1: Chi-square test for classification of NCCT appearances fate in 
relation to recanalisation. 
 
Risk of infarction 
Hypodense areas versus 
isodense swollen areas 
Non-recanalized versus recanalized 
Isodense swollen areas 
Odds ratio 11.9 4.8 
95% CI 4.4 to 32.6 1.5 to 14.9 
Significance level P < 0.0001 P = 0.006 
Table 5. 2: The odds of developing infarction in isodense swollen areas with 
confidence interval and p values. 
 
As is presented in Figure 5.4, the categorisation of readers to NCCT 
appearances yielded the following: 11.9% of overall ASPECTS areas were 
classified as isodense swollen, 12.8% as hypodense and 75.1% as appearing 
normally. 
Of isodense swollen areas, 38.3% were infarcted and 61.6% returned to 
normal. Recanalisation was associated with normalisation of 46.6% of the total 
areas categorised as isodense swollen and 75.6% of totally recanalised areas. In 
contrast, absence of recanalisation was associated with infarction of 23.3% of 
the total areas categorised as isodense swollen and 60.8% of total infarcted 
isodense swollen areas. Correlation between isodense swelling and infarction in 
relation to recanalisation is statistically significant with p value <0.05 as can be 
seen in Table 5-1. However, the contingency coefficient is only 22%, which 
indicates a weak relationship.   
It was found that 90.7% of areas categorised by readers as hypodense ended in 
infarction and only 9.3% were normal on follow-up scans. Of the total infarcted 
hypodense areas, 69.4% were infarcted with absence of recanalisation and 30.3% 
infarcted in its presence. The association of hypodense areas with fate of 
179 
 
infarction in relation to recanalisation is statistically significant with P <0.05 and 
has a relation strength of 42%.  
Areas categorised as normally appearing by readers remained normal on 
follow-up scans in 71.1% of the total. However, the infarcted normally appearing 
areas occurred in 74.7% of totally non-recanalised areas. This relation between 
normally classified tissue, infarction and recanalisation status has statistical 
significance with P value <0.05 and it showed a strength of 40%. 
From Table 5.2, it is clear that the hypodense areas had 11.9 times the odds 
as isodense swollen areas to infarct. This shows statistical significance with p 
<0.05 and the 95% CI does not contain the null value. In isodense swollen areas, 
persistent occlusion increased the odds of infarction by 4.8 times when 
compared with state of evident recanalization  with 95% CI empty of the null 
value and statistical significance of p=0.006.  
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5.2.2 Fate of Tissue Compartments as Categorised 
by Perfusion Parameters 
 
Figure 5. 5: Distribution of proportion and absolute numbers of areas fate for 
penumbra, core and normally appeared tissue [I.F.swelling: isodense swelling, 
REC: recanalisation]. 
 
Tissue compartment Chi-square Contingency coefficient Significance level 
Penumbra  fate 64.2 0.33 P < 0.0001 
Core  fate 287 0.59 P < 0.0001 
Normal tissue fate 256.2 0.57 P < 0.0001 
Table 5. 3: Chi-square test for classification of tissue compartments according 
to fate and recanalisation. 
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Risk of infarction 
Core  areas versus 
penumbra areas 
Non-recanalized versus recanalized 
penumbra areas 
Odds ratio 422 10.5 
95% CI 25.5 to 6953 4.3 to 26 
Significance level P < 0.0001 P < 0.0001 
Table 5. 4: The odds of developing infarction in isodense swollen areas with 
confidence interval and p values. 
From Figure 5.5, it can be seen that 53.6% of the total studied ASPECTS areas 
had normal perfusion parameters, 23.6% had core parameters and 22.8% 
displayed penumbra perfusion thresholds.  
Of the penumbra areas, 63.5% returned to normal on follow-up scans while 
36.3% were infarcted. In absence of recanalisation, penumbra ended in 
infarction in 75% of totally infarcted salvageable tissue and normalisation of only 
25%. In areas with evident recanalisation,  85.1% of penumbra tissue returned to 
normal perfusion status and 14.9% were infarcted while in areas without 
recanalisation, 64.7% of penumbra ended in infarction and 35.2% returned to 
normal perfusion. The classification of penumbra according to fate and 
recanalisation was statistically significant with p <0.05, albeit the strength of 
relation was only 33%. No core areas returned to normal on follow-up scans and 
100% of areas categorised as core ended in infarction. However, the percentage 
of infarcted core areas with recanalisation was lower than that without evidence 
of recanalisation. Classification of the fate of core areas in relation to 
recanalisation status was statistically significant with p <0.05 and good relation 
strength of 59%.  
Results showed that 92.8% of normally perfused remained normal on follow-up 
scans and only 7.1% of normally perfused areas ended in infarction. The 
proportion of infarcted normal areas was lower in the presence of recanalisation 
compared with those in its absence. This classification of normal tissue fate had 
statistical significance with good relation at 57.6%. In Table 5.4, core areas are 
421.7 times more likely to infarct than the penumbra regions with high 
statistical significance. However, non-recanalised penumbra areas had 10.4 
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times the odds to infarct than the recanalised penumbra areas with 95% CI being 
empty of the null value and high statistical significance. 
 
5.3 Relation of NCCT Appearances with 
Perfusion Categories 
 
 
Figure 5. 6: Proportion and frequency of each perfusion categorised areas in 
relation to NCCT appearances [I.F.Swelling, isodense swelling]. 
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NCCT category Chi-square Contingency coefficient Significance level 
Isodense swelling  matching 68.6 0.34 P < 0.0001 
Hypodensity matching 137.4 0.46 P < 0.0001 
Normal appearance matching 158.4 0.48 P < 0.0001 
Table 5. 5: Chi-square test for relation of NCCT appearances with perfusion 
categorised areas.  
 Figure 5-6 demonstrates the NCCT appearances as categorised by readers 
and their correspondent perfusion category. Generally, readers were correctly 
matching the perfusion category in 69.6% of the total matched areas, and the 
most common correct match was for normally appearing tissue to normal 
perfusion followed by hypodensity to core, and then isodense swelling to 
penumbra. Of the total mismatched categories, classification of penumbra as 
normal on NCCT was the most common with 41.7% followed by core as normal 
with 34.8%. In only 6.9% was penumbra categorised as hypodensity and in 11.8% 
core as isodense swelling of the total mismatch. In general, normally perfused 
areas were not commonly coded as isodense swollen or hypodense by readers 
with only 2.8% of total. However, readers categorised normally perfused areas as 
isodense swelling more frequently than as hypodensity. 
Fifty-nine per cent of the areas named isodense swelling by readers had 
penumbra perfusion and 29.3% had core perfusion. The correlation of isodense 
swelling with perfusion categories is statistically significant with p <0.05 and a 
strength of 34%.  
Of hypodense areas, 81.2% had core perfusion and 17.2% had penumbra 
perfusion. This classification had statistical significance as is seen in Table 5.5 
with strength of 45.7% 
In addition, 69.2% of normally categorised areas were normally perfused 
tissue on PCT while 16.7% were penumbra and only 13.9% were core. As 
demonstrated in Table 5.5, the correlation between normal appearance on 
NCCT and its perfusion category on PCT has a high statistical significance with p 
value < 0.05 and strength of relation at 48.3%.  
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5.4 Prediction of Tissue Perfusion and Fate by 
NCCT Appearances 
1- Isodense Swelling 
 
Penumbra Core infarction 
Sensitivity 31.86% 14.40% 13.61% 
Specificity 93.86% 89.11% 88.96% 
Positive Likelihood Ratio 5.19 1.32 1.23 
Negative Likelihood Ratio 0.73 0.96 0.97 
Positive Predictive Value 59.02% 29.51% 38.33% 
Negative Predictive Value 83.22% 76.69% 67.12% 
Table 5. 6: Predictive statistics of isodense swelling to penumbra, core and 
infarction. 
From Table 5-4 it is clear that isodense swelling is generally a low-sensitivity 
sign for penumbra, core and infarction. However, it had the highest predictive 
values for penumbra when compared to core and the final fate of infarction. 
Although sensitivity to penumbra is low, it is higher than that for core and 
infarction. Additionally, in case of absence of isodense swelling on NCCT, there 
is a good probability of absence of penumbra with a negative predictive value up 
to 83.2%. The positive likelihood ratio of 5.19 indicates an increased likelihood 
of penumbra when isodense swelling is seen on the NCCT but with a negative 
likelihood ratio of 0.73 that absence of isodense swelling can’t exclude presence 
of penumbra. On the other hand, prediction of core by isodense swelling appears 
less likely when compared with penumbra prediction findings.  
Isodense swelling appears to be a specific sign of penumbra with a value up to 
93.8% and its presence on NCCT can indicate penumbra. A rather high specificity 
to core was also found, however, exclusion of normal tissue from calculation 
yielded specificity to penumbra of 74% and to core of only 23%. The positive 
predictive value is not as high as specificity, with only 59% probability of 
penumbra when isodense swelling is reported on NCCT. For prediction of fate, 
the pattern was more similar to the prediction of core with a very low sensitivity 
and a rather high specificity. However, this might reflect that isodense swelling 
is in general less likely to infarct. A positive predictive value of only 38.3% and a 
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positive likelihood ratio of 1.23 are both indicative of very low probability of 
infarction in isodense swollen areas. This is also supported by the high negative 
likelihood ratio of 0.97, which indicates that absence of isodense swelling dose 
not exclude infarction. 
2- Hypodensity 
 
Core Penumbra infarction 
Sensitivity 41.60% 9.73% 34.91% 
Specificity 96.96% 86.98% 98.21% 
Positive Likelihood Ratio 13.69 0.75 19.49 
Negative Likelihood Ratio 0.60 1.04 0.66 
Positive Predictive Value 81.25% 17.19% 90.77% 
Negative Predictive Value 83.99% 77.63% 74.94% 
Table 5. 7: Predictive statistics of hypodensity to core, penumbra and 
infarction. 
 
As is presented in Table 5.7, hypodensity is not so sensitive to core with 
sensitivity of only 41.6%. However, there is a good probability of 83.9% of 
absence of core when hypodensity is not seen on NCCT, as can be concluded 
from the negative predictive value. In addition, hypodensity seems to increase 
the likelihood of core significantly with a positive likelihood ratio of 13.69. On 
the other hand, a negative likelihood ratio of 0.60 is not adequate to make the 
absence of hypodensity on NCCT an exclusion sign for core. In contrast, 
hypodensity is highly specific for core and had good probability to be a core with 
the positive predictive value of 81.25%.  
The prediction of penumbra by hypodensity is generally very poor, as can be 
seen from the statistics in Table 5.7. Although hypodensity showed a rather high 
specificity to penumbra, the positive likelihood ratio and positive predictive 
value were very low and indicate decreased likelihood of penumbra. In contrast, 
hypodensity had prediction values for infarction that were almost similar to 
those for core. It is a very specific sign for infarction too. In case of positive 
hypodensity on NCCT, there is a significantly increased likelihood of infarction 
186 
 
with a positive likelihood ratio of 19.49 and a positive predictive value of 90.7%. 
However, hypodensity is not as sensitive as a sign to infarction, with a low 
negative predictive value and high negative likelihood ratio that makes it likely 
to miss many areas that are going to infarct. 
3-Prediction of Perfusion Categories by NCCT 
Appearances as Categorised by at Least Four 
Readers 
 
 
Isodense swelling to 
penumbra 
Hypodensity to core 
Sensitivity 42.11% 50.00% 
Specificity 93.63% 96.97% 
Positive Likelihood Ratio 6.61 16.50 
Negative Likelihood Ratio 0.62 0.52 
Positive Predictive Value 64.86% 84.00% 
Negative Predictive Value 85.27% 85.91% 
Table 5. 8: Predictive statistics of hypodensity and isodense swelling in case of 
agreement by at least four readers. 
Table 5.8 presents prediction statistics of both hypodensity and isodense 
swelling for core and penumbra respectively, when agreement on seeing them 
on NCCT was made by at least four readers. It can be noted that there is a 
general increase in power of prediction of both changes when compared to those 
presented in Tables 5.6 and 5.7. Although sensitivity of both changes was 
improved, they are not high enough to make hypodensity and isodense swelling 
sensitive signs to correspondent perfusion category. Specificity and predictive 
values have not changed greatly. However, the likelihood ratios were improved 
in favour of increased likelihood of penumbra with positive isodense swelling and 
core in the case of positive hypodensity.   
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4- Comparison of Prediction Between Trained and 
Untrained Groups. 
 
NCCT category 
Isodense swelling to 
penumbra 
Hypodensity to core 
Predictive parameter Trained Untrained Trained Untrained 
Sensitivity 41.25% 9.09% 39.58% 48.28% 
Specificity 92.51% 96.43% 97.61% 95.83% 
Positive Likelihood Ratio 5.51 2.55 16.56 11.59 
Negative Likelihood Ratio 0.64 0.94 0.62 0.54 
Positive Predictive Value 62.26% 37.50% 86.36% 70.00% 
Negative Predictive Value 84.01% 81.82% 80.86% 90.20% 
Table 5. 9:Predictive statistics of isodense swelling and hypodensity for the 
scans of trained group and scans of untrained group. 
 
By dividing the scans into two groups in relation to status of readers, trained 
versus untrained, for the purpose of comparing prediction statistics, there were 
differences in the level of predictive power of each early ischaemic change to 
correspondent perfusion characteristics on PCT.  
As can be seen from Table 5.9, isodense swelling had higher sensitivity to 
penumbra when scans were read by trained readers than untrained readers. 
Although the value is generally low (41.25%), it differs from the very low value 
attained by untrained readers (9.1%). In contrast, specificity was high in both 
groups but with a higher value among untrained readers. Trained readers 
attained better values of positive predictive value and positive likelihood ratio 
for penumbra than those achieved by untrained readers who showed much lower 
values. However, the negative predictive value and negative likelihood ratios 
were almost similar in both groups. 
For hypodensity prediction of core, prediction power appeared generally 
almost similar in trained and untrained groups. A higher sensitivity level of 50% 
was achieved by the untrained readers compared with only 39.5% by the trained 
group. However, good specificity with more than 90% was attained by both 
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groups. Trained readers had a higher positive likelihood ratio and positive 
predictive values than untrained readers, who achieved better values of 
negative likelihood ratio and negative predictive value. 
5.5 Comparison of Perfusion Parameters 
Across the Three NCCT Appearances. 
 
Perfusion 
parameter 
CBV(ml\100g) MTT seconds CBF(ml\100g\min) 
ANOVA Mean P value Mean P value Mean P value 
Isodense 
swelling 
2.5 
P >0.05 x Normal 
P <0.05 x 
hypodensity 
9.9 
P <0.05 x Normal 
P >0.05 x 
hypodensity 
19.1 
P <0.05 x Normal 
P <0.05 x hypodensity 
Hypodensity 1.2 
P <0.05 x Isodense 
swelling 
P <0.05 x Normal 
10.3 
P >0.05 x Isodense 
swelling 
P <0.05 x Normal 
8.1 
P <0.05 x Isodense 
swelling 
P <0.05 x Normal 
Normal 
appearance 
2.3 
P >0.05 x Isodense 
swelling 
P 
<0.05 x 
Hypodensity 
6.1 
P <0.05 x Isodense 
swelling 
P <0.05 x 
Hypodensity 
24.6 
P <0.05 x Isodense 
swelling 
P <0.05 x Hypodensity 
Table 5. 10: Comparison of averages of mean transient time MTT, cerebral 
blood volume CBV and cerebral blood flow CBF across the three NCCT 
appearances. 
 
Table 5-10 presents one-way ANOVA comparison between averages of the 
relative values of perfusion parameters matched with the three appearances of 
EICs on NCCT. Although areas of isodense swelling had higher average CBV values 
than that of normal tissue, it did not differ significantly from it. Hypodensity had 
very low CBV values in comparison with isodense swollen and normal areas with 
statistical significance at p value < 0.05. In Figure 5-7, the bulk of CBV values 
for isodense swelling located above that for normal and hypodense areas. Values 
for normal areas appeared more consistent with close minimum and maximum 
values to median value. However, CBV values for isodense swelling and 
hypodensity had a wide range around the median.  
189 
 
The MTT values for both isodense and hypodense areas prolonged significantly 
compared to those of normal tissue with statistically significant difference which 
is demonstrated in Figure 5-8 as well. However, hypodense areas had the most 
prolonged MTT values among the three categories with no statistically significant 
difference from that of isodense swelling.  
In CBF maps, isodense swelling had a statistically significant low CBF value 
compared to normal tissue and statistically significant high value compared to 
hypodense areas. This difference is also illustrated in Figure 5-9. The 
hypodensity compartment showed very low CBF with most values being less than 
10ml\100g\min and deviated significantly from values of normal tissue. 
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Figure 5. 7: Box and whisker plots of CBV values with minimum and maximum 
values for the three NCCT categories: hypodensity, isodense swelling and normal 
tissue. 
190 
 
MTT
NCCT Appaerances as categoriesd by readers.
M
T
T
 S
ec
o
n
d
Normal Isodense swelling Hypodensity
0
2
4
6
8
10
12
14
16
18
20
 
 
Figure 5. 8: Box and whisker plots of MTT values with minimum and maximum 
values for the three NCCT categories: hypodensity, isodense swelling and normal 
tissue. 
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Figure 5. 9: Box and whisker plots of CBF values with minimum and maximum 
values for the three NCCT categories: hypodensity, isodense swelling and normal 
tissue. 
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Chapter VI: Discussion 
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6.1 Discussion. 
 
Both isodense swelling and hypodensity are prevalent on NCCT within the first 
six hours of stroke onset, representing the distinct changes that occur in the 
acute stage of ischaemia and signify different pathophysiological status of 
ischaemic brain tissue. It was previously described that isodense swelling is more 
likely to represent penumbra, whereas hypodensity is more likely to represent 
the core. The results of this study confirm these observations.  The prevalence 
of EICs depends on the inclusion criteria for the study from which the scans are 
taken, hence their prevalence varied among reports in the literature. I reported 
41% prevalence of isodense swelling in this study, which is higher than that 
reported in the previous studies. However, this percentage includes scans 
reviewed after training, so this might be a consequence of the study rather than 
a difference in either the patient population or the observers’ prior beliefs. 
Hypodensity showed prevalence within the range of the previous reported 
values. Although there were a few studies which reported prevalence of 
isodense swelling as distinct from hypodensity; the figure that appears in this 
study differed from the figures reported in those studies (119;120) of high 
prevalence for hypodensity and low for isodense swelling, in that hypodensity 
had a rather low prevalence and isodense swelling had a high prevalence. This 
might be attributed in part to the increased recognition of isodense swelling at 
the expense of hypodensity which can be noticed when the first and second sets 
of scans are compared (from 29.4% in first set scans to 46.8% in second set 
scans). The trained group were able to recognise more areas with isodense 
swelling than the untrained group without much change in the diagnosis of 
hypodensity. The reduction of sensitivity and improvement of specificity of 
hypodensity in relation to core can also be noted after training, so it may be 
that the introduction of a clearer definition for isodense swelling also caused 
readers to re-classify abnormal areas as swelling rather than hypodensity. 
Hypodensity has been recognised as indicative of tissue infarction since the 
introduction of CT in the 1970s. Less marked radiolucency has been recognised 
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in association with brain CT in more acute stages of stroke within a few hours of 
onset as imaging has been undertaken at earlier time points, and particularly 
because clinical trials followed by clinical practice have focused on thrombolytic 
drug therapy delivery. Recognition of its prognostic relevance – either indicating 
more extensive or more severe ischaemia – has been reflected in exclusion 
criteria for major stroke trials for more than 15 years (43).  
Over time, improved recognition of early ischaemic parenchymal changes can 
be noted in the increase in prevalence on reanalysis of thrombolysis trials; for 
example, from 31% to 52% in the NINDS trial dataset. The focus of the previous 
research and its detection was illustrated in many papers which involved 
reliability studies on EICs in acute ischaemia. However, defining radiolucency 
becomes more complex in very acute stroke and with advances in CT technology. 
Differences between grey scale shades for hypodensity and normal brain tissue 
on NCCT are difficult to perceive, but despite this both experienced and less 
experienced CT readers in this study recognised hypodensity in a similar number 
of scans to what the literature would predict.  
Authors have referred to the favourable fate of isodense swelling compared to 
hypodensity (75;107), but a clear definition of isodense swelling has been 
lacking, and the specific influence of isodense swelling on a patient’s outcome 
has not been evaluated separately from hypodensity. Most systematic 
approaches to EIC recognition, such as ASPECTS and the “rule of thirds”, do not 
distinguish hypodensity from isodense swelling. 
Tissue that is both swollen and hypodense is likely to be due to ischaemic 
oedema and occurs in conjunction with decreased radiolucency and featured by 
effaced sulci and loss of CSF spaces in general, with local mass effects. In 
contrast, isodense swelling is proposed to be a manifestation of congested blood 
vessels due to local hyperaemia without any change in density, or sometimes 
increased density. Mass effects also appear in association with this swelling as 
effacement of sulci. This appearance is usually exclusive for isolated forms of 
isodense swelling; however, mixed isodense swelling with hypodensity occurs as 
islets of bright areas either surrounding boundaries or dispersed within the dark 
patch of hypodensity.   
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In 1997, von Kummer et al (119) mentioned focal swelling without hypodensity 
appeared in 2% of the scans which showed swelling and interpreted this as a 
reflection of the compensatory vasodilatation in ischaemic areas. This sign was 
not subsequently analysed. Additionally, they reported two other types of 
swelling associated with small hypodensity in 35% of scans and with large 
hypodensity in 92% of scans. These two types were included for the 
determination of the extent of hypodensity on acute NCCT by the rule of thirds. 
However, Von Kummer et al. did not illustrate whether these swellings were 
oedema due to ischaemia or a mixture of isodense swollen areas with 
hypodensity. These findings by Von Kummer et al. indicate that the prevalence 
of isodense swelling might be greater than the very low values reported by 
previous studies if the mixture of hypodensity and isodense swelling was further 
assessed and the components treated separately. This type of mixed isodense 
swelling is not uncommon and more likely to be found on NCCT based on the 
theory of ischaemic penumbra which states that penumbra tissue occurs in the 
ischaemic zone surrounding the infarct core. In this study, the high frequency of 
isodense swelling might also be due to reporting of the mixed type of isodense 
swelling.  
The ASPECTS system measures EICs as one change without taking into 
consideration its type in the total score value. Adaptation of ASPECTS to 
hypodensity or isodense swelling can be done as in this study. Separation of EICs 
by ASPECTS can yield different score values and consequently different tissue 
fate predictions. For example, one patient involved in this study had a total 
ASPECTS of two, ASPECTS including hypodensity only was eight, and ASPECTS 
including isodense swelling only was four. The total and isodense swelling 
ASPECTS predicted unfavourable outcomes, whereas hypodensity ASPECTS 
predicted a favourable outcome. This patient had a good clinical outcome on 
day 30, with a Rankin scale of one. However, the exact effect of isodense 
swelling on patient’s outcome has not yet been clarified yet. The three forms of 
ASPECTS were measured separately in this study in regard to assessment of 
agreement among readers. The first form was total ASPECTS, which represented 
the usual way of reading the scans by treating hypodensity and isodense swelling 
as a one ischaemic change, while the second was for hypodensity alone and the 
third was for isodense swelling alone. The way of reading scans by readers 
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showed various patterns of agreement with each form of ASPECTS in response to 
the different variables of this study. In general, the total score and hypodensity 
forms of ASPECTS had similar trends in readers’ agreements across the different 
assessed compartments of the study, which reflects the underestimation of 
isodense swelling and superiority of hypodensity recognition by readers.  
The originally described ASPECTS system has the disadvantage of undefined 
boundaries meaning their determination is therefore subjective. Ischaemic 
changes are not exclusive to a region when they develop, but commonly affect 
adjacent areas and do not necessarily involve changes throughout all of an 
anatomical region. Therefore, abnormal ASPECTS areas, particularly cortical 
ones, may not reflect the exact size of ischaemic change; however, they do 
reflect the presence of an abnormality. Moreover, they might have a mixture of 
findings beside the normal tissue with unclear separation in their proportions. 
Therefore, analysis of findings within areas of ASPECTS might help in the 
estimation of final infarct volume, as has been seen in the mixed fate of some of 
ASPECTS areas in this study. However, there was a discrepancy in the final fate 
of areas diagnosed as having both hypodensity and isodense swelling on NCCT 
and penumbra and core on PCT. Most ROIs of mixed hypodensity and swelling on 
NCCT ended in infarction, whereas ROIs containing mixed penumbra and core on 
PCT had a variable fate that included both infarction and normality. This might 
have arisen from the small number of mixed areas detected on NCCT and the 
definition of tissue category that relied upon the majority view of readers rather 
than on expert or consensus review. Therefore, a larger sample and a consensus 
on final diagnosis of changes on NCCT might result in a different pattern of 
tissue ROI outcomes for ROIs of mixed change.     
Although ASPECTS has the flexibility to read hypodensity and isodense 
swelling in acute ischaemia, it does not include the Hyperdense Vessel Sign, 
which may have prognostic value (161). The Hyperdense Vessel Sign is distinct 
from brain parenchymal changes (isodense swelling and hypodensity). Detection 
of the HMCA sign is improved by using thin slice instead of thick slice CT scans. 
Similar results were found by Kim et al who reported increased sensitivity with 
thin slices scans (163). However, the MCA “dot” sign appeared more often on 
thick slices than on thin slices. The increased depiction of “dot” signs on thick 
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slices could be attributed to the perpendicular courses of MCA branches in 
Sylvian fissure and M3 area to the coronal direction of CT slices, which gives 
more chances for thrombosed segments to be visualised in a number of slices 
beyond the scope of 5mm. This might also be the reason behind the very poor 
recognition of proximal MCA occlusions on thick slices, which has a horizontal 
course in coronal direction making its visualisation in reconstructed thick 
sections very unlikely ( the partial volume effect).     
The ability of readers to recognise isodense swelling on NCCT has been 
studied in only a few instances. Na et al. sought mainly the physiological 
background of isodense swollen areas on NCCT by using diffusion and perfusion-
weighted MRI and they mentioned that the two readers in their study agreed 
moderately on IS with kappa 0.50. A later study by Muir et al. found very poor 
interobserver agreement among 5 readers with kappa 0.08. Other studies were 
not clear on their definition of swelling and might have involved both types of 
swelling at the same time. The patterns of interobserver agreement for isodense 
swelling were not examined by any of the studies found in the literature search. 
Therefore, the results of this study cannot be directly compared to any other.  
In this study, the interobserver agreement on isodense swelling varied greatly 
in relation to the different factors that were assessed. Among all untrained 
readers, agreement was as poor as previously reported with average pairwise 
kappa 0.093 (75), but among the most consistent trained readers, agreement 
was similar to that found by Na et al. (120), with mean pairwise kappa 0.50. The 
level of agreement also differed according to the type of statistical measure 
used to assess agreement. This can be seen when the free marginal kappa and 
Fliess’s kappa in this study were used to assess agreement on isodense swelling. 
By the first measure, agreement was high, and almost perfect on some 
occasions, while, at the same time, Fleiss’s kappa gave very poor levels of 
agreement.  The approach of agreement using pairwise kappa for pairs of 
readers gives full information on the pattern and strength of agreement. This 
was used by Von Kummer et al (94) for assessment of interobserver agreement 
on the EICs along with other statistical measures and it gave detailed 
information on how readers agreed on EICs. The same approach was also taken 
by Grotta et al. to assess variability among and within groups of readers.  
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Studying the factors that were previously mentioned in the literature as 
modifying factors for agreement can help the overall understanding how readers 
are affected in their interpretation of NCCT findings in acute stroke. However, 
we did not include the effect of internsic factors related to brain factors like old 
infarcts and atherosclerotic changes on observers agreement because I were 
conserned mainly with  testing the training of how to read the changes and 
differentiate them from each other on the observer agreement in detecting 
isodense swelling and to less extent how other general controllable factors can 
improve or worsen the agreement.  Although agreement on isodense swelling 
was poor in the set of scans that were used to assess the effect of slice thickness 
and clinical data on interobserver agreement, trends in readers’ agreement can 
be identified.  
Unlike previous results, readers in this study had better interobserver 
agreement when they were unaware of the affected hemisphere. This discrepant 
result could be in part due to the effect of slice thickness where the thin slices 
comprised most of the scans that were presented with clinical data. Other 
factors that might have affected the performance of readers include that 
readers were aware that scans were taken from acute stroke patients and, 
therefore, were more attentive to EICs on NCCT. In addition, because scans 
were repeated within the set with changing variables, the effect of the 
subconscious memory recalling scans cannot be eliminated.  However, when 
scans were provided with clinical information, greater detail of clinical data was 
associated with better agreement compared to limited information restricted to 
identifying the affected side. Despite this, the provision of clinical data had no 
statistically significant effect on observer agreement. This in itself might explain 
why clinical data sometimes increased agreement level but other times had no 
effect on it when assessed in previous studies (94;132;150). In general, knowing 
clinical data might improve reading of scans, but it does not seem to be 
essential for detection of acute ischaemia. however, clinical information is still 
important in routine practise for early diagnoses of acut cerebral ischaemia.  
Lev et al. used fixed slice thickness of scans for evaluation of the effect of 
soft-copy (variable window settings; width and centre level) in their review of 
detection of EICs (149). In this study, I found that with fixed window width, 
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changing the slice thickness from 0.9mm to 5mm increased the interobserver 
agreement on hypodensity and total ASPECTS significantly. This result supports 
the conclusions of Tanaka et al (154). Agreement on the presence of isodense 
swelling was non-significantly better on thin slice scans, but the very low 
prevalence of this finding reported in the first stage of the study means that this 
finding must be considered with caution. Therefore, although the 5 mm slices 
improve interobserver agreement on hypoattenuation and total score, it is not 
clear if this, or the opposite, is true for isodense swelling. Additionally, thick 
slices might reduce recognition of the Hyperdense Sylvian “dot” sign. Overall, 
variation in presentation of scans in regard to slice thickness and window width 
will affect detection of EICs; hence, the recommendations by Dr Francesca Ng et 
al. (155) to routinely use both thin and thick reconstructions is supported by the 
results of this study. 
In previous studies there has always been an emphasis on the importance of 
training on the performance of readers. Von Kummer et al. found a significant 
increase in performance of ECASS II investigators after training in reading acute 
NCCT scans. He suggested that careful CT reading by ECASS II investigators might 
have contributed to a reduction in ICH incidence in patients recruited to that 
trial (152) compared to previous studies. In addition, it was suggested by Muir et 
al (75) that the poor agreement on isodense swelling might have been due to a 
lack of defining criteria that can distinguish between isodense swelling and 
hypodensity. In this study I sought the effect of consensus on definitions for EICs 
among readers on the level of interobserver agreement. As was found in chapter 
4, training had a generally positive effect on the agreement on isodense swelling 
and there was a significant increase in interobserver agreement and a decrease 
in variability of agreements among pairs of observers. Additionally, training was 
associated with increased prevalence of isodense swelling and sensitivity to 
penumbra. The same scenario was observed by Von Kummer when training ECASS 
II investigators on recognition of EICs (152). At the same time, recognition of 
hypodensity showed no significant change between trained and untrained 
readers. Using average pairwise kappa for each reader in both groups helped to 
detect individuals who agreed poorly with all other observers, which will reduce 
the overall agreement level. The presence of inconsistent agreements might 
mask the true level of agreement. Exclusion of observers with consistently weak 
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agreement increased agreement across the three studied categories of ASPECTS 
score, as expected, and allowed better clarification of effect of training. This 
was also done by Von Kummer et al. (94) when assessing the agreement on EICs. 
However, evaluation of the same group of readers before and after training 
revealed a different pattern of results. Those readers showed a drop in 
interobserver agreement on the total ASPECTS and hypodensity after training, 
with performance similar change in isodense swelling. This discrepant result was 
due in part to the inconsistent performance of one reader who was unconvinced 
of the defining criteria developed in the consensus stage. When this reader was 
excluded, there was a general improvement in the level of agreement in both 
stages as well as increased post-training agreement on hypodensity, with 
comparable agreement on isodense swelling before and after training. A 
significant difference in agreement on the total ASPECTS in favour of the pre-
training set of scans persisted; however, the very high levels of agreement that 
were achieved before consensus might reflect familiarity with the established 
use of ASPECTS in defining areas as normal or abnormal, with deterioration in 
performance being a consequence of the introduction of a more detailed 
breakdown of the usual assessment into more categories. Using different sets of 
CT scans in both stages of study might also have caused this result.  In general, 
this outlying performance of same readers compared to the general results of 
the whole group might be attributed to a number of factors, including the 
predominant composition of this group being expert readers who showed more 
conservative responses at the consensus stage, and observer fatigue (this group 
read 72 scans in total). In comparison, other observers were trainees who 
participated only once in the study. In general, although training of the same 
participants had a contradictory effect on the agreement level, training reduced 
the variability in agreement and increased consistency in the performance of 
readers, particularly for isodense swelling.     
The medical speciality of readers had no effect on agreement in this study 
compared to the previous studies by Wardlaw et al which showed that 
neuroradiologists are better than non-neuroradiologists in reading the scan 
(101;121)  Although neuroradiologists showed less interobserver agreement in 
comparison with neurologists, they agreed well on hypodensity. However, 
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neuroradiologists showed very reserved decisions in categorising areas as being 
isodense swollen; therefore, they had very poor agreement on isodense swelling. 
However, fewer neuroradiologists participated in comparison with stroke 
neurologists and so within the group comparisons of agreement were less 
reliable because there were only two neuroradiologists in training. Overall, 
these results are consistent with other studies which found no significant 
difference in performance of different specialities (117;122;150). On the other 
hand, the experience of readers affected their responsiveness to training in this 
study. Trainee readers exhibited poorer interobserver agreement compared to 
experts when there was no training on recognition of EICs and showed significant 
differences to experts regarding total ASPECTS. This result is similar to that 
obtained by Fiebach et al, who showed generally lower agreement among 
novices than experts(151) and differs in that after training, trainees’ general 
level of agreement became higher than that of experts. However, this is not the 
case for isodense swelling, which had very poor agreement before training in 
both groups and improved significantly in both after consensus, although 
trainees achieved higher agreement than experts. In fact, experts appeared 
more conservative in their response to consensus definitions than did trainees. 
This might explain the significant drop in their agreement on total ASPECTS and 
their agreement on hypodensity after consensus.  As was found by ACCESS 
authors, years of experience in reading the scans might not be a determinant of 
agreement by readers, but might influence their response to training.  
As can be seen from the interobserver agreement data on individual ASPECTS 
areas, readers showed very poor agreement on isodense swelling in ganglionic 
areas, including caudate nucleus, lentiform nucleus and internal capsule. The 
final area appeared to be the least recognised area of ASPECTS either before or 
after training, and in general it had, a perfect agreement level by using the free 
marginal kappa which reflects the area being considered to be of normal 
appearance by most readers. In general, subcortical areas appear to be very 
difficult to assess for isodense swelling, therefore, they have the poorest level of 
agreement of the ASPECTS areas. This is due to the anatomical nature of 
subcortical areas of very small areas in a narrow space with overlapping 
boundaries which render their differentiation from each other difficult 
sometimes. Also, subcortical areas may be affected by beam hardening artefact 
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effect and variable skull thickness. Additionally, the definition of isodense 
swelling given in consensus does not involve features that distinguish isodense 
swelling in these areas. However, cortical areas had a higher level of agreement 
on isodense swelling which reflects the fact that it is easier to see it in these 
areas. In reference to training, isodense swelling recognition had the same trend 
pre- and post-training with continuation of restricted recognition of isodense 
swelling on cortical areas. In contrast, hypodensity could be seen in any ASPECTS 
region. 
Readers had almost perfect intraobserver agreement on both isodense 
swelling and hypodensity and were able to reproduce their readings effectively. 
This was also compatible with findings by Muir et al. (75) and Saur et al. (117) 
who both reported high values of intraobserver agreement. However, the effect 
of subconscious memory on repeated scans within the set could not be entirely 
disregarded in the interpretation of the high intraobserver agreement level. 
Nevertheless, the high levels of intrinsic agreement of readers indicate good 
consistency in interpreting EICs by single readers. 
ROIs defined by the majority of readers as exhibiting isodense swelling were 
of normal appearance on follow-up NCCT in 62% of cases: of these, 76% were 
associated with recanalization. In 38% of ROIs with isodense swelling, there was 
tissue infarction at follow-up. In contrast, 90% of areas that were categorised as 
hypodense proceeded to infarction. The data in this study showed that 
categorisation of an ASPECTS area as hypodense rather than as isodense swollen 
was associated with odds of infarction greater than eleven, and in isodense 
swollen ROIs, the absence of recanalization was associated with odds of 
infarction up to four times higher. Consequently, this might mean that a patient 
with an acute stroke with isodense swollen areas on NCCT might benefit from 
thrombolysis more than a patient with hypodense areas. ROIs categorised by 
perfusion characteristics had very similar outcomes to those based on NCCT EIC 
features. Penumbra had a normal fate in 63% of its regions and 76% of them 
gained normality with reperfusion, while core regions all went on to infarction 
irrespective of recanalization. Penumbral ROIs increased odds of infarction up to 
10 times in the absence of recanalization.  
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The perfusion patterns of areas categorised as isodense swollen varied. Only 
59% had penumbra characteristics, while the remainder, had mainly “core” 
perfusion. Recognition of core as isodense swollen areas on NCCT rendered the 
specificity of isodense swelling for abnormal perfusion (either penumbra or core) 
high in this study. The specificity of isodense swelling for core was only 23% 
compared to 74% for penumbra after the exclusion of ROIs categorised as 
normal, which is a situation more relevant to clinical practice. Penumbral tissue 
was predominantly categorised as being of normal appearance by readers, As 
might be expected, therefore, sensitivity of isodense swelling for penumbra is 
low in this study, although it is higher (31.9%) than that reported by Muir et al. 
at (17.4%)(75). This high missing rate of penumbra could be due to two factors; 
first, a lack of consensus on isodense swelling definition among readers which 
appears in the soaring of sensitivity from only 9% before training up to 41% after 
training; secondly, considerations of the maximum number of votes for 
categorisation of areas in this study which appears in an increased sensitivity of 
up to 42% when the maximum vote was adjusted to just four readers. Along the 
same lines, a high portion of core areas are also categorised as normally 
appearing, reflected in low sensitivity of hypodensity for core perfusion in this 
study. However, the likelihood ratios for hypodensity being associated with core 
perfusion and subsequent infarction (13.6 and 19.4, respectively) confirm that 
the recognition of hypodensity on NCCT is strongly associated with core, rather 
than penumbral, perfusion. The sensitivity of hypodensity to core decreased 
after training whereas specificity increased after training. This in part might be 
attributed to increased recognition of mixed areas which had both hypodensity 
and isodense swelling. Additionally, reducing the vote threshold increased the 
sensitivity to 50% and also other predictive statistics to core.  
Perfusion parameters of ASPECTS areas as categorised by readers as isodense 
swollen, hypodense or normally appearing, indicating their different 
pathophysiological states. Areas of isodense swelling had high CBV values, 
reduced CBF and prolonged MTT, whereas hypodense areas corresponded with 
substantially reduced CBV and CBF and prolonged MTT. These enhance the 
correlation of isodense swelling with penumbra and hypodensity with core. 
However, normal-appearing regions generally had normal perfusion parameters. 
The high CBV values found in isodense swollen areas are consistent with the 
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hypothesis that swelling reflects engorged blood vessels due to local 
hyperaemia, with brightness in these areas being due to blood protein content. 
These findings support the findings of previous studies which combined NCCT 
with MRI (107;120) and PCT (75;102). Thus, NCCT gives gross information on the 
changes of perfusion parameters in response to ischaemia while PCT provides a 
more sophisticated assessment of acute ischaemic regions, allowing a further 
classification of hypoperfused tissue on the basis of outcome prediction. Some 
isodense swollen areas had non-penumbra perfusion characteristics on PCT, 
although it showed prolonged MTT but normal CBV and CBF. These areas could 
represent benign oligaemic areas, although this is not defined by perfusion 
thresholds for PCT. This reflects the general criticism that the thresholds that 
are defining penumbra on PCT might not be robust and valid because they do not 
distinguish it from oligaemic tissue.  However, benign oligaemia might appear on 
NCCT as isodense swollen areas and can be mistaken for penumbra.  In this 
study, areas which had prolonged MTT but normal CBV and CBF were categorised 
as normal tissues on PCT. However, they might be blamed for the small 
proportion of normal tissue which progressed into infarctions, as shown 
previously.  
This study confirms the feasibility of using web technology as a tool for 
clinical research in imaging. This enhances recommendations stated by ACCESS 
group on benefits of web technology in reading the scans (101).    
 
6.2 Limitations of the study 
 
Because of the study design, fatigue and subconscious memory effects cannot 
be excluded from affecting the performance of readers and they may have 
affected the results to some extent. 
On a 4cm detector-width CT scanner, as used here, perfusion CT covers a 
limited volume of brain tissue; therefore, some scans had very low slices for the 
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upper cortical regions of ASPECTS with loss of complete coverage of perfusion of 
vertex areas which limited the complete evaluation of areas.   
Presentation through a web-based interface meant that readers were not able 
to change window settings to adjust the scan contrast. 
The consensus stage assembled individual reader comments and feedback but 
did not include a meeting of all readers. This could be less strong than face-to-
face group presentations for convincing readers about the definitions adopted. 
ASPECTS areas have no clear boundaries and ischaemic change might happen 
in-between areas which could be considered by some readers to happen in two 
areas and by others to be involved in one area. Subjectivity in reading areas’ 
boundaries cannot be eliminated from affecting the agreement levels in this 
study. 
6.3 Conclusions 
 Penumbral tissue can be seen on acute NCCT scans as isodense 
swollen areas. 
 Isodense swelling is a distinctive feature of acute ischaemia and is 
different from hypodensity, and it is prevalent on acute NCCT scans within 
the first few hours post stroke onset; it represents ischaemic tissue at risk of 
infarction but whose fate is variable, predominantly determined by 
recanalisation status. 
 Isodense swelling can be defined in NCCT scans as areas without 
changed density or with a slight increase in density with evidence of local 
swelling. It might appear isolated or mixed with hypodensity as bright areas 
either surrounding or dispersed through the dark patch of hypodensity. 
 Isodense swelling should not be mixed with hypodensity in 
estimating the extent of EIC on NCCT and should be withdrawn from ASPECTS 
when reading hypodensity. 
 More than half of isodense areas recover, particularly with 
restoration of reperfusion. 
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 Absence of recanalization increases the risk of infarction of 
isodense areas fourfold.  
 Reliability in detection of isodense swelling is good with perfect 
intraobserver agreement, moderate interobserver agreement and high 
specificity for penumbra. 
 Interobserver agreement on EICs is affected by CT technology 
where thick slices scans appears to improve agreement on hypodensity and 
detection of hyperdense “dot” sign, and  worse detection of HMCA sign. 
 Different statistical measures of agreement result in different 
levels of agreement and the analysis of paired agreements between 
individual readers is the most reliable way in concluding the accurate level of 
agreement, determination of inconsistent observers and performing the 
statistical significance testing. 
 Experience of readers in reading the scans does not affect 
agreement but it affects the response of readers to training. 
 The area of brain tissue involved with EICs affects the level of 
agreement and should be considered when measuring EICs by using the 
ASPECTS template.     
 The sensitivity of isodense swelling to penumbra is still low 
together with sensitivity of hypodensity to core, which indicates a high 
missing rate and the need for further improvements in approaching them on 
NCCT. 
 Training is effective in improving the overall performance of 
reading acute NCCT and reducing the missing rate of EICs. 
  
 Isodense swelling has perfusion characteristics of penumbra when 
its regions on NCCT were matched with their correspondents on perfusion 
maps, and this study confirms results published previously on the different 
pathophysiology of isodense swelling and hypodensity. 
 This study adds confirmation to the validity of the ASPECTS system 
as a robust searching tool of EICs in acute stroke. It is flexible and can be 
adapted to measure each ischaemic change separately with good reliability. 
However, it does not measure the hyperdense vessel sign.   
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Dear (reader)  
I am a Libyan doctor doing an MSc and I am looking at the interpretation of acute CTs, specifically the 
swelling versus hypodensity issue. I am just e-mailing you to know if you would be willing to participate in 
the study to send you the first set of the scans? . They come as links in email that take you to a short online 
questionnaire about each scan, and there are about 40 in all at this stage. Once we complete this set, 
which supposed to finish on December 15, the plan is to identify what is generally agreed to represent 
swelling and do some "training" for consistency, then have a second look at agreement. Your participation 
will be very important to me and your opinion on scans of great value. 
Kind Regards 
Dear participant 
Thank you for participating in the CT reading study seeking to determine agreement on isodense swelling 
and hypodensity in acute stroke. Links to the [first] set of scans and score sheets are listed below: 
1. http://www.surveymonkey.com/s/9H9QLMT 
2. http://www.surveymonkey.com/s/VH78JJ3 
3. http://www.surveymonkey.com/s/V6WQGQ8 
4. http://www.surveymonkey.com/s/VHB3NLF 
5. http://www.surveymonkey.com/s/VB5QNGC 
6. http://www.surveymonkey.com/s/8BK5GFH 
7. http://www.surveymonkey.com/s/SW2VLCG 
8. http://www.surveymonkey.com/s/SWJ5MWH 
9. http://www.surveymonkey.com/s/SWR5Q7N 
10. http://www.surveymonkey.com/s/SWTGG2X 
11. http://www.surveymonkey.com/s/SW3D5FX 
12. http://www.surveymonkey.com/s/SWHY58L 
13. http://www.surveymonkey.com/s/SWZXPHC 
14. http://www.surveymonkey.com/s/RNQZ7MX 
15. http://www.surveymonkey.com/s/SSVMR6R 
16. http://www.surveymonkey.com/s/SSDG5SJ 
17. http://www.surveymonkey.com/s/SSQL3X5 
18. http://www.surveymonkey.com/s/SSRWNWD 
19. http://www.surveymonkey.com/s/SST3WYJ 
20. http://www.surveymonkey.com/s/SSFDH2K 
21. http://www.surveymonkey.com/s/VH5F27P 
22. http://www.surveymonkey.com/s/SRJPZJC 
23. http://www.surveymonkey.com/s/SRFC5S7 
24. http://www.surveymonkey.com/s/V62367K 
25. http://www.surveymonkey.com/s/VP5CKNH 
26. http://www.surveymonkey.com/s/STD96FF 
27. http://www.surveymonkey.com/s/STCPGZ3 
28. http://www.surveymonkey.com/s/STQBWFW 
29. http://www.surveymonkey.com/s/STTS2ZS 
30. http://www.surveymonkey.com/s/STXTW6M 
31. http://www.surveymonkey.com/s/STBKF2M 
32. http://www.surveymonkey.com/s/VBFW8CF 
33. http://www.surveymonkey.com/s/SML57LM 
34. http://www.surveymonkey.com/s/VHXXRBV 
35. http://www.surveymonkey.com/s/SMDZZBQ 
36. http://www.surveymonkey.com/s/SMSK6SC 
37. http://www.surveymonkey.com/s/SMTV8WW 
38. http://www.surveymonkey.com/s/RSKNGJM 
39. http://www.surveymonkey.com/s/RS75RT9 
40. http://www.surveymonkey.com/s/RS2BPKX 
These links are uniquely tied to this survey and your email address. Please do not forward this message. 
Note; if the scans are not clear, you can change the zoom level of the scans by a click on the zoom zone at 
the right corner of your computer. 
Thanks for your participation! 
 
Table 1:  First set invitation e-mails. 
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Dear Participant 
 Thank you for participating in the CT reading study for the second time. It was most generous of you to put aside some 
of your time to finish the first set of scans. I do really appreciate your assistance and look forward to receiving your 
response on the second set of CT scans. 
As with the first set of scans, I am seeking to determine agreement on isodense swelling and hypodensity in acute stroke. 
However, this time I am first circulating a short power point presentation [ attached] that is intended to establish a 
common definition for these CT appearances based on the responses to the first set of scans. I would be grateful if you 
could read through this presentation, in particular the distinction between partial and complete loss of grey-white 
matter differentiation, before confirming that you are ready to review the second set of scans. Please send an email to 
confirm that you have read through the presentation: after this is received, links to the second set of scans will be sent, 
with an ASPECTS template also included with clarification of its regions.Note; There is the incentive of a £10 amazon 
gift voucher for each set of scan reads that is completed within 15 days!.                                                                                                                                        
I am looking forward to hear from you. 
Kind Regards 
 
Table 2:Consensus invitation e-mail. 
 
Dear participant 
Thanks for your participation. 
Your reader code is [   ] please sign it at the end of each score sheet. 
Please read the clinical information before reading the scan. We hinted the affected hemisphere by body 
side.  Right side symptoms = Left hemisphere stroke. 
The deadline for completing the survey is;  dd/mm/yy. 
There is the incentive of a £10 amazon gift voucher for each set of scan reads that is 
completed within this time limit!. 
Aspects score sheet is attached. 
Here are the links to the [second] set of scans and score sheets are listed below; 
1- http://www.surveymonkey.com/s/H93GS3S 
2- http://www.surveymonkey.com/s/H9PG2W2 
3- http://www.surveymonkey.com/s/HDV79MK 
4- http://www.surveymonkey.com/s/HD98P23 
5- http://www.surveymonkey.com/s/HDYZJQB 
6- http://www.surveymonkey.com/s/HDJ75X2 
7- http://www.surveymonkey.com/s/HDWML89 
8- http://www.surveymonkey.com/s/HDR7BCV 
9- http://www.surveymonkey.com/s/HDX9GNM 
10- http://www.surveymonkey.com/s/HDF6BTY 
11- http://www.surveymonkey.com/s/HDHG7KF 
12- http://www.surveymonkey.com/s/HDPF5Q8 
13- http://www.surveymonkey.com/s/HY899B8 
14- http://www.surveymonkey.com/s/HYV6DN3 
15- http://www.surveymonkey.com/s/HY9SZZN 
16- http://www.surveymonkey.com/s/HYCNDPP 
17- http://www.surveymonkey.com/s/HYW8C2G 
18- http://www.surveymonkey.com/s/HYTL2ND 
19- http://www.surveymonkey.com/s/HYXXP2R 
20- http://www.surveymonkey.com/s/HY3H2PJ 
21- http://www.surveymonkey.com/s/HYH8Z8P 
22- http://www.surveymonkey.com/s/HYP5MBM 
23- http://www.surveymonkey.com/s/HYZYJX3 
24- http://www.surveymonkey.com/s/H2K98JW 
25- http://www.surveymonkey.com/s/H28X2Q5 
26- http://www.surveymonkey.com/s/H2VR57F 
27- http://www.surveymonkey.com/s/H2DQSYG 
28- http://www.surveymonkey.com/s/H227NBL 
29- http://www.surveymonkey.com/s/H2C6P2Q 
30- http://www.surveymonkey.com/s/H2WSQZF 
31- http://www.surveymonkey.com/s/H2SG9GH 
32- http://www.surveymonkey.com/s/H2XVVML 
These links are uniquely tied to this survey and your email address. Please do not forward this message. 
Thanks for your participation! 
 
 
 
 
Table 3: Second set invitation 
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Figure 1; ASPECTS template [ Supraganglionic level image is loaded from the 
official web site for description of ASPECTS(227)] 
210 
 
 
Figure 2: Example of a scan from first set loaded to Survey Monkey. 
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Figure 3: Example of a scan from second set loaded to Survey Monkey. 
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Figure 4: a to e, are the slides of consensus power point sheet presented to 
readers. 
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Figure(s) 5: First set scans. 
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Figure (s) 6; Second Set Scans. 
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HYPODENSITY CAUDATE LENTIFORM I.CAPSULE INSULA M1 M2 M3 M4 M5 M6 
SCAN-1 0 0 0 1 0 0 0 0 2 0 
SCAN-2 0 4 0 4 0 0 0 0 0 0 
SCAN-3 0 1 1 3 0 2 0 1 2 0 
SCAN-4 1 1 1 5 0 2 1 1 2 0 
SCAN-5 1 4 1 2 1 2 1 0 0 0 
SCAN-6 1 2 0 9 7 5 0 3 1 0 
SCAN-7 2 2 1 2 1 5 7 3 1 5 
SCAN-8 0 7 3 6 1 5 3 3 5 5 
SCAN-9 4 7 3 6 5 6 6 6 6 6 
SCAN-10 1 4 0 1 0 1 0 0 0 1 
SCAN-11 0 0 0 0 1 1 4 3 0 0 
SCAN-12 2 4 2 3 0 1 0 1 1 0 
SCAN-13 0 0 0 1 0 7 6 0 1 1 
SCAN-14 1 4 0 4 0 0 0 0 0 0 
SCAN-15 0 1 0 1 0 0 0 1 2 2 
SCAN-16 1 1 2 2 1 0 3 4 6 2 
SCAN-17 2 2 2 5 1 2 3 1 3 2 
SCAN-18 0 1 2 2 1 1 1 0 1 0 
SCAN-19 7 9 5 6 4 4 1 0 2 0 
SCAN-20 1 1 1 1 0 0 0 0 0 0 
SCAN-21 0 0 0 0 0 1 0 2 6 0 
SCAN-22 4 8 2 9 8 9 5 0 1 0 
SCAN-23 0 7 1 9 4 5 0 5 5 1 
SCAN-24 0 1 1 0 0 0 1 0 0 0 
SCAN-25 7 6 1 3 0 1 0 0 0 0 
SCAN-26 2 2 1 1 0 0 0 0 0 0 
SCAN-27 0 4 3 7 7 8 4 2 4 0 
SCAN-28 0 1 0 3 2 1 1 1 2 1 
SCAN-29 0 0 1 0 0 0 1 0 2 2 
SCAN-30 0 0 0 0 0 1 3 0 0 2 
SCAN-31 1 7 3 3 2 0 0 1 0 0 
SCAN-32 1 4 1 8 2 6 3 3 4 3 
Table 4: Table of readers’ responses to hypodensity in scans of second set. 
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FOCAL 
SWELLING 
CAUDATE LENTIFORM I.CAPSULE INSULA M1 M2 M3 M4 M5 M6 
SCAN-1 0 1 0 1 0 1 1 0 2 0 
SCAN-2 0 0 0 6 2 4 3 0 2 1 
SCAN-3 0 1 0 4 2 7 2 4 6 3 
SCAN-4 0 0 0 3 0 1 0 1 4 2 
SCAN-5 0 0 0 2 1 6 1 0 1 0 
SCAN-6 1 1 0 4 6 6 0 1 2 0 
SCAN-7 0 1 0 2 1 7 8 3 3 7 
SCAN-8 0 1 0 3 4 5 6 7 8 8 
SCAN-9 0 2 2 4 3 7 7 5 7 7 
SCAN-10 0 0 0 0 0 1 1 0 0 0 
SCAN-11 0 0 0 0 1 3 2 5 9 8 
SCAN-12 0 2 0 1 0 1 0 1 2 1 
SCAN-13 1 0 0 0 1 4 6 0 6 8 
SCAN-14 0 1 0 1 2 1 1 0 1 0 
SCAN-15 0 0 0 2 1 2 0 3 4 4 
SCAN-16 0 0 0 0 2 2 5 3 6 6 
SCAN-17 0 0 0 0 0 2 3 0 0 1 
SCAN-18 1 0 0 3 3 4 2 2 4 2 
SCAN-19 2 2 2 1 1 4 0 1 2 2 
SCAN-20 0 0 0 1 1 2 2 2 3 3 
SCAN-21 0 0 0 1 1 1 0 2 4 2 
SCAN-22 1 3 0 6 5 4 5 1 3 3 
SCAN-23 0 0 0 1 3 4 2 2 2 4 
SCAN-24 0 0 0 1 0 2 5 0 1 0 
SCAN-25 0 0 0 1 0 1 1 0 1 0 
SCAN-26 1 0 0 0 0 0 0 1 0 1 
SCAN-27 0 1 0 5 5 6 4 7 9 5 
SCAN-28 0 0 0 2 3 3 2 2 3 1 
SCAN-29 0 0 0 0 0 0 1 1 0 0 
SCAN-30 0 0 0 1 0 1 3 0 0 5 
SCAN-31 0 0 0 6 6 9 8 7 7 6 
SCAN-32 0 2 1 3 6 6 3 4 5 4 
Table 5: Table of responses to isodense swelling in scans of second set 
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TOTAL R-1 R-2 R-3 R-4 R-5 R-6 R-7 R-8 R-9 R-10 R-11 
SCAN-1 9 9 9 10 10 7 9 10 9 10 10 
SCAN-2 8 8 6 10 9 7 6 10 7 7 8 
SCAN-3 5 10 10 5 8 3 6 8 8 9 5 
SCAN-4 9 9 9 7 6 7 8 10 7 6 9 
SCAN-5 6 10 10 7 8 8 10 9 6 5 9 
SCAN-6 5 8 7 7 9 5 6 5 6 7 7 
SCAN-7 5 9 6 7 4 5 8 5 8 2 6 
SCAN-8 2 5 1 5 4 3 1 8 7 6 5 
SCAN-9 3 7 1 0 4 1 2 6 1 2 8 
SCAN-10 9 10 8 8 10 9 10 8 10 8 10 
SCAN-11 5 8 7 9 7 6 7 7 6 8 7 
SCAN-12 6 10 5 5 10 8 7 8 10 10 10 
SCAN-13 7 8 6 6 6 7 6 8 6 8 8 
SCAN-14 8 10 8 10 9 4 10 8 9 10 8 
SCAN-15 7 10 5 7 9 5 10 10 9 7 10 
SCAN-16 6 10 6 6 8 6 7 7 8 0 9 
SCAN-17 5 9 8 1 8 8 8 9 8 8 9 
SCAN-18 3 10 8 8 4 6 10 9 5 9 9 
SCAN-19 6 8 2 3 8 4 7 7 6 3 8 
SCAN-20 8 10 7 4 10 10 10 10 10 2 10 
SCAN-21 10 8 5 8 9 6 10 9 9 9 10 
SCAN-22 3 7 3 2 5 4 6 5 4 6 5 
SCAN-23 5 10 4 5 8 3 3 7 6 3 7 
SCAN-24 8 9 10 10 9 6 10 8 8 10 10 
SCAN-25 7 9 6 7 9 7 10 8 6 8 9 
SCAN-26 8 9 10 10 10 9 10 10 10 5 10 
SCAN-27 3 7 3 5 6 4 4 6 3 4 2 
SCAN-28 10 9 2 7 9 7 7 10 10 9 8 
SCAN-29 10 9 9 7 10 9 10 9 10 10 9 
SCAN-30 8 8 7 10 9 9 10 8 8 10 10 
SCAN-31 4 7 2 10 2 3 3 6 2 0 8 
SCAN-32 4 7 7 3 3 3 6 5 7 0 10 
 
Table 6:Total ASPECTS scores for Second set’ scans. 
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HYPODENSITY R-1 R-2 R-3 R-4 R-5 R-6 R-7 R-8 R-9 R-10 R-11 
SCAN-1 10 9 9 10 10 10 9 10 10 10 10 
SCAN-2 9 10 8 10 10 10 10 10 8 9 9 
SCAN-3 8 10 10 9 8 10 8 8 10 9 10 
SCAN-4 10 9 9 7 10 9 10 7 7 7 9 
SCAN-5 9 10 10 7 10 10 10 10 7 6 9 
SCAN-6 7 10 7 7 9 5 8 5 6 9 9 
SCAN-7 5 9 8 7 8 6 8 5 8 7 9 
SCAN-8 8 6 3 5 9 7 1 8 7 10 8 
SCAN-9 3 9 1 0 7 7 6 6 1 7 8 
SCAN-10 9 10 8 8 10 9 10 8 10 10 10 
SCAN-11 9 8 9 9 9 9 10 8 8 10 10 
SCAN-12 8 10 6 5 10 9 9 8 10 10 10 
SCAN-13 8 10 8 6 8 10 8 8 7 10 10 
SCAN-14 8 10 8 10 9 10 10 8 9 10 8 
SCAN-15 10 10 8 7 10 10 10 10 9 9 10 
SCAN-16 6 10 6 6 9 7 10 10 9 6 9 
SCAN-17 6 9 9 1 10 8 8 9 8 10 9 
SCAN-18 7 10 8 8 10 10 10 10 9 10 10 
SCAN-19 8 9 5 3 9 4 7 7 6 6 8 
SCAN-20 10 10 10 10 10 10 10 10 10 6 10 
SCAN-21 10 8 9 8 9 9 10 9 9 10 10 
SCAN-22 5 9 6 2 5 7 7 5 4 7 7 
SCAN-23 5 10 4 5 8 4 6 8 7 9 7 
SCAN-24 10 9 10 10 10 10 10 9 8 10 10 
SCAN-25 8 9 6 7 9 8 10 8 6 9 9 
SCAN-26 8 10 10 10 10 10 10 10 10 6 10 
SCAN-27 5 10 7 5 6 6 7 6 6 8 5 
SCAN-28 10 9 4 7 9 10 9 10 10 10 10 
SCAN-29 10 9 9 7 10 10 10 9 10 10 10 
SCAN-30 10 10 7 10 10 10 10 9 8 10 10 
SCAN-31 9 9 9 10 8 8 10 8 7 6 9 
SCAN-32 7 10 7 3 4 9 9 6 7 6 8 
 
Table 7; ASPECTS scores for hypodensity. Second set 
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I.SWELLING R-1 R-2 R-3 R-4 R-5 R-6 R-7 R-8 R-9 R-10 R-11 
SCAN-1 9 10 10 10 10 7 9 10 9 10 10 
SCAN-2 9 8 7 10 9 7 6 10 9 8 9 
SCAN-3 7 10 10 5 8 3 6 9 8 10 5 
SCAN-4 9 10 10 10 6 8 9 10 9 10 10 
SCAN-5 7 10 10 10 8 8 10 9 8 9 10 
SCAN-6 7 8 10 10 9 9 10 6 8 8 8 
SCAN-7 8 9 6 10 4 8 8 5 8 5 7 
SCAN-8 4 9 4 7 4 6 3 9 9 4 7 
SCAN-9 5 8 3 10 4 4 2 10 5 5 10 
SCAN-10 10 10 10 10 10 10 10 10 10 8 10 
SCAN-11 6 8 8 10 7 7 7 7 7 8 7 
SCAN-12 8 10 9 10 8 8 7 10 10 10 10 
SCAN-13 8 8 8 6 6 7 6 8 7 8 8 
SCAN-14 10 10 10 10 9 5 10 10 10 10 10 
SCAN-15 7 10 5 10 9 5 10 10 10 8 10 
SCAN-16 7 10 6 10 8 9 7 7 8 4 10 
SCAN-17 9 10 9 10 8 10 10 10 10 8 10 
SCAN-18 6 10 10 10 4 6 10 9 6 9 9 
SCAN-19 8 9 7 10 9 10 7 7 9 7 10 
SCAN-20 8 10 10 7 4 10 10 10 10 6 10 
SCAN-21 10 10 5 10 9 7 10 9 10 9 10 
SCAN-22 8 8 4 10 6 6 8 5 7 9 8 
SCAN-23 10 10 10 10 9 9 3 9 8 4 10 
SCAN-24 8 10 10 10 9 6 10 9 9 10 10 
SCAN-25 9 10 10 10 10 9 10 10 9 9 10 
SCAN-26 10 9 10 10 10 9 10 10 10 9 10 
SCAN-27 6 7 3 10 6 8 4 7 5 6 6 
SCAN-28 10 10 4 10 9 7 7 10 10 9 8 
SCAN-29 10 10 10 10 10 9 10 10 10 10 9 
SCAN-30 8 8 10 10 9 9 10 8 8 10 10 
SCAN-31 5 8 3 10 3 5 3 8 3 4 9 
SCAN-32 7 7 10 10 3 4 7 5 9 4 10 
 
Table 8; ASPECTS scores for isodense swelling. Second set 
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CAU 
HYPO 
LEN 
HYPO 
ICAPP 
HYPO 
INS 
HYPO 
M1 
HYPO 
M2 
HYPO 
M3 
HYPO 
M4 
HYPO 
M5 
HYPO 
M6 
HYPO 
SCAN-1 1 0 0 0 1 0 1 2 2 2 
SCAN-2 1 1 0 1 0 0 0 0 0 0 
SCAN-3 0 0 0 0 0 0 0 0 0 0 
SCAN-5 0 1 0 2 0 0 0 1 0 0 
SCAN-6 2 2 0 2 2 1 0 2 2 0 
SCAN-7 0 1 0 1 0 0 1 0 1 0 
SCAN-8 0 0 0 1 0 0 0 0 0 0 
SCAN-9 0 0 0 0 0 0 0 0 0 0 
SCAN-10 0 1 0 1 0 1 0 0 0 0 
SCAN-11 0 0 0 0 1 0 0 2 1 0 
SCAN-12 0 0 0 0 0 0 0 0 1 0 
SCAN-13 1 2 0 3 3 2 1 2 2 1 
SCAN-14 0 2 0 2 1 1 0 0 0 0 
SCAN-15 0 0 0 0 1 0 1 2 2 2 
SCAN-17 1 3 1 3 2 1 1 2 1 0 
SCAN-18 0 1 0 0 0 0 0 0 1 0 
SCAN-19 0 1 0 0 0 0 0 0 0 0 
SCAN-20 1 3 0 2 1 0 0 1 0 1 
SCAN-21 1 2 1 3 2 1 2 1 1 1 
SCAN-22 0 0 0 0 0 0 0 0 0 0 
SCAN-23 2 2 1 2 0 1 1 0 2 1 
SCAN-24 0 1 1 0 0 0 0 0 0 0 
SCAN-25 0 2 0 0 0 0 0 0 0 0 
SCAN-26 0 0 0 0 0 0 0 0 0 0 
SCAN-28 0 3 1 0 0 0 0 0 0 0 
SCAN-29 0 0 0 0 0 0 1 0 2 0 
SCAN-30 0 0 0 0 0 0 0 0 0 0 
SCAN-31 1 2 0 1 0 0 0 0 1 0 
SCAN-32 1 2 0 1 0 1 0 1 2 1 
SCAN-33 0 0 0 0 0 0 0 0 0 0 
SCAN-34 3 3 0 2 1 0 0 0 1 1 
SCAN-35 0 0 0 0 0 0 0 0 0 0 
SCAN-36 0 1 0 0 0 0 0 0 0 0 
SCAN-37 0 0 0 0 0 0 0 0 0 0 
SCAN-39 0 1 1 1 1 0 0 1 0 0 
SCAN-40 1 2 1 2 2 2 2 2 1 0 
 
Table 9; table of readers’ responses to hypodensity of scans of first set 
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SCAN 
NUMBER 
CAU 
SW 
LEN 
SW 
ICAP 
SW 
INS 
SW 
M1 
SW 
M2 
SW 
M3 
SW 
M4 
SW 
M5 
SW 
M6 
SW 
SCAN-1 0 0 0 0 0 0 0 2 2 2 
SCAN-2 0 2 0 0 0 0 1 0 0 0 
SCAN-3 0 0 0 0 0 0 0 0 0 0 
SCAN-5 0 2 0 1 2 2 2 0 0 0 
SCAN-6 0 0 0 0 0 0 0 2 2 1 
SCAN-7 0 0 0 1 1 1 0 0 1 0 
SCAN-8 0 0 0 0 0 0 0 0 0 0 
SCAN-9 0 0 0 0 0 0 0 0 0 0 
SCAN-10 0 0 0 0 1 0 0 0 0 0 
SCAN-11 0 1 1 0 0 0 0 0 0 0 
SCAN-12 0 0 0 0 0 0 0 0 0 0 
SCAN-13 0 0 0 0 1 1 0 2 2 2 
SCAN-14 1 0 0 0 2 2 1 1 0 1 
SCAN-15 0 0 0 0 0 0 0 1 2 2 
SCAN-17 1 1 1 1 1 1 1 3 3 2 
SCAN-18 0 0 0 0 0 0 0 0 0 0 
SCAN-19 0 0 0 0 0 0 0 0 2 1 
SCAN-20 1 0 0 1 1 2 3 2 2 1 
SCAN-21 0 0 0 0 2 2 1 1 2 2 
SCAN-22 0 1 1 0 0 0 0 0 0 0 
SCAN-23 1 1 1 1 0 1 1 0 0 0 
SCAN-24 0 0 0 0 0 0 0 0 0 0 
SCAN-25 0 0 0 1 0 1 1 0 1 1 
SCAN-26 0 0 0 0 0 0 0 0 0 0 
SCAN-28 1 0 0 0 1 1 0 0 0 0 
SCAN-29 0 0 0 0 0 0 0 0 0 0 
SCAN-30 0 0 0 0 0 0 1 0 0 0 
SCAN-31 1 0 0 2 2 3 2 1 2 2 
SCAN-32 0 0 1 2 2 2 0 2 2 2 
SCAN-33 0 1 1 1 0 0 0 0 0 0 
SCAN-34 0 0 0 0 0 0 0 0 0 0 
SCAN-35 0 0 0 0 2 1 0 1 0 0 
SCAN-36 0 1 0 1 1 1 1 2 2 0 
SCAN-37 0 0 0 0 0 0 0 0 1 0 
SCAN-39 1 1 0 1 2 1 0 0 1 1 
SCAN-40 0 0 0 3 2 2 0 0 1 1 
 
Table 10; table of readers’ responses to isodense swelling of scans of first set 
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BOTH 
CHANGES 
R-1 R-2 R-3 R-4 R-5 R-6 R-7 R-8 R-9 
SCAN-1 8 7 5 6 10 6 6 7 10 
SCAN-2 8 10 9 7 8 6 10 9 10 
SCAN-3 10 10 10 10 10 10 10 10 10 
SCAN-5 8 7 5 6 10 4 9 10 10 
SCAN-6 3 8 2 0 6 4 2 2 9 
SCAN-7 8 10 6 9 10 7 9 10 10 
SCAN-8 8 9 10 7 10 10 10 10 10 
SCAN-9 10 10 10 7 9 10 10 9 10 
SCAN-10 7 10 8 9 10 8 10 9 10 
SCAN-11 10 6 8 10 9 10 9 9 10 
SCAN-12 9 10 9 10 8 10 10 10 10 
SCAN-13 0 6 1 0 5 3 1 3 9 
SCAN-14 2 7 3 7 7 5 9 6 10 
SCAN-15 8 8 5 6 5 7 6 7 10 
SCAN-17 0 3 0 9 10 5 10 6 10 
SCAN-18 10 10 9 7 10 9 10 10 10 
SCAN-19 9 10 8 10 5 8 10 10 8 
SCAN-20 5 4 2 3 4 3 8 4 10 
SCAN-21 7 7 2 3 10 1 2 8 10 
SCAN-22 10 10 8 8 10 10 10 9 10 
SCAN-23 6 5 2 8 7 7 6 4 10 
SCAN-24 10 9 10 10 10 10 9 10 10 
SCAN-25 8 10 4 9 8 9 10 8 10 
SCAN-26 8 10 10 10 10 10 10 10 10 
SCAN-28 7 8 8 5 8 7 9 10 10 
SCAN-29 9 8 9 7 10 10 10 10 10 
SCAN-30 9 10 9 10 10 10 10 10 10 
SCAN-31 3 4 2 6 8 5 7 3 10 
SCAN-32 4 6 2 2 10 3 2 8 10 
SCAN-33 10 7 10 8 7 10 10 10 10 
SCAN-34 5 5 7 8 2 7 7 7 10 
SCAN-35 10 10 8 10 10 9 10 10 10 
SCAN-36 9 10 4 8 7 7 10 5 9 
SCAN-37 8 9 10 9 10 10 10 10 10 
SCAN-39 0 8 6 8 9 5 9 8 7 
SCAN-40 2 7 2 2 10 1 2 9 10 
 
Table 11; ASPECTS scores for both changes. first set 
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ISODENSE 
SWELLING 
R-1 R-2 R-3 R-4 R-5 R-6 R-7 R-8 R-9 
SCAN-1 8 7 10 10 10 7 10 7 10 
SCAN-2 8 9 9 10 10 9 10 10 10 
SCAN-3 10 10 10 10 10 10 10 10 10 
SCAN-5 8 8 5 10 10 7 10 10 10 
SCAN-6 4 10 7 10 10 7 10 4 10 
SCAN-7 8 10 7 10 10 9 10 10 10 
SCAN-8 8 10 10 7 10 10 10 10 10 
SCAN-9 10 10 10 8 10 10 10 10 10 
SCAN-10 7 10 9 10 10 10 10 10 10 
SCAN-11 10 8 10 10 10 10 9 10 10 
SCAN-12 10 10 10 10 8 10 10 10 10 
SCAN-13 0 10 7 10 10 5 10 5 10 
SCAN-14 8 10 5 8 9 7 10 8 10 
SCAN-15 8 8 10 10 6 7 10 7 10 
SCAN-17 0 7 0 10 10 8 10 8 10 
SCAN-18 10 10 10 8 10 10 10 10 10 
SCAN-19 9 10 8 10 7 9 10 8 10 
SCAN-20 5 8 3 10 9 6 10 4 10 
SCAN-21 7 8 8 10 10 4 10 10 10 
SCAN-22 10 10 8 10 10 10 10 10 10 
SCAN-23 10 10 5 10 10 10 7 7 10 
SCAN-24 10 10 10 10 10 10 9 10 10 
SCAN-25 8 10 6 10 10 10 10 8 10 
SCAN-26 8 10 10 10 10 10 10 10 10 
SCAN-28 8 10 9 10 9 8 10 10 10 
SCAN-29 9 10 10 10 10 10 10 10 10 
SCAN-30 9 10 9 10 10 10 10 10 10 
SCAN-31 7 4 3 10 8 8 10 5 10 
SCAN-32 4 7 3 10 10 6 10 10 10 
SCAN-33 10 7 10 10 10 10 10 10 10 
SCAN-34 10 10 10 10 10 10 7 10 10 
SCAN-35 10 10 8 10 10 8 10 10 10 
SCAN-36 9 9 4 10 8 8 10 7 10 
SCAN-37 8 9 10 10 10 10 10 10 10 
SCAN-39 4 9 6 10 10 7 10 9 7 
SCAN-40 2 8 8 10 10 8 10 10 10 
Table 12; ASPECTS scores for isodense swelling. First set 
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HYPODENSITY R-1 R-2 R-3 R-4 R-5 R-6 R-7 R-8 R-9 
SCAN-1 9 10 6 6 10 6 6 9 10 
SCAN-2 10 10 10 7 8 7 7 9 10 
SCAN-3 10 10 10 10 10 10 10 10 10 
SCAN-5 10 9 10 6 10 7 9 10 10 
SCAN-6 6 8 5 0 7 4 2 2 9 
SCAN-7 8 10 9 9 10 7 9 9 10 
SCAN-8 10 9 10 7 10 10 10 10 10 
SCAN-9 10 10 10 8 8 10 10 9 10 
SCAN-10 9 10 9 9 10 8 10 9 10 
SCAN-11 10 8 8 10 9 10 9 9 10 
SCAN-12 10 10 9 10 8 10 10 10 10 
SCAN-13 9 6 4 0 5 3 1 3 9 
SCAN-14 8 7 9 7 7 8 9 8 10 
SCAN-15 9 10 5 6 5 7 6 9 10 
SCAN-17 9 6 4 9 10 5 10 8 10 
SCAN-18 10 10 9 7 10 9 10 10 10 
SCAN-19 10 10 10 10 8 9 10 10 10 
SCAN-20 8 6 9 3 4 6 8 6 10 
SCAN-21 10 9 4 3 10 1 2 8 10 
SCAN-22 10 10 10 8 10 10 10 9 10 
SCAN-23 6 5 6 8 7 7 6 7 10 
SCAN-24 10 9 10 10 10 10 9 10 10 
SCAN-25 10 10 9 9 8 9 10 10 10 
SCAN-26 10 10 10 10 10 10 10 10 10 
SCAN-28 7 8 9 6 8 9 9 9 10 
SCAN-29 9 8 9 7 10 10 10 10 10 
SCAN-30 10 10 10 10 10 10 10 10 10 
SCAN-31 6 10 9 6 8 6 7 6 10 
SCAN-32 10 9 9 2 10 3 2 8 10 
SCAN-33 10 10 10 8 7 10 10 10 10 
SCAN-34 5 5 7 8 2 7 7 7 10 
SCAN-35 10 10 10 10 10 10 10 10 10 
SCAN-36 10 10 10 8 9 9 10 8 9 
SCAN-37 10 10 10 9 10 10 10 10 10 
SCAN-39 6 9 10 8 9 6 9 9 10 
SCAN-40 8 9 4 2 10 2 2 9 10 
 
Table 13; ASPECTS scores for hypodensity. First set. 
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CBV ML\100G MTT SEC CBF ML\100G\SEC 
ISODENSE 
SWELLING 
HYPOATT
ENUATED 
NORMAL ISODENSE 
SWELLING 
HYPOATT
ENUATED 
NORMAL ISODENSE 
SWELLING 
HYPOATT
ENUATED 
NORMAL 
10.0787 1.3952 21.3818 5.52483 4.96873 2.676942 35.281 14.0337 25.974 
10.3974 2.204 21.5996 6.33092 5.089803 2.720831 10.3974 4.1029 36.8785 
10.84 2.47 21.778 6.731104 5.285573 2.720831 25.7133 12.4043 27.4187 
11.5818 2.64 21.82 6.790278 5.285573 2.960313 26.5391 4.3642 27.2257 
12.0177 2.886 21.8777 6.827653 5.925401 3.80616 14.3522 5.7064 21.8777 
13.1 3.3188 22 6.84627 6.432465 4.169544 13.5213 2.886 32.7091 
13.1523 3.4451 22.6 7.210319 6.459025 4.240913 18.34 4.0405 33.8719 
13.19 3.8 23.2675 7.289161 6.629215 4.388145 17.7762 12.5324 29.3648 
13.2671 4.0405 23.46 7.338825 6.686583 4.423879 15.6833 8.8026 26.896 
13.4672 4.1029 23.543 7.37 7.164658 4.775658 12.0177 12.2352 21.3255 
13.5213 4.1058 23.5748 7.521145 7.703123 4.857464 17.548 4.9638 24.661 
13.82 4.166 23.582 7.79706 7.775641 4.96849 13.1523 4.1058 26.027 
13.9 4.2604 23.84 7.80836 8.697246 4.996959 14.3157 36.194 31.0087 
14.3157 4.3642 23.88 7.846077 8.949469 5.079731 19.9173 7.3055 13.7869 
14.3522 4.4801 24.5824 7.933903 9.164581 5.115944 20.2681 9.7488 19.3519 
14.4 4.5281 24.62 8.029411 9.22 5.131476 13.4672 7.65 21.3818 
14.6056 4.804 24.661 8.261903 9.414064 5.157775 19.656 10.8023 49.3971 
15 4.9638 25.1 8.751452 9.432243 5.278867 16.7603 3.3188 40.9325 
15.612 4.9794 25.2617 8.96131 9.537468 5.288792 13.2671 12.1419 37.1262 
15.6833 5.039 25.6644 9.056336 9.682783 5.294019 13.19 10.19 83.4675 
16.191 5.2 25.8 9.390996 10.118181 5.427859 13.82 8.75 16.3568 
16.1998 5.6 25.807 9.419049 10.13 5.43239 22.6 5.039 15.9132 
16.7603 5.7064 25.974 9.647521 10.218151 5.462219 18.55 3.8 26.8622 
16.788 5.7398 26.027 9.682783 10.228017 5.476491 20.3 2.64 12.7901 
17.548 6.1205 26.12 9.720539 10.291421 5.485181 13.9 5.6 13.07 
17.7762 6.143 26.1823 9.779921 10.318207 5.503384 30.97 5.2 15.2956 
18.34 6.1569 26.2 9.85 10.345099 5.504539 18.344 17.4 19.6184 
18.344 7.3055 26.26 9.991686 10.394518 5.527813 13.1 4.804 28.0735 
18.55 7.65 26.64 10.00919 10.6 5.550259 16.788 4.166 15.3641 
18.711 8.5382 26.8622 10.077245 10.881049 5.550831 10.0787 12.8725 17.3258 
19.656 8.75 26.896 10.08857 10.89241 5.568498 15 8.5382 13.224 
19.839 8.8026 27.2257 10.119399 10.991598 5.640055 14.4 9.482 20.3036 
19.9173 9.1926 27.4187 10.155788 11.164637 5.701114 18.711 2.47 34.5326 
20.2681 9.482 27.771 10.291421 11.197328 5.712409 23.1 3.4451 32.63 
20.3 9.7488 28.0735 10.316151 11.204567 5.712409 11.5818 5.7398 23.46 
21.0169 10.19 28.5 10.338224 11.307744 5.750449 34.1856 4.9794 18.8108 
21.4394 10.3163 29.3648 10.364828 11.41869 5.780079 23.5837 4.4801 17.8481 
22.6 10.76 30.16 10.889998 11.455635 5.80349 10.84 12.2891 20.83 
22.7 10.8023 31.0087 11.177371 11.579246 5.821829 14.6056 4.5281 19.683 
23.1 12.1419 32.03 11.41869 12.096177 5.833223 28.1922 6.1569 35.5415 
23.215 12.2352 32.6237 11.459434 12.178389 5.836774 16.1998 12.2952 32.8193 
23.5837 12.2891 32.63 11.552592 12.449391 5.928176 19.839 10.3163 20.289 
25.293 12.2952 32.7091 12.104215 12.655656 5.977395 16.191 10.76 35.158 
25.7133 12.4043 32.78 12.24752 12.733707 5.978883 21.0169 15.3431 21.5996 
26.5391 12.5324 32.8193 12.641343 13.017704 5.988234 21.4394 6.143 23.88 
28.1922 12.8725 33.8719 13.172432 13.373694 5.99 41.7056 4.2604 21.82 
30.97 13.368 34.5326 13.258983 13.386538 6.035621 31.5593 2.204 26.64 
31.5593 13.5393 35.158 13.575391 13.632531 6.044509 23.215 13.5393 24.5824 
34.1856 14.0337 35.317 13.802231 13.757729 6.0563 25.293 9.1926 18.92 
35.281 15.3431 35.346 14.167705 14.245719 6.05635 22.7 1.3952 15.81 
41.7056 17.4 35.5415 14.198427 14.693551 6.06 15.612 6.1205 32.6237 
 36.194 35.5851 14.291383 15.853109 6.082532  13.368 26.26 
  36.8785 16.95 19.41 6.087055   23.543 
  36.979   6.141673   32.03 
  37.1262   6.244808   12.208 
  40.8111   6.260478   35.317 
  40.9325   6.296417   16.167 
  41.485   6.296682   21.0207 
  49.3971   6.301333   10.06 
  83.4675   6.3033   23.582 
 
Table 14; Perfusion parameters for each NCCT appearance. 
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Figure 7: Scans analysis for consensus. Red dots; hypodensity. Green dots; 
isodense swelling. 
 
 
Figure 8: Scans of consensus. Red dots; hypodensity. green dots; isodense 
swelling. 
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Figure 9: Consensus analysis. Red arrow heads; hypodensity. Green arrows head; 
Isodense swelling. 
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Figure 10: Consensus analysis; red dots; hypodensity. green dots; isodense 
swelling. 
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Pairwise kappa tables 
 
 
Blinded set agreements ( without clinical 
data) 
Non-blinded set agreements ( with 
clinical data) 
Total 
ASPECTS 
Hypodensity Isodense 
swelling 
Total 
ASPECTS 
Hypodensity Isodense 
swelling 
-0.001 -0.069 -0.103 -0.042 -0.04 -0.277 
0.043 -0.043 -0.102 -0.04 0.01 -0.222 
0.052 0.044 -0.091 -0.038 0.01 -0.171 
0.058 0.046 -0.088 -0.009 0.03 -0.159 
0.067 0.073 -0.086 0.008 0.032 -0.153 
0.102 0.09 -0.077 0.03 0.033 -0.129 
0.136 0.098 -0.07 0.041 0.038 -0.118 
0.146 0.109 -0.064 0.055 0.042 -0.115 
0.151 0.146 -0.062 0.065 0.049 -0.107 
0.219 0.176 -0.061 0.087 0.061 -0.101 
0.231 0.197 -0.045 0.096 0.103 -0.089 
0.239 0.261 -0.014 0.154 0.13 -0.087 
0.259 0.268 0 0.193 0.177 -0.077 
0.261 0.288 0 0.368 0.195 -0.077 
0.415 0.351 0 0.403 0.211 -0.072 
0.456 0.364 0 0.404 0.272 -0.071 
0.477 0.383 0 0.426 0.281 -0.01 
0.509 0.402 0 0.429 0.288 -0.009 
0.52 0.413 0 0.48 0.38 -0.008 
0.528 0.444 0 0.516 0.432 -0.007 
0.56 0.448 0.033 0.517 0.438 0.032 
0.573 0.45 0.033 0.527 0.459 0.051 
0.579 0.478 0.102 0.549 0.466 0.063 
0.613 0.515 0.274 0.562 0.466 0.069 
0.641 0.571 0.308 0.58 0.479 0.07 
0.643 0.606 0.313 0.582 0.512 0.084 
0.644 0.615 0.333 0.606 0.564 0.175 
0.685 0.623 0.357 0.622 0.6 0.183 
0.722 0.63 0.43 0.632 0.613 0.256 
0.735 0.636 0.451 0.645 0.703 0.257 
0.756 0.686 0.483 0.673 0.739 0.334 
0.771 0.693 0.483 0.697 0.751 0.402 
0.783 0.725 0.611 0.709 0.762 0.402 
0.783 0.736 0.625 0.741 0.769 0.453 
0.825 0.786 0.669 0.755 0.795 0.478 
0.869 0.879 0.75 0.776 0.849 0.609 
 
Table 15: Pairwise kappa for each ASPECTS category when scans are blinded and 
non-blinded. 
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Full clinical data 
Minimum clinical data 
 
 
 
 
 
 
Total  Hypodensity 
Isodense 
swelling 
Total Hypodensity 
Isodense 
swelling 
-0.055 0.017 -0.25 -0.273 -0.253 -0.41 
-0.046 0.048 -0.177 -0.084 -0.119 -0.336 
-0.025 0.06 -0.143 -0.054 -0.06 -0.317 
-0.025 0.08 -0.131 -0.041 -0.059 -0.222 
-0.008 0.1 -0.116 -0.007 -0.057 -0.17 
0 0.154 -0.115 0.005 -0.034 -0.153 
0.023 0.157 -0.084 0.009 -0.024 -0.138 
0.151 0.166 -0.084 0.012 -0.02 -0.138 
0.19 0.175 0 0.058 -0.008 -0.138 
0.217 0.188 0 0.062 0.009 -0.135 
0.222 0.241 0 0.094 0.043 -0.13 
0.254 0.243 0 0.095 0.053 -0.128 
0.348 0.265 0 0.135 0.096 -0.124 
0.447 0.291 0 0.146 0.105 -0.115 
0.495 0.308 0 0.162 0.207 -0.109 
0.565 0.324 0 0.203 0.237 -0.105 
0.565 0.339 0 0.217 0.292 -0.088 
0.569 0.38 0 0.279 0.297 -0.078 
0.604 0.419 0 0.313 0.301 -0.022 
0.613 0.421 0 0.359 0.313 0.071 
0.633 0.448 0 0.441 0.387 0.072 
0.658 0.454 0 0.442 0.388 0.098 
0.658 0.525 0.006 0.503 0.396 0.108 
0.67 0.55 0.046 0.511 0.418 0.134 
0.671 0.556 0.051 0.514 0.491 0.138 
0.672 0.579 0.186 0.547 0.519 0.183 
0.682 0.652 0.197 0.561 0.62 0.195 
0.686 0.718 0.231 0.571 0.63 0.251 
0.692 0.727 0.273 0.621 0.667 0.295 
0.701 0.729 0.325 0.647 0.722 0.314 
0.715 0.73 0.328 0.682 0.722 0.315 
0.732 0.771 0.427 0.685 0.776 0.327 
0.754 0.776 0.548 0.751 0.781 0.546 
0.776 0.783 0.63 0.755 0.857 0.568 
0.789 0.789 0.667 0.76 0.879 0.65 
0.806 0.882 1 0.762 0.883 0.696 
 
Table 16: Pairwise kappa for each set of scans in relation to amount of clinical 
data  across the three categories of ASPECTS. 
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Thick slices scans (5mm) 
Thin slices scans (0.9mm) 
 
 
 
 
 
 
Total  Hypodensity 
Isodense 
swelling 
Total Hypodensity 
Isodense 
swelling 
0.053 0.067 -0.249 -0.144 -0.085 -0.168 
0.07 0.088 -0.161 -0.11 -0.062 -0.145 
0.071 0.089 -0.159 -0.084 -0.05 -0.136 
0.074 0.109 -0.148 -0.077 -0.044 -0.11 
0.09 0.114 -0.13 -0.041 -0.028 -0.106 
0.093 0.13 -0.125 -0.02 -0.028 -0.088 
0.201 0.184 -0.115 0 -0.024 -0.086 
0.208 0.222 -0.11 0.022 -0.013 -0.08 
0.354 0.266 -0.109 0.049 -0.004 -0.069 
0.393 0.288 -0.101 0.057 0 -0.068 
0.409 0.313 -0.096 0.088 0.027 -0.068 
0.422 0.368 -0.068 0.119 0.084 -0.052 
0.43 0.369 -0.036 0.167 0.149 -0.048 
0.437 0.377 -0.033 0.192 0.208 -0.047 
0.458 0.391 -0.017 0.197 0.266 -0.045 
0.499 0.395 -0.017 0.3 0.275 -0.022 
0.53 0.409 -0.016 0.412 0.277 -0.018 
0.561 0.453 -0.003 0.412 0.312 0.015 
0.626 0.499 0 0.423 0.363 0.016 
0.63 0.543 0 0.432 0.377 0.079 
0.655 0.565 0 0.444 0.394 0.089 
0.661 0.566 0 0.466 0.4 0.095 
0.663 0.585 0 0.468 0.411 0.099 
0.673 0.591 0 0.474 0.444 0.113 
0.677 0.62 0 0.538 0.45 0.114 
0.68 0.636 0 0.545 0.46 0.116 
0.682 0.638 0.126 0.565 0.476 0.246 
0.687 0.683 0.138 0.614 0.512 0.287 
0.694 0.705 0.168 0.641 0.555 0.348 
0.73 0.728 0.203 0.673 0.59 0.365 
0.734 0.741 0.249 0.698 0.613 0.432 
0.746 0.758 0.517 0.703 0.616 0.436 
0.76 0.78 0.636 0.719 0.684 0.506 
0.77 0.862 0.644 0.763 0.764 0.508 
0.832 0.862 0.665 0.764 0.798 0.535 
0.846 0.866 0.723 0.793 0.814 0.566 
 
Table 17: Pairwise kappa for scans with thick slices and scans with thin slices 
across the three categories of ASPECTS. 
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Scan’s set Total ASPECTS Hypodensity Isodense swelling 
Parameter APK CI* SD** variance APK CI* SD** variance APK CI* SD** variance 
Blinded 0.45 
0.35-
0.54 
0.27 0.0.74 0.39 
0.31-
0.48 
0.26 0.066 0.14 
0.06-
0.23 
0.26 0.068 
Non-
blinded 
0.38 
0.29-
0.48 
0.27 0.077 0.35 
0.26-
0.45 
0.28 0.079 0.051 
-
0.02-
0.12 
0.22 0.047 
t-test 
P value 
 
0.965 
 
0.34 
 
0.53 
 
0.62 
0.089 
 
1.72 
Full C\D 0.46 
0.35-
0.45 
0.29 0.086 0.42 
0.33-
0.51 
0.25 0.066 0.11 
0.02-
0.19 
0.26 0.071 
Minimum 
C\D 
 
0.32 
0.22-
0.42 
0.29 0.088 0.32 
0.21-
0.43 
0.33 0.11 0.05 
-
0.05-
0.14 
0.27 0.77 
t-test 
P value 
 
1.97 
 
0.05 
1.42 
 
0.16 
548.5* 
 
0.26 
Thick slices 0.50 
0.42-
0.58 
0.24 0.062 0.46 
0.38-
0.55 
0.24 0.061 
0.066 
 
-
0.02-
0.15 
0.25 0.065 
Thin slices 0.34 
0.24-
0.44 
0.29 0.088 0.31 
0.21-
0.39 
0.27 0.075 0.1 
0.02-
0.17 
0.22 0.049 
t-test 
P value 
 
2.51 
 
0.01 
2.64 
 
0.01 
-0.60 
 
0.55 
 
Table 18: Comparison of average pairwise kappa (APK) of each group of 
variables across the three ASPECTS’ categories. [ significance level is at P < 
0.05]. [ C\D clinical data, SD; standard deviation, CI; confidence interval] 
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Table 19: Pairwise kappa 
for each category of 
ASPECTS for trained and 
untrained groups of 
readers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total ASPECTS Hypodensity Isodense swelling 
Trained Untrained Trained Untrained Trained Untrained 
0.418 0.072 0.5 0.031 0.301 0.06 
0.446 0.587 0.273 0.588 0.473 0.356 
0.669 0.505 0.613 0.33 0.649 -0.115 
0.471 0.729 0.591 0.273 0.32 0.566 
0.603 0.225 0.519 0.472 0.477 -0.045 
0.656 0.559 0.633 0.213 0.419 -0.06 
0.649 0.731 0.523 0.305 0.629 0.544 
0.5 0.557 0.584 0.565 0.141 0.262 
0.422 -0.029 0.494 0.042 0.402 0.008 
0.213 0.601 -0.053 0.577 0.289 0.252 
0.406 0.438 0.035 0.316 0.335 -0.119 
0.117 0.537 -0.134 0.269 0.218 0.363 
0.339 0.383 0.098 0.538 0.449 0.147 
0.381 0.395 0.064 0.222 0.518 -0.188 
0.419 0.504 0.273 0.45 0.277 0.304 
0.18 0.02 0.106 0.051 0.109 0.026 
0.405 0.617 -0.002 0.555 0.254 0.457 
0.111 0.564 0.055 0.723 -0.027 -0.015 
0.259 0.796 0.11 0.701 0.208 0.435 
0.284 0.194 0.28 0.269 0.231 0.048 
0.386 0.602 -0.012 0.495 0.454 -0.053 
0.448 0.01 0.505 0.046 0.407 -0.053 
0.261 0.5 0.305 0.503 0.2 -0.084 
0.625 0.754 0.538 0.752 0.593 -0.108 
0.534 0.78 0.5 0.782 0.287 -0.083 
0.377 0.208 0.259 0.228 0.371 -0.075 
0.414 0.109 0.593 0.052 -0.035 -0.058 
0.209 0.539 0.266 0.541 0.47 0.259 
0.386 0.248 0.13 0.278 0.029 -0.134 
0.301 0.188 0.553 0.154 0.012 0.106 
0.265 0.048 0.391 0.033 -0.056 0.054 
0.419 0.521 0.428 0.534 0.135 0.479 
0.337 0.716 0.411 0.866 0.12 -0.135 
0.285 0.022 0.313 0.059 0.128 -0.05 
0.391 0.538 0.634 0.611 0.174 0.005 
0.471 0.064 0.352 0.133 0.589 -0.004 
0.71  0.493  0.492  
0.531  0.634  0.321  
0.597  0.428  0.465  
0.522  0.372  0.395  
0.34  0.565  0.188  
0.379  0.294  0.051  
0.559  0.561  0.296  
0.395  0.619  0.064  
0.594  0.622  0.343  
0.565  0.581  0.27  
0.428  0.038  0.65  
0.622  0.461  0.533  
0.452  0.479  0.144  
0.499  0.464  0.366  
0.329  0.224  0.354  
0.513  0.658  0.408  
0.438  0.472  0.346  
0.399  0.317  0.376  
0.143  0.286  0.066  
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Untrained 
Readers 
READE
R-1 
READER-
2 
READER-
3 
READER-
4 
READER-
5 
READER-
6 
READER-
7 
READER-
8 
READER-
9 
P
a
ir
w
is
e
 k
a
p
p
a
 0.072 -0.029 0.02 0.01 0.109 0.048 0.022 0.064 0.064 
0.587 0.601 0.617 0.5 0.539 0.521 0.538 0.538 0.022 
0.505 0.438 0.564 0.754 0.248 0.716 0.716 0.521 0.048 
0.729 0.537 0.796 0.78 0.188 0.188 0.248 0.539 0.109 
0.225 0.383 0.194 0.208 0.208 0.78 0.754 0.5 0.01 
0.559 0.395 0.602 0.602 0.194 0.796 0.564 0.617 0.02 
0.731 0.504 0.504 0.395 0.383 0.537 0.438 0.601 -0.029 
0.557 0.557 0.731 0.559 0.225 0.729 0.505 0.587 0.072 
APK 0.49 0.42 0.50 0.47 0.26 0.53 0.47 0.49 0.039 
Table 20: Pairwise kappa of each untrained reader on total ASPECTS with overall 
average [APK]. 
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0.418 0.406 0.284 0.209 0.391 0.34 0.565 0.499 0.438 0.143 0.143 
0.446 0.117 0.386 0.386 0.471 0.379 0.428 0.329 0.399 0.399 0.438 
0.669 0.339 0.448 0.301 0.71 0.559 0.622 0.513 0.513 0.329 0.499 
0.471 0.381 0.261 0.265 0.531 0.395 0.452 0.452 0.622 0.428 0.565 
0.603 0.419 0.625 0.419 0.597 0.594 0.594 0.395 0.559 0.379 0.34 
0.656 0.18 0.534 0.337 0.522 0.522 0.597 0.531 0.71 0.471 0.391 
0.649 0.405 0.377 0.285 0.285 0.337 0.419 0.265 0.301 0.386 0.209 
0.5 0.111 0.414 0.414 0.377 0.534 0.625 0.261 0.448 0.386 0.284 
0.422 0.259 0.422 0.5 0.405 0.18 0.419 0.381 0.339 0.117 0.406 
 0.213 0.213 0.422 0.5 0.649 0.656 0.603 0.471 0.669 0.446 0.418 
APK 0.50 0.28 0.42 0.37 0.49 0.45 0.53 0.41 0.50 0.35 0.37 
Table 21: Pairwise kappa of each trained reader on total ASPECTS with overall 
average [APK]. 
 
Untrained READER-
1 
READER-
2 
READER-
3 
READER-
4 
READER-
5 
READER-
6 
READER-
7 
READER-
8 
READER-
9 
P
a
irw
ise
 K
a
p
p
a
 
0.031 0.042 0.051 0.046 0.052 0.033 0.059 0.133 0.133 
0.588 0.577 0.555 0.503 0.541 0.534 0.611 0.611 0.059 
0.33 0.316 0.723 0.752 0.278 0.866 0.866 0.534 0.033 
0.273 0.269 0.701 0.782 0.154 0.154 0.278 0.541 0.052 
0.472 0.538 0.269 0.228 0.228 0.782 0.752 0.503 0.046 
0.213 0.222 0.495 0.495 0.269 0.701 0.723 0.555 0.051 
0.305 0.45 0.45 0.222 0.538 0.269 0.316 0.577 0.042 
0.565 0.565 0.305 0.213 0.472 0.273 0.33 0.588 0.031 
APK 0.35 0.37 0.44 0.41 0.32 0.45 0.49 0.50 0.055 
Table 22: Pairwise kappa of each untrained reader on hypodensity with overall 
average. 
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R
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R
-
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a
 
0.5 0.035 0.28 0.266 0.634 0.565 0.581 0.464 0.472 0.286 0.286 
0.273 -0.134 -0.012 0.13 0.352 0.294 0.038 0.224 0.317 0.317 0.472 
0.613 0.098 0.505 0.553 0.493 0.561 0.461 0.658 0.658 0.224 0.464 
0.591 0.064 0.305 0.391 0.634 0.619 0.479 0.479 0.461 0.038 0.581 
0.519 0.273 0.538 0.428 0.428 0.622 0.622 0.619 0.561 0.294 0.565 
0.633 0.106 0.5 0.411 0.372 0.372 0.428 0.634 0.493 0.352 0.634 
0.523 -0.002 0.259 0.313 0.313 0.411 0.428 0.391 0.553 0.13 0.266 
0.584 0.055 0.593 0.593 0.259 0.5 0.538 0.305 0.505 -0.012 0.28 
0.494 0.11 0.11 0.055 -0.002 0.106 0.273 0.064 0.098 -0.134 0.035 
-0.053 -0.053 0.494 0.584 0.523 0.633 0.519 0.591 0.613 0.273 0.5 
APK 0.47 0.05 0.36 0.37 0.40 0.46 0.44 0.44 0.47 0.17 0.41 
 
Table 23: Pairwise kappa of trained readers on hypodensity with overall 
average. 
 
 
Untrained READER-
1 
READER-
2 
READER-
3 
READER-
4 
READER-
5 
READER-
6 
READER-
7 
READER-
8 
READER-
9 
P
a
irw
ise
 K
a
p
p
a
 
0.06 0.008 0.026 -0.053 -0.058 0.054 -0.05 -0.004 -0.004 
0.356 0.252 0.457 -0.084 0.259 0.479 0.005 0.005 -0.05 
-0.115 -0.119 -0.015 -0.108 -0.134 -0.135 -0.135 0.479 0.054 
0.566 0.363 0.435 -0.083 0.106 0.106 -0.134 0.259 -0.058 
-0.045 0.147 0.048 -0.075 -0.075 -0.083 -0.108 -0.084 -0.053 
-0.06 -0.188 -0.053 -0.053 0.048 0.435 -0.015 0.457 0.026 
0.544 0.304 0.304 -0.188 0.147 0.363 -0.119 0.252 0.008 
0.262 0.262 0.544 -0.06 -0.045 0.566 -0.115 0.356 0.06 
APK 0.20 0.13 0.22 -0.088 0.031 0.22 -0.08 0.22 -0.002 
 
Table 24: Pairwise kappa untrained readers on isodense swelling with overall 
average. 
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0.301 0.335 0.231 0.47 0.174 0.188 0.27 0.366 0.346 0.066 0.066 
0.473 0.218 0.454 0.029 0.589 0.051 0.65 0.354 0.376 0.376 0.346 
0.649 0.449 0.407 0.012 0.492 0.296 0.533 0.408 0.408 0.354 0.366 
0.32 0.518 0.2 -0.056 0.321 0.064 0.144 0.144 0.533 0.65 0.27 
0.477 0.277 0.593 0.135 0.465 0.343 0.343 0.064 0.296 0.051 0.188 
0.419 0.109 0.287 0.12 0.395 0.395 0.465 0.321 0.492 0.589 0.174 
0.629 0.254 0.371 0.128 0.128 0.12 0.135 -0.056 0.012 0.029 0.47 
0.141 -0.027 -0.035 -0.035 0.371 0.287 0.593 0.2 0.407 0.454 0.231 
0.402 0.208 0.208 -0.027 0.254 0.109 0.277 0.518 0.449 0.218 0.335 
0.289 0.289 0.402 0.141 0.629 0.419 0.477 0.32 0.649 0.473 0.301 
APK 0.41 0.26 0.31 0.091 0.38 0.23 0.39 0.26 0.40 0.33 0.27 
 
Table 25: Pairwise kappa of trained readers on isodense swelling with overall 
average(APK). 
 
Untrained Reader-1 Reader-2 Reader-3 Reader-6 Reader-8 
P
a
irw
ise
 
k
a
p
p
a
 
0.587 0.601 0.617 0.521 0.521 
0.729 0.537 0.796 0.796 0.617 
0.731 0.504 0.504 0.537 0.601 
0.557 0.557 0.731 0.729 0.587 
APK 0.651 0.54975 0.662 0.64575 0.5815 
Table 26: Pairwise kappa of untrained readers after exclusion of outliers on 
total ASPECTS with overall average. 
 
Trained Reader-1 Reader-3 Reader-5 Reader-7 Reader-9 
P
a
irw
ise
 
k
a
p
p
a
 
0.669 0.448 0.71 0.622 0.622 
0.603 0.625 0.597 0.594 0.559 
0.656 0.377 0.522 0.597 0.71 
0.649 0.422 0.649 0.603 0.669 
APK 0.64425 0.468 0.6195 0.604 0.64 
 
Table 27: Pairwise kappa of trained readers after exclusion of outliers on total 
ASPECTS with overall average. 
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Untrained Reader-1 Reader-2 Reader-3 Reader-6 Reader-8 
P
a
irw
ise
 
k
a
p
p
a
 
0.588 0.577 0.555 0.534 0.534 
0.273 0.269 0.701 0.701 0.555 
0.305 0.45 0.45 0.269 0.577 
0.565 0.565 0.305 0.273 0.588 
APK 0.43275 0.46525 0.50275 0.44425 0.5635 
 
Table 28: Pairwise kappa of untrained readers after exclusion of outliers on 
hypodensity with overall average. 
 
Trained Reader-1 Reader-3 Reader-5 Reader-7 Reader-9 
P
a
irw
ise
 
k
a
p
p
a
 
0.613 0.505 0.493 0.461 0.461 
0.519 0.538 0.428 0.428 0.493 
0.523 0.259 0.259 0.538 0.505 
0.494 0.494 0.523 0.519 0.613 
APK 0.53725 0.449 0.42575 0.4865 0.518 
 
Table 29:Pairwise kappa of trained readers after exclusion of outliers on 
hypodensity with overall average. 
 
Untrained Reader-1 Reader-2 Reader-3 Reader-6 Reader-8 
P
a
irw
ise
 
k
a
p
p
a
 
0.356 0.252 0.457 0.479 0.479 
0.566 0.363 0.435 0.435 0.457 
0.544 0.304 0.304 0.363 0.252 
0.262 0.262 0.544 0.566 0.356 
APK 0.432 0.29525 0.435 0.46075 0.386 
 
Table 30: Pairwise kappa of untrained readers after exclusion of outliers on 
isodense swelling with overall average. 
 
 
 
Trained Reader-1 Reader-3 Reader-5 Reader-7 Reader-9 
P
a
irw
ise
 
k
a
p
p
a
 
0.649 0.407 0.492 0.533 0.533 
0.477 0.593 0.465 0.465 0.492 
0.629 0.371 0.371 0.593 0.407 
0.402 0.402 0.629 0.477 0.649 
APK 0.53925 0.44325 0.48925 0.517 0.52025 
 
Table 31: Pairwise kappa of trained readers after exclusion of outliers on 
isodense swelling with overall average. 
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Total ASPECTS Hypodensity Isodense swelling 
Pre-training Post-training Pre-training Post-training Pre-training Post-training 
0.395 0.111 0.213 -0.053 -0.188 -0.035 
0.504 0.18 0.222 0.055 -0.083 -0.027 
0.537 0.213 0.269 0.106 -0.06 0.109 
0.557 0.259 0.273 0.11 -0.053 0.12 
0.559 0.337 0.305 0.411 0.262 0.141 
0.602 0.414 0.45 0.494 0.304 0.208 
0.729 0.422 0.495 0.5 0.363 0.287 
0.731 0.5 0.565 0.584 0.435 0.289 
0.78 0.534 0.701 0.593 0.544 0.402 
0.796 0.656 0.782 0.633 0.566 0.419 
Table 32: Pairwise kappa of  same readers before and after training for each 
ASPECTS category. 
 
READER-
A1 
READER-
A2 
READER-
B1 
READER-
B2 
READER-
C1 
READER-
C2 
READER-
D1 
READER-
D2 
READER-
E1 
READER-
E2 
0.729 0.656 0.557 0.18 0.731 0.534 0.559 0.337 0.559 0.337 
0.78 0.5 0.395 0.111 0.602 0.414 0.602 0.414 0.731 0.534 
0.796 0.422 0.504 0.259 0.504 0.422 0.395 0.111 0.557 0.18 
0.537 0.213 0.537 0.213 0.796 0.422 0.78 0.5 0.729 0.656 
0.273 0.633 0.565 0.106 0.305 0.5 0.213 0.411 0.213 0.411 
0.782 0.584 0.222 0.055 0.495 0.593 0.495 0.593 0.305 0.5 
0.701 0.494 0.45 0.11 0.45 0.11 0.222 0.055 0.565 0.106 
0.269 -0.053 0.269 -0.053 0.701 0.494 0.782 0.584 0.273 0.633 
0.566 0.419 0.262 0.109 0.544 0.287 -0.06 0.12 -0.06 0.12 
-0.083 0.141 -0.188 -0.027 -0.053 -0.035 -0.053 -0.035 0.544 0.287 
0.435 0.402 0.304 0.208 0.304 0.208 -0.188 -0.027 0.262 0.109 
0.363 0.289 0.363 0.289 0.435 0.402 -0.083 0.141 0.566 0.419 
Table 33: Pairwise kappa of each reader before and after training for each 
ASPECTS category. (1) pre training (2) post training. 
 
 
Total ASPECTS Hypodensity Isodense swelling 
Neuroradiologists Stroke 
neurologists 
Neuroradiologists Stroke 
neurologists 
Neuroradiologists Stroke 
neurologists 
0.143 0.669 0.266 0.613 0.47 0.649 
0.391 0.471 0.13 0.591 0.029 0.32 
0.471 0.603 0.313 0.519 0.128 0.477 
0.209 0.656 0.634 0.633 0.174 0.419 
0.386 0.422 0.352 0.494 0.589 0.402 
0.285 0.213 0.286 -0.053 0.066 0.289 
 0.513  0.658  0.533 
 0.339  0.098  0.144 
 0.381  0.064  0.407 
 0.419  0.273  0.2 
 0.18  0.106  0.593 
 0.259  0.11  0.287 
 0.622  0.461  0.296 
 0.452  0.479  0.064 
 0.448  0.505  0.343 
 0.261  0.305  0.449 
 0.625  0.538  0.518 
 0.534  0.5  0.277 
 0.559  0.561  0.109 
 0.395  0.619  0.208 
 0.594  0.613  0.408 
 
Table 34: Pairwise kappa in each ASPECTS category for neuroradiologists and 
stroke physicians. 
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Stroke neurologists 
Total ASPECTS Hypodensity Isodense swelling 
Trained Untrained Trained Untrained Trained Untrained 
0.587, 0.601, 
0.617 
0.729, 0.537, 
0.796 
0.225, 0.383, 
0.194 
0.731, 0.504, 
0.557, 0.539, 
0.521, 0.188, 
 
0.669, 0.339, 
0.448 
0.471, 0.381, 
0.261 
0.603, 0.419, 
0.625 
0.656, 0.18, 
0.534 
0.422, 0.259, 
0.559 
0.213, 0.622, 
0.395 
0.513, 0.452, 
0.594 
 
0.588, 0.577, 
0.555 
0.273, 0.269, 
0.701 
0.472, 0.538, 
0.269 
0.305, 0.45, 
0.565, 0.541, 
0.534, 0.154, 
 
0.613, 0.098, 
0.505 
0.591, 0.064, 
0.305 
0.519, 0.273, 
0.538 
0.633, 0.106, 0.5 
0.494, 0.11, 
0.561 
-0.053, 0.461, 
0.619 
0.658, 0.479, 
0.622 
 
 
0.356, 0.252 
0.566, 0.363 
-0.045, 0.147 
0.544, 0.304 
0.262, 0.479 
0.457, 0.259 
0.435, 0.106 
0.048, 
 
0.649, 0.2, 0.277 
0.32, 0.593, 
0.109 
0.477, 0.287, 
0.208 
0.419, 0.296, 
0.408 
0.402, 0.064, 
0.289, 0.343, 
0.533, 0.449, 
0.144, 0.518, 
0.407, , 
 
 
Table 35: Pairwise kappa of stroke neurologists for each ASPECTS category 
before and after training. 
 
 
 Neuroradiologists* Stroke neurologists** 
Parameter Trained Untrained P 
Value 
Trained Untrained P value 
Total ASPECTS 11.67 21 0.13 0.46 0.51 >0.05 
Hypodensity 11.50 20 0.13 0.41 0.45 >0.05 
Isodense 
swelling 
8.33 0 0.13 0.35 0.30 >0.05 
 
Table 36:  Comparison of average pairwise kappa between different specialities 
before and after training. 
 
 
Experts 
Total ASPECTS Hypodensity Isodense swelling 
Trained Untrained Trained Untrained Trained Untrained 
0.649, 0.285 
0.5, 0.405 
0.422, 0.111 
0.213, 0.259 
, 0.377 
, 0.414 
 
0.438, 0.564 
0.537, 0.796 
0.395, 0.602 
0.504, 0.754 
0.716, 0.78 
 
0.523, 0.584, 
0.494, -0.053 
,0.313, -0.002 
0.055,0.11 
,0.259 
,0.593 
 
0.316, 0.723 
0.269, 0.701 
0.222, 0.495 
0.45, 0.752 
0.866, 0.782 
 
0.629, 0.254 
0.141, -0.027 
0.402, 0.208 
0.289, 0.371 
0.128, -0.035 
 
-0.119, -0.015, 
0.363, 0.435, 
-0.188, -0.053, 
0.304, -0.108, 
-0.135, -0.083, 
, , 
 
 
Table 37: Pairwise kappa of trained and untrained expert readers for each 
ASPECTS category. 
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Trainees 
Total ASPECTS Hypodensity Isodense swelling 
Trained Untrained Trained Untrained Trained Untrained 
0.34, 0.565, 
0.499 
0.379, 0.428, 
0.329 
0.559, 0.622, 
0.513 
0.395, 0.452, 
0.594, 0.438, 
0.143, 0.399, 
 
0.064, 0.539 
0.109, 0.587 
0.072, 0.225 
 
 
0.565, 0.581, 
0.464 
0.294, 0.038, 
0.224 
0.561, 0.461, 
0.658 
0.619, 0.479, 
0.622, 0.472, 
0.286, 0.317, 
 
0.541, 0.133 
0.588, 0.052 
0.472, 0.031 
 
0.188, 0.27, 
0.366 
0.051, 0.65, 
0.354 
0.296, 0.533, 
0.408 
0.064, 0.144, 
0.343, 0.346, 
0.066, 0.376, 
0.259, -0.004 
0.356, -0.058 
-0.045, 0.06 
 
 
Table 38: Pairwise kappa of trained and untrained trainee readers for each 
ASPECTS category. 
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Recommendations by examiners for correction of this thesis; 
1- Spelling and sentences composition corrections. 
2- Addition of IST-III study to thrombolytic therapy section. 
3- More information on how choosing the appropriate literature for literature 
review. 
4- Explanation of absence of assessment of effect of other factors on 
agreement as old strokes and also absence of standard. 
5- The broad assessment of agreement needs to be mentioned in 
conclusions. 
 
